| value | count | graph |
|---|
| HeLa | 3 | ************************************************************ |
| HeLa S3 | 3 | ************************************************************ |
| Caco-2 | 3 | ************************************************************ |
| Jurkat | 3 | ************************************************************ |
| HeLa cell | 3 | ************************************************************ |
| Hep G2 | 3 | ************************************************************ |
| Daudi | 3 | ************************************************************ |
| HeLa cells | 3 | ************************************************************ |
| Saos-2 | 3 | ************************************************************ |
| Osa-Cl | 3 | ************************************************************ |
| Ntera-2 | 3 | ************************************************************ |
| Raji | 3 | ************************************************************ |
| BjAB | 3 | ************************************************************ |
| HuT78 | 3 | ************************************************************ |
| Namalwa | 3 | ************************************************************ |
| YUSITI | 3 | ************************************************************ |
| MANCA | 3 | ************************************************************ |
| C2C12 | 3 | ************************************************************ |
| N2A | 3 | ************************************************************ |
| RIN-m-5F | 3 | ************************************************************ |
| Ax2 | 2 | **************************************** |
| Ax4 | 2 | **************************************** |
| Sf9 | 2 | **************************************** |
| Bge | 2 | **************************************** |
| Schneider cells | 2 | **************************************** |
| SF-21 | 2 | **************************************** |
| E.coli | 2 | **************************************** |
| Madin-Darby Canine Kidney (MDCK) | 2 | **************************************** |
| CCl64 | 2 | **************************************** |
| Ptk-2 | 2 | **************************************** |
| HL-60 | 2 | **************************************** |
| Madin-Darby canine Kidney | 2 | **************************************** |
| MADIN-DARBY BOVINE KIDNEY | 2 | **************************************** |
| C-9 | 2 | **************************************** |
| tobacco BY-2 | 2 | **************************************** |
| me-1 | 2 | **************************************** |
| plant line S29 | 2 | **************************************** |
| Chinese spring | 2 | **************************************** |
| E.coli XL1-Blue | 2 | **************************************** |
| E.coli Y1090 | 2 | **************************************** |
| Columbia | 2 | **************************************** |
| XL1-Blue | 2 | **************************************** |
| HT-1080 | 2 | **************************************** |
| HepG2 | 2 | **************************************** |
| Vero | 2 | **************************************** |
| lymphoblastoid | 2 | **************************************** |
| K562 | 2 | **************************************** |
| MCF-7 | 2 | **************************************** |
| Molt4 | 2 | **************************************** |
| Cos7 | 2 | **************************************** |
| NALM6 | 2 | **************************************** |
| Colo 205 | 2 | **************************************** |
| MG63 | 2 | **************************************** |
| HUT 78 | 2 | **************************************** |
| MKN45 | 2 | **************************************** |
| MCF7 | 2 | **************************************** |
| CFPAC-1 | 2 | **************************************** |
| HeLaS3 | 2 | **************************************** |
| LNCaP | 2 | **************************************** |
| Caco2 | 2 | **************************************** |
| CEM | 2 | **************************************** |
| HaCaT | 2 | **************************************** |
| COS-1 | 2 | **************************************** |
| B-cell | 2 | **************************************** |
| Jurkat T cell | 2 | **************************************** |
| MOLT-4 | 2 | **************************************** |
| FRhK-4 | 2 | **************************************** |
| JAR | 2 | **************************************** |
| DAKIKI | 2 | **************************************** |
| EBV | 2 | **************************************** |
| Saos-2/B10 | 2 | **************************************** |
| Caco2-bbe | 2 | **************************************** |
| Meg-01 | 2 | **************************************** |
| Nu-6-1 | 2 | **************************************** |
| Ramos | 2 | **************************************** |
| Panc1 | 2 | **************************************** |
| Nalm-6 | 2 | **************************************** |
| Caki-1 | 2 | **************************************** |
| Reh | 2 | **************************************** |
| HSC93 | 2 | **************************************** |
| Therad 7 (59/19.59) | 2 | **************************************** |
| Colo 320 | 2 | **************************************** |
| SK-MEL-28 | 2 | **************************************** |
| Daudi Burkitt lymphoma | 2 | **************************************** |
| KATOIII | 2 | **************************************** |
| NALM 6 | 2 | **************************************** |
| Hep-2 | 2 | **************************************** |
| MIA-PaCa-2 | 2 | **************************************** |
| HuH-7 | 2 | **************************************** |
| KATO-III | 2 | **************************************** |
| NTera2D1 | 2 | **************************************** |
| LX-1 | 2 | **************************************** |
| AGS | 2 | **************************************** |
| Hut-78 | 2 | **************************************** |
| Ek | 2 | **************************************** |
| VAVY | 2 | **************************************** |
| CTL 29S15 | 2 | **************************************** |
| human-mouse trioma cell line | 2 | **************************************** |
| KRC103 | 2 | **************************************** |
| LOUCKES | 2 | **************************************** |
| hybridoma | 2 | **************************************** |
| NTera2/D1 | 2 | **************************************** |
| Hela cervical carcinoma | 2 | **************************************** |
| heterohybridoma:46E7 | 2 | **************************************** |
| Fom-A | 2 | **************************************** |
| Human placenta | 2 | **************************************** |
| WI38 human fibroblast (ATCC) | 2 | **************************************** |
| human PBL | 2 | **************************************** |
| DE5 | 2 | **************************************** |
| PATU 8988s | 2 | **************************************** |
| WEHI-3 | 2 | **************************************** |
| CHO-K1 | 2 | **************************************** |
| WEHI231 | 2 | **************************************** |
| RAW264.7 | 2 | **************************************** |
| RINm5F | 2 | **************************************** |
| chinese hamster ovary cell | 2 | **************************************** |
| Nb2-Sp | 2 | **************************************** |
| BALB/c 3T3 | 2 | **************************************** |
| EL4 | 2 | **************************************** |
| bEND.3 | 2 | **************************************** |
| BTC3 | 2 | **************************************** |
| ATT-20 | 2 | **************************************** |
| ANA-1 | 2 | **************************************** |
| P388D1 | 2 | **************************************** |
| Murine Erythroleukemia Cell GM0086E | 2 | **************************************** |
| Swiss 3T3 | 2 | **************************************** |
| P3x63-Ag8.653 | 2 | **************************************** |
| H9c2 | 2 | **************************************** |
| Rat-1 | 2 | **************************************** |
| sp2/0 | 2 | **************************************** |
| Ob1771 | 2 | **************************************** |
| MDCT | 2 | **************************************** |
| Mikbeta1 | 2 | **************************************** |
| B6SutA | 2 | **************************************** |
| hepa-1c1c7 | 2 | **************************************** |
| BTC-1 | 2 | **************************************** |
| Fao | 2 | **************************************** |
| KiSV-MC4w | 2 | **************************************** |
| RAT1A | 2 | **************************************** |
| embryonal carcinoma cell line | 2 | **************************************** |
| Nb2-11C | 2 | **************************************** |
| Neuro2A | 2 | **************************************** |
| lambda GT10 | 2 | **************************************** |
| RBL-1 (mucosal mast cell like) | 2 | **************************************** |
| Ehrlich Ascites Tumor | 2 | **************************************** |
| hybridoma (x63-Ag8.165 x spleen cells) | 2 | **************************************** |
| X63-Ag8.653 X BALB /c spleen | 2 | **************************************** |
| 11.1B/C | 2 | **************************************** |
| 11.4B/c | 2 | **************************************** |
| 14f1.1 | 2 | **************************************** |
| Epithelioma papulosum cyprini | 2 | **************************************** |
| n/a | 1 | ******************** |
| P39 | 1 | ******************** |
| Q13 | 1 | ******************** |
| RO2J T-lymphoma | 1 | ******************** |
| NB4 | 1 | ******************** |
| 11-18 | 1 | ******************** |
| ATCC CRL-2772 | 1 | ******************** |
| BY-2 | 1 | ******************** |
| GB3 | 1 | ******************** |
| CRL-1669 BCL1 Clone 13.20-3B3 | 1 | ******************** |
| CRL-2070 NE | 1 | ******************** |
| RCB-1283 B16 melanoma | 1 | ******************** |
| RCB-0559 K-1 . F1 | 1 | ******************** |
| RCB-0035 WEHI-3 | 1 | ******************** |
| RCB-0464 Meth-A | 1 | ******************** |
| RCB-0544 MBT-2 | 1 | ******************** |
| CCL-142 RAG | 1 | ******************** |
| CRL-1734 SCA-9 clone 15 | 1 | ******************** |
| CRL-2116 JC | 1 | ******************** |
| RCB-0545 OHTA | 1 | ******************** |
| RCB-0549 Cle-H3 | 1 | ******************** |
| CRL-1751 WEHI 164 | 1 | ******************** |
| CRL-1443 BC3H1 | 1 | ******************** |
| CRL-2065 MLTC-1 | 1 | ******************** |
| CRL-2028 SR-4987 | 1 | ******************** |
| CRL-1702 WEHI 231 | 1 | ******************** |
| RCB-0558 LLC | 1 | ******************** |
| RCB-0526 Jyg-MC(A) | 1 | ******************** |
| RCB-0527 Jyg-MC(B) | 1 | ******************** |
| CRL-1722 L5178Y-R | 1 | ******************** |
| TIB-55 BB88 | 1 | ******************** |
| UNDEFINED_CELL_LINE | 1 | ******************** |
| mixture of B16-F10Y and melan-c | 1 | ******************** |
| NB69 | 1 | ******************** |
| GI1 | 1 | ******************** |
| H4 | 1 | ******************** |
| IMR32 | 1 | ******************** |
| NT2 | 1 | ******************** |
| SK-N-SH | 1 | ******************** |
| TF-1 | 1 | ******************** |
| NB9 | 1 | ******************** |
| SK-N-MC | 1 | ******************** |
| R1 ES cells | 1 | ******************** |
| 9-15-C cells | 1 | ******************** |
| HL60 | 1 | ******************** |
| pool of RNA from Jurkat (ATCC No. TIB-152), HepG2 (ATCC No. HTB-8065), FHs 738Lu (ATCC No. HTB-157 ), U87MG (ATCC No. HTB-14) | 1 | ******************** |
| HepG2 (ATCC No. HTB-8065) | 1 | ******************** |
| NIH-Sape 4 | 1 | ******************** |
| Schneider L2 cell | 1 | ******************** |
| Schneiders L2 cell | 1 | ******************** |
| Kc167 | 1 | ******************** |
| NIH-Sape-4 | 1 | ******************** |
| Schneider | 1 | ******************** |
| BmN | 1 | ******************** |
| YC | 1 | ******************** |
| HM1:IMSS | 1 | ******************** |
| R1072 | 1 | ******************** |
| Ax-2 | 1 | ******************** |
| NSC-HyCu15B | 1 | ******************** |
| S2 | 1 | ******************** |
| T9 isolate | 1 | ******************** |
| 777 | 1 | ******************** |
| D3-I | 1 | ******************** |
| LENIN | 1 | ******************** |
| IL3000 | 1 | ******************** |
| Sua5.1* | 1 | ******************** |
| NISES-BoMo-OH | 1 | ******************** |
| NISES-BoMo-Cam1 | 1 | ******************** |
| AI35 | 1 | ******************** |
| NIAS-AeAl-2 | 1 | ******************** |
| IL2343 | 1 | ******************** |
| hermaphroditic clonal line CIWsx2 | 1 | ******************** |
| DAE15 | 1 | ******************** |
| MOS55 | 1 | ******************** |
| C710 | 1 | ******************** |
| AP61 | 1 | ******************** |
| Schneider 2 (S2) | 1 | ******************** |
| NTU-MV | 1 | ******************** |
| Kc(7E10) | 1 | ******************** |
| V121 | 1 | ******************** |
| Schneider S2 | 1 | ******************** |
| embryonic Bge | 1 | ******************** |
| serodeme cell line | 1 | ******************** |
| E.coli JM101 w/pcMC17 | 1 | ******************** |
| R. Kessin | 1 | ******************** |
| 18 hrs. post immunization | 1 | ******************** |
| ovotestis | 1 | ******************** |
| lambda-gt11 | 1 | ******************** |
| DH-alpha | 1 | ******************** |
| Benzimidazole sensitive | 1 | ******************** |
| V-12M-2 | 1 | ******************** |
| female sterile line 3987 | 1 | ******************** |
| clone W2MEF | 1 | ******************** |
| Drosophila Kc-derived 167 cell line | 1 | ******************** |
| Kc 7E10 | 1 | ******************** |
| Kc | 1 | ******************** |
| TaA2/D7 | 1 | ******************** |
| mbn-2 | 1 | ******************** |
| Kc0 | 1 | ******************** |
| l(2)mbn | 1 | ******************** |
| Schneider II | 1 | ******************** |
| Kc cells | 1 | ******************** |
| Kc cell | 1 | ******************** |
| SB2040 | 1 | ******************** |
| MH-1 | 1 | ******************** |
| 67(3)-X, 5(20)-IV | 1 | ******************** |
| Oregon P2 | 1 | ******************** |
| venom gland | 1 | ******************** |
| Kauvar's 0-3 hrs embryo | 1 | ******************** |
| N2 | 1 | ******************** |
| protoscolex | 1 | ******************** |
| squid optic lobe | 1 | ******************** |
| (E. coli) Y1090 cells | 1 | ******************** |
| (E.coli) Y1090 cells | 1 | ******************** |
| AX | 1 | ******************** |
| venom gland tissue mRNA | 1 | ******************** |
| photoreceptor cell | 1 | ******************** |
| BENat 1 | 1 | ******************** |
| BENat 1.2 | 1 | ******************** |
| BENat 1.3 | 1 | ******************** |
| HM-1:1MSS | 1 | ******************** |
| SAW142 | 1 | ******************** |
| HM-1:IMSS | 1 | ******************** |
| SAW 142 | 1 | ******************** |
| D7 | 1 | ******************** |
| E.coli DH5 alpha | 1 | ******************** |
| ITMAP 263 | 1 | ******************** |
| epithelial | 1 | ******************** |
| DH-33 | 1 | ******************** |
| M3 | 1 | ******************** |
| IPLB-Sf21-AE | 1 | ******************** |
| l(2) mbn | 1 | ******************** |
| l2mbn | 1 | ******************** |
| C7-10 | 1 | ******************** |
| Aag-2 | 1 | ******************** |
| HU-1062 | 1 | ******************** |
| Aag2 | 1 | ******************** |
| C9.1; clonal line derived from MO7 clonal line | 1 | ******************** |
| TN-368 | 1 | ******************** |
| cultured S2 | 1 | ******************** |
| 427 | 1 | ******************** |
| N | 1 | ******************** |
| Schneider line 2 | 1 | ******************** |
| TC 221 | 1 | ******************** |
| SL2 | 1 | ******************** |
| C6/36 | 1 | ******************** |
| syngen 1, 69(1)-VII | 1 | ******************** |
| 69 (1)-VII | 1 | ******************** |
| 69(1)-VII | 1 | ******************** |
| Schneider's S2 cells | 1 | ******************** |
| Schneider cell line 2 (SL2) | 1 | ******************** |
| TaA1272 | 1 | ******************** |
| TaA3H4H | 1 | ******************** |
| TaA 288 | 1 | ******************** |
| UM-BGE-1 | 1 | ******************** |
| EATRO 2340 | 1 | ******************** |
| K-Ax3 | 1 | ******************** |
| DAE100 | 1 | ******************** |
| Bge cells | 1 | ******************** |
| IDE8 | 1 | ******************** |
| isolate VA-2 (P-1) | 1 | ******************** |
| isolate LA-10-1 | 1 | ******************** |
| Sua1B | 1 | ******************** |
| CCL-125 | 1 | ******************** |
| ASE cells | 1 | ******************** |
| Tn5 | 1 | ******************** |
| Ld | 1 | ******************** |
| high five (BTI-TN-5BI-4) | 1 | ******************** |
| IAL-PID2 | 1 | ******************** |
| CH1 | 1 | ******************** |
| High Five | 1 | ******************** |
| ATCC 50148 | 1 | ******************** |
| 3D7 | 1 | ******************** |
| CF203 | 1 | ******************** |
| BTI-Tn-5B1-4 | 1 | ******************** |
| ASE-IV | 1 | ******************** |
| normalized Head pF1c-1 | 1 | ******************** |
| SICII (GM1) | 1 | ******************** |
| primary culture from trochophore larvae | 1 | ******************** |
| Schneider 2 | 1 | ******************** |
| TaIM | 1 | ******************** |
| sexual clonal line CIWsx2 | 1 | ******************** |
| TU291 | 1 | ******************** |
| C34 | 1 | ******************** |
| ME49 | 1 | ******************** |
| Schneider's Drosophila Line 2 (SL2) | 1 | ******************** |
| IPLB-LdFB; fat body cell line | 1 | ******************** |
| C6/36 (Igarashi) | 1 | ******************** |
| 4a3A | 1 | ******************** |
| H446 | 1 | ******************** |
| primary osteoclast | 1 | ******************** |
| cultured T cells | 1 | ******************** |
| 3201 | 1 | ******************** |
| primary | 1 | ******************** |
| HTLV-1-transformed T-cell line B761-3 | 1 | ******************** |
| PtK2 | 1 | ******************** |
| PK15 | 1 | ******************** |
| MDCK | 1 | ******************** |
| LuMC | 1 | ******************** |
| LLC-PK1 cells | 1 | ******************** |
| F647a | 1 | ******************** |
| B405 | 1 | ******************** |
| KSH5b | 1 | ******************** |
| adriamycin-resistant subline of FT-1 | 1 | ******************** |
| LPS-stimulated PBMC | 1 | ******************** |
| HTLV-I-transformed T cell line | 1 | ******************** |
| LPS-stimulated CRFK | 1 | ******************** |
| HTS-1 | 1 | ******************** |
| CRFK | 1 | ******************** |
| GL-DOX4000 | 1 | ******************** |
| FT1 | 1 | ******************** |
| FT-1 | 1 | ******************** |
| HOS | 1 | ******************** |
| MDBK | 1 | ******************** |
| bovine endometrial cell | 1 | ******************** |
| GL-1 | 1 | ******************** |
| CL-1 | 1 | ******************** |
| bovine intramuscular preadipocyte (BIP cell) | 1 | ******************** |
| CM-MC | 1 | ******************** |
| LLC-PK1 | 1 | ******************** |
| MYA-1 | 1 | ******************** |
| Crandell-Rees feline kidney | 1 | ******************** |
| primary chondrocytes | 1 | ******************** |
| PHeSC-A1 | 1 | ******************** |
| Spleen | 1 | ******************** |
| BL2C7 | 1 | ******************** |
| BL4H9 | 1 | ******************** |
| BL5H4 | 1 | ******************** |
| BL7B7 | 1 | ******************** |
| BL7G1 | 1 | ******************** |
| BAEC | 1 | ******************** |
| L3CT | 1 | ******************** |
| SCC 2/88 | 1 | ******************** |
| MDBK (Madin Darby Bovine Kidney); ATCC CCL-22 | 1 | ******************** |
| Shimozuma-1; malignant lymphoma derived cell line | 1 | ******************** |
| PK-15 | 1 | ******************** |
| BL20 | 1 | ******************** |
| immortalized L45s of T cell lineage | 1 | ******************** |
| FL4 | 1 | ******************** |
| BR mastocytoma | 1 | ******************** |
| trachea cell line | 1 | ******************** |
| RS-2 | 1 | ******************** |
| 3201B | 1 | ******************** |
| Madin-Darby bovine kidney (MDBK) | 1 | ******************** |
| bovine aortic endothelial cell | 1 | ******************** |
| OK | 1 | ******************** |
| H276 | 1 | ******************** |
| H34-26 | 1 | ******************** |
| H315 | 1 | ******************** |
| M9 | 1 | ******************** |
| P4 | 1 | ******************** |
| F41 | 1 | ******************** |
| K6 | 1 | ******************** |
| DH82 | 1 | ******************** |
| K1 | 1 | ******************** |
| CPA47 | 1 | ******************** |
| corneal endothelial | 1 | ******************** |
| Crandell feline kidney (CRFK) cells | 1 | ******************** |
| IPI-2I | 1 | ******************** |
| RK-13 | 1 | ******************** |
| LLC-PK1 porcine kidney epithelial | 1 | ******************** |
| RS2 | 1 | ******************** |
| MDCK-C7 | 1 | ******************** |
| granulosa | 1 | ******************** |
| CD8 | 1 | ******************** |
| Madin-Darby canine kidney cells; MDCK | 1 | ******************** |
| hemangiosarcoma | 1 | ******************** |
| HIG-82 | 1 | ******************** |
| DH 82 | 1 | ******************** |
| G355-5 | 1 | ******************** |
| AH927 | 1 | ******************** |
| Madin-Darby canine kidney; MDCK | 1 | ******************** |
| BL3 | 1 | ******************** |
| primary lymphocyte | 1 | ******************** |
| Madin-Darby ATCC Number: CCL-22 | 1 | ******************** |
| TpMD409 | 1 | ******************** |
| TpM803 | 1 | ******************** |
| Thei | 1 | ******************** |
| B-sarcoma | 1 | ******************** |
| TBL3 | 1 | ******************** |
| EqG3 | 1 | ******************** |
| OK cells | 1 | ******************** |
| articular chondrocytes | 1 | ******************** |
| AFRC CR2 | 1 | ******************** |
| IMCE28 | 1 | ******************** |
| IMCE12 | 1 | ******************** |
| IMCE3 | 1 | ******************** |
| PigMel | 1 | ******************** |
| LK98 | 1 | ******************** |
| IBRS2 | 1 | ******************** |
| RK | 1 | ******************** |
| mesangioblast | 1 | ******************** |
| NBL-1 | 1 | ******************** |
| SCCF1 | 1 | ******************** |
| KO-1; derived from cat naturally infected with feline leukemia virus | 1 | ******************** |
| MDCK; ATCC CCL 34 | 1 | ******************** |
| N/N1003A | 1 | ******************** |
| BL-3 | 1 | ******************** |
| Madin-Darby | 1 | ******************** |
| CDV strain Onderstepoort-infected DH82 | 1 | ******************** |
| MDCK-II | 1 | ******************** |
| Madin Darby Canine Kidney (MDCK) epithelial cells | 1 | ******************** |
| DH82; ATCC CRL-10389 | 1 | ******************** |
| OKP | 1 | ******************** |
| DH82 (CDV-infected, strain Onderstepoort) | 1 | ******************** |
| PK-15 stimulated with poly-inosinic poly-cytidylic acid | 1 | ******************** |
| peripheral blood mononuclear cell | 1 | ******************** |
| 104-C1 | 1 | ******************** |
| Mv 1 Lu; ATCC CCL-64 | 1 | ******************** |
| FGL | 1 | ******************** |
| F02 | 1 | ******************** |
| LMC | 1 | ******************** |
| BL2M3 | 1 | ******************** |
| pp25 | 1 | ******************** |
| KSH-5a | 1 | ******************** |
| BLT2 | 1 | ******************** |
| BTL-PC3 | 1 | ******************** |
| BLSC-KU-1 | 1 | ******************** |
| F648b | 1 | ******************** |
| FeLV A (Glasgow-A) | 1 | ******************** |
| PAE | 1 | ******************** |
| BLSC-KU1 | 1 | ******************** |
| NM514 | 1 | ******************** |
| CMT12 | 1 | ******************** |
| CMT27 | 1 | ******************** |
| CMT28 | 1 | ******************** |
| putative embryonic stem cell | 1 | ******************** |
| kidney OK cell line | 1 | ******************** |
| RCE1 | 1 | ******************** |
| PK(15) | 1 | ******************** |
| Fc2Lu | 1 | ******************** |
| MDCK (Madin Darby canine kidney cell) | 1 | ******************** |
| TaA288 | 1 | ******************** |
| IB-RS-2 | 1 | ******************** |
| NBL-6 | 1 | ******************** |
| LLCPK1-F+ | 1 | ******************** |
| PK15 NTD (nucleoside transporter deficient) | 1 | ******************** |
| ES cell | 1 | ******************** |
| PED | 1 | ******************** |
| MDCK; ATCC CCL-34 | 1 | ******************** |
| PK15; PK13 | 1 | ******************** |
| ATCC CCL-34 | 1 | ******************** |
| BR | 1 | ******************** |
| LLC-PK-1 | 1 | ******************** |
| allotype-specific 12f2 | 1 | ******************** |
| RL-5(11/11 | 1 | ******************** |
| RL-5 (11/11) | 1 | ******************** |
| BAE | 1 | ******************** |
| PBLCL62.G4 | 1 | ******************** |
| OK-cell | 1 | ******************** |
| MDCK II | 1 | ******************** |
| LLC-PK1 clone | 1 | ******************** |
| E. coli DH5 (clone pjptRABB) | 1 | ******************** |
| rpe | 1 | ******************** |
| Madin-Darby II | 1 | ******************** |
| PEC-A | 1 | ******************** |
| PAP-HT25 | 1 | ******************** |
| XL1.B | 1 | ******************** |
| LLC-PK | 1 | ******************** |
| MBDK | 1 | ******************** |
| ATCC CCL 64 | 1 | ******************** |
| MDCK cell | 1 | ******************** |
| ln lambda-Zap | 1 | ******************** |
| MDCK (Madin-Darby kidney) | 1 | ******************** |
| TST-3 (103C) | 1 | ******************** |
| SGBAR-1 | 1 | ******************** |
| B657 G6TpM | 1 | ******************** |
| Madin Darby Canine Kidney (MDCK) | 1 | ******************** |
| primary vascular smooth muscle | 1 | ******************** |
| Mv1Lu | 1 | ******************** |
| OK cell | 1 | ******************** |
| RB-1 | 1 | ******************** |
| TST-3 | 1 | ******************** |
| B4 | 1 | ******************** |
| B11 | 1 | ******************** |
| B12 | 1 | ******************** |
| B13 | 1 | ******************** |
| S2.2 ECACC 92040117 | 1 | ******************** |
| transplantable tumor line (CAC-8) in nude mice | 1 | ******************** |
| Madin-Darby canine kidney (MDCK) cells | 1 | ******************** |
| fetal thigh myoblast-enriched cell culture | 1 | ******************** |
| ML2 myelonocytic cell line | 1 | ******************** |
| skin mastocytoma cell line BR | 1 | ******************** |
| MDCK (Madin Darby Canine Kidney) | 1 | ******************** |
| primary cell line of rabbit corneal stromal fibroblasts | 1 | ******************** |
| HRE-H9 and RBE-7 | 1 | ******************** |
| T cell clone G6.567 | 1 | ******************** |
| RL5 T | 1 | ******************** |
| MCH5-4 | 1 | ******************** |
| trophoblast | 1 | ******************** |
| Crandell feline kidney cells | 1 | ******************** |
| LLC-PK(1) | 1 | ******************** |
| EBTR | 1 | ******************** |
| fetal chotyledon | 1 | ******************** |
| aortic endothelial | 1 | ******************** |
| MDCK. | 1 | ******************** |
| DO6 | 1 | ******************** |
| PCR of cDNA from cell line PsyI | 1 | ******************** |
| alveolar macrophage | 1 | ******************** |
| primary alveolar macrophages | 1 | ******************** |
| Mink lung epithelial CC1 64 cell | 1 | ******************** |
| PCR performed on cDNA to total polyA+ mRNA | 1 | ******************** |
| rabbit ileal mucosal | 1 | ******************** |
| B/MT.4A.17.H5.A5. | 1 | ******************** |
| BLS1 | 1 | ******************** |
| D409/N2 | 1 | ******************** |
| XL1 Blue | 1 | ******************** |
| seq. obtained by PCR | 1 | ******************** |
| (OS) MDCK | 1 | ******************** |
| (OR) MDCK | 1 | ******************** |
| heart (ventricle) | 1 | ******************** |
| longissimus dorsi muscle | 1 | ******************** |
| bone marrow cells | 1 | ******************** |
| D19 | 1 | ******************** |
| porcine brain microvessels; porcine liver RNA for RACE-PCR | 1 | ******************** |
| Pt K2 | 1 | ******************** |
| Madin Darby Bovine Kidney (MDBK) | 1 | ******************** |
| TAH46; Theileria annulata (hissar) infected leukocyte line | 1 | ******************** |
| A9-B12 | 1 | ******************** |
| sheep adipose cDNA | 1 | ******************** |
| nonstimulated aorta endothelial cells | 1 | ******************** |
| HD59 | 1 | ******************** |
| BME | 1 | ******************** |
| 8990 | 1 | ******************** |
| OK cell line | 1 | ******************** |
| aortic endothelial cell | 1 | ******************** |
| MDBK (BVD-free) | 1 | ******************** |
| LLC-RK1 | 1 | ******************** |
| D18.1 | 1 | ******************** |
| D18.2 | 1 | ******************** |
| D18.3 | 1 | ******************** |
| D18.4 | 1 | ******************** |
| Bu(IMR-31) | 1 | ******************** |
| peripheral blood | 1 | ******************** |
| LPS-stimulated alveolar macrophages | 1 | ******************** |
| PMA-stimulated alveolar macrophages | 1 | ******************** |
| Primary Endothelial Line | 1 | ******************** |
| LPS-stimulated | 1 | ******************** |
| CD4+T | 1 | ******************** |
| MDCKII | 1 | ******************** |
| Eye tumor cell line | 1 | ******************** |
| fetal bovine aortic endothelial | 1 | ******************** |
| LLC-PK1 clone 4 | 1 | ******************** |
| thymocyte | 1 | ******************** |
| ST-6 (Adenocarcinoma Cell Line) | 1 | ******************** |
| Mardin Dabey Kidney Cell (MDCK) | 1 | ******************** |
| YR2 | 1 | ******************** |
| Madin-Darby canine kidney (MDCK), type I | 1 | ******************** |
| BY2 | 1 | ******************** |
| green line | 1 | ******************** |
| Mp | 1 | ******************** |
| A-18 | 1 | ******************** |
| XD6S | 1 | ******************** |
| yellow cell line | 1 | ******************** |
| SR1 | 1 | ******************** |
| ILC3279 | 1 | ******************** |
| 156-1 | 1 | ******************** |
| M18 | 1 | ******************** |
| immature pollen grains cultured in a nutrient-free medium | 1 | ******************** |
| RIB40 | 1 | ******************** |
| shikonin-producing cell | 1 | ******************** |
| C-9 (mt-) | 1 | ******************** |
| T-13 | 1 | ******************** |
| M-18 | 1 | ******************** |
| Bright Yellow-2 | 1 | ******************** |
| VUT-77011 | 1 | ******************** |
| A89 | 1 | ******************** |
| RIB 40 | 1 | ******************** |
| Oc | 1 | ******************** |
| H1-2 | 1 | ******************** |
| NC | 1 | ******************** |
| AS cell line | 1 | ******************** |
| H | 1 | ******************** |
| Bright Yellow 2 | 1 | ******************** |
| IAM | 1 | ******************** |
| IAM C-27 | 1 | ******************** |
| ALT213 | 1 | ******************** |
| non-embryogenic cells | 1 | ******************** |
| NIES-67 and NIES-68 | 1 | ******************** |
| Ak-1 | 1 | ******************** |
| ALT301 | 1 | ******************** |
| Bright Yellow -2 | 1 | ******************** |
| Yellow line | 1 | ******************** |
| C9 | 1 | ******************** |
| IPG | 1 | ******************** |
| UTEX642 | 1 | ******************** |
| NUSV-4001 | 1 | ******************** |
| B-4500 | 1 | ******************** |
| Samsun | 1 | ******************** |
| PL-TS-1(clade A3) | 1 | ******************** |
| CS-156(clade F1) | 1 | ******************** |
| derived from leaf callus | 1 | ******************** |
| 137C | 1 | ******************** |
| 95:88:22 | 1 | ******************** |
| A3/85 | 1 | ******************** |
| 137C+ | 1 | ******************** |
| SB-M (Horn, M.E., Sherrard, J.J., Widholm, J.M. Plant Physiol. 72, 426-429, 1983) | 1 | ******************** |
| C20D | 1 | ******************** |
| Mill | 1 | ******************** |
| Msk8 | 1 | ******************** |
| NT-1 | 1 | ******************** |
| CCMP696 | 1 | ******************** |
| suspension culture cell T87 | 1 | ******************** |
| AP2002 | 1 | ******************** |
| CCMP1831 | 1 | ******************** |
| ft-2525 | 1 | ******************** |
| PC5/5 | 1 | ******************** |
| T87 | 1 | ******************** |
| A17 | 1 | ******************** |
| 2009 | 1 | ******************** |
| BY2; Bright Yellow 2 | 1 | ******************** |
| T87 tissue culture cells | 1 | ******************** |
| tobacco genetic tumor | 1 | ******************** |
| Bright Yellow T-13 | 1 | ******************** |
| SB-P | 1 | ******************** |
| non-embryogenic callus | 1 | ******************** |
| A66 | 1 | ******************** |
| cki1-1 | 1 | ******************** |
| Hn | 1 | ******************** |
| male sterility line C022A | 1 | ******************** |
| male fertility line C022B | 1 | ******************** |
| red | 1 | ******************** |
| W64A | 1 | ******************** |
| tobacco SR1 | 1 | ******************** |
| suspension cells: BTF11 from Dr. B. Ishida, USDA PGEC Albany, CA. | 1 | ******************** |
| de Ruiter line 83G38 | 1 | ******************** |
| NT1 (suspension cultured 3 days) | 1 | ******************** |
| NT1 | 1 | ******************** |
| DS1 | 1 | ******************** |
| Hn11 | 1 | ******************** |
| E.coli; DH5 alpha | 1 | ******************** |
| 10 | 1 | ******************** |
| cultured | 1 | ******************** |
| cDNA clone of 4-day-old ectomycorrhiza from Eucalyptus globulus-Pisolithus tinctorius | 1 | ******************** |
| salt-stressed leaves | 1 | ******************** |
| inbred line A188 | 1 | ******************** |
| Pc5neu | 1 | ******************** |
| Sbe4 | 1 | ******************** |
| cv. Bomi | 1 | ******************** |
| Y1090 | 1 | ******************** |
| E. coli JM109 | 1 | ******************** |
| E. coli XL1-Blue | 1 | ******************** |
| E. coli NM514 | 1 | ******************** |
| T87 Arabidopsis thaliana cells | 1 | ******************** |
| Rice suspension cell culture | 1 | ******************** |
| C1 | 1 | ******************** |
| elicited cell culture | 1 | ******************** |
| GD2 | 1 | ******************** |
| SU2 somatic embryo line | 1 | ******************** |
| Pc5 | 1 | ******************** |
| E4 suspension | 1 | ******************** |
| R4F14 | 1 | ******************** |
| diploid line HH80/1201/7 | 1 | ******************** |
| RA3 | 1 | ******************** |
| barley cDNA library | 1 | ******************** |
| C4 | 1 | ******************** |
| LpSp3 | 1 | ******************** |
| mutant 56 | 1 | ******************** |
| E. coli Y1090 | 1 | ******************** |
| B | 1 | ******************** |
| W22 | 1 | ******************** |
| RRIM 600 | 1 | ******************** |
| HA | 1 | ******************** |
| cell suspension culture line W001C | 1 | ******************** |
| cultured parsley Pc5neu | 1 | ******************** |
| Pc/5 | 1 | ******************** |
| Msk 8 | 1 | ******************** |
| DH-alpha F' | 1 | ******************** |
| cultured cell | 1 | ******************** |
| root tissue | 1 | ******************** |
| SP1 | 1 | ******************** |
| SN:BOL3 allele | 1 | ******************** |
| Bean cell suspension cultures treatd with fungal elicitor | 1 | ******************** |
| H84 | 1 | ******************** |
| BL-21 | 1 | ******************** |
| TBS-10 | 1 | ******************** |
| E.coli DH5alpha | 1 | ******************** |
| Solanum tuberosum | 1 | ******************** |
| 19 | 1 | ******************** |
| Pc 5/neu | 1 | ******************** |
| E.coli, DH 5alpha | 1 | ******************** |
| MC1022 | 1 | ******************** |
| E.coli BNN132 | 1 | ******************** |
| pistil one day pre-anthesis | 1 | ******************** |
| E.coli Y 1090 | 1 | ******************** |
| Limbras 10 | 1 | ******************** |
| Tassels (male flowers) | 1 | ******************** |
| Tassels (mail flowers) | 1 | ******************** |
| Lp VII | 1 | ******************** |
| cultured Parsley cells | 1 | ******************** |
| ABA treated leaf | 1 | ******************** |
| Verona | 1 | ******************** |
| pollen | 1 | ******************** |
| Halo | 1 | ******************** |
| E.coli DH5alpha transformed with cDNA-insert cloned into pBluescript KS | 1 | ******************** |
| N.tabacum SR1, T-DNA transfected construct R(5) | 1 | ******************** |
| Paldal | 1 | ******************** |
| Glycine max | 1 | ******************** |
| BMS cell suspension | 1 | ******************** |
| P. miliaceum leaf tissue | 1 | ******************** |
| Asparagus plant cell culture | 1 | ******************** |
| Dianella | 1 | ******************** |
| melon cantaloup charentais | 1 | ******************** |
| W115 | 1 | ******************** |
| Fusarium monoliforms infected maize embryo | 1 | ******************** |
| Pollen of Phleum Pratense /Charge 24W28-7C | 1 | ******************** |
| SNT1005 | 1 | ******************** |
| Antirrhinum plant T249 17 | 1 | ******************** |
| P.sativum L., dwarf phenotype | 1 | ******************** |
| S.tuberosum L. Desiree | 1 | ******************** |
| Ginkgo biloba | 1 | ******************** |
| E.coli XLI-Blue | 1 | ******************** |
| pBluescript SK(-) in XL1-Blue | 1 | ******************** |
| Nicotiana tabacum cv Samsun | 1 | ******************** |
| maize A188 | 1 | ******************** |
| ATCC 64032 Sacharomyces cerevisiae erg10' (F.Karst, France) | 1 | ******************** |
| guayule stembark | 1 | ******************** |
| cell suspension culture | 1 | ******************** |
| Escherichia coli | 1 | ******************** |
| Eucalyptus gunnii, clone 832 (Association Foret Cellulose, France) | 1 | ******************** |
| Black Mexican Sweet Corn maize suspension culture | 1 | ******************** |
| T87 cell line | 1 | ******************** |
| Lolium temulentum L. Ba 3081 | 1 | ******************** |
| pBluescript SK9(-) in XL1-Blue | 1 | ******************** |
| suspension cell culture Pc5 /neu | 1 | ******************** |
| Eucalyptus gunnii (Association Foret Cellulose, France) | 1 | ******************** |
| ventus | 1 | ******************** |
| JI:430 BC1\9RR | 1 | ******************** |
| maize root | 1 | ******************** |
| A2 | 1 | ******************** |
| mycelia of the organism | 1 | ******************** |
| V12/2 root culture | 1 | ******************** |
| VS-300 | 1 | ******************** |
| E.coli JM 109 | 1 | ******************** |
| flash | 1 | ******************** |
| A.thalian Co | 1 | ******************** |
| A.thaliana Co | 1 | ******************** |
| S. tuberosum ssp tuberosum var. Desiree | 1 | ******************** |
| Shogun | 1 | ******************** |
| C20 | 1 | ******************** |
| T. aestivum var. Biggar | 1 | ******************** |
| Triticum aestivum var. Biggar | 1 | ******************** |
| T.aestivum var. Biggar | 1 | ******************** |
| wild-type A69Y | 1 | ******************** |
| FAP75141 | 1 | ******************** |
| Cd-300 | 1 | ******************** |
| NRRL 3 | 1 | ******************** |
| Rumex acetosa | 1 | ******************** |
| Arborio | 1 | ******************** |
| Tam 107 Hard Red Winter | 1 | ******************** |
| B.napus sp Jet neuf | 1 | ******************** |
| A.glutinosa seeds harvested in Weerribben, Netherlands | 1 | ******************** |
| R1 | 1 | ******************** |
| synchronized cell suspension culture | 1 | ******************** |
| strain #B164.80 of Sammlung von Algenkulturen (SAG), Goettingen | 1 | ******************** |
| W64 | 1 | ******************** |
| R1 /RPA | 1 | ******************** |
| R1/RPA | 1 | ******************** |
| Petite Havana SR1 | 1 | ******************** |
| Dok | 1 | ******************** |
| RA3 cell suspension | 1 | ******************** |
| Bomi | 1 | ******************** |
| cv. Borszczagowski | 1 | ******************** |
| PEWI | 1 | ******************** |
| Ohio State University Stock Center no. Col-0 | 1 | ******************** |
| Landsberg erecta | 1 | ******************** |
| LH82 | 1 | ******************** |
| Desiree | 1 | ******************** |
| 10F | 1 | ******************** |
| Kalle | 1 | ******************** |
| samsun NN | 1 | ******************** |
| VFNT Cherry | 1 | ******************** |
| KL-5-M | 1 | ******************** |
| Milyang 23 | 1 | ******************** |
| xanthi N.C. | 1 | ******************** |
| E.coli SOLR | 1 | ******************** |
| HA401B | 1 | ******************** |
| cell suspension | 1 | ******************** |
| Masterpiece | 1 | ******************** |
| Hanna | 1 | ******************** |
| Jemalong J5 | 1 | ******************** |
| T87 cell suspension | 1 | ******************** |
| Harosoy 63 | 1 | ******************** |
| KL-2-M | 1 | ******************** |
| Himalaya | 1 | ******************** |
| Rumbler-RA3 | 1 | ******************** |
| Nipponbare | 1 | ******************** |
| Baker 296 | 1 | ******************** |
| Rambler A2 | 1 | ******************** |
| PHA025 | 1 | ******************** |
| C24 | 1 | ******************** |
| EL64 | 1 | ******************** |
| T87-C3 | 1 | ******************** |
| Topas | 1 | ******************** |
| suspension culture PC5/5 | 1 | ******************** |
| chalqueno | 1 | ******************** |
| LH195 | 1 | ******************** |
| (Lindl.) Rchb. f | 1 | ******************** |
| Hybrid F1 PxPc6 | 1 | ******************** |
| stock JI.8 | 1 | ******************** |
| Arabidopsis Biological Resource Center, Ohio, stock number G3D8T7 | 1 | ******************** |
| lambda PRL1 | 1 | ******************** |
| Black Mexican Sweet | 1 | ******************** |
| E2A1C6 | 1 | ******************** |
| Phleum pratense pollen/charge 24W28-7c | 1 | ******************** |
| pollen of Phleum pratense/charge 24W28-7C | 1 | ******************** |
| Holcus lanatus inflorescence/ Charge Borstel I/92 | 1 | ******************** |
| E4 | 1 | ******************** |
| Val88-1 | 1 | ******************** |
| SP-47 | 1 | ******************** |
| XLOLR | 1 | ******************** |
| LE87 | 1 | ******************** |
| LT | 1 | ******************** |
| AB15-12-1 | 1 | ******************** |
| CO93P | 1 | ******************** |
| cell suspension RA3 | 1 | ******************** |
| T7 | 1 | ******************** |
| anthocyanin-accumulating | 1 | ******************** |
| LpVII | 1 | ******************** |
| P57Si | 1 | ******************** |
| At7 | 1 | ******************** |
| CI31A | 1 | ******************** |
| 558 | 1 | ******************** |
| suspension cell culture | 1 | ******************** |
| 74 A | 1 | ******************** |
| anthocyanin accumulating (DCb) cells | 1 | ******************** |
| Bright Yellow 2 (BY-2) | 1 | ******************** |
| Norwich | 1 | ******************** |
| suspension culture CP3a | 1 | ******************** |
| MP183L | 1 | ******************** |
| V12/2 | 1 | ******************** |
| SC58/1 | 1 | ******************** |
| 9Cr58 A12A2 | 1 | ******************** |
| suspension culture | 1 | ******************** |
| 21gr | 1 | ******************** |
| SR 1 | 1 | ******************** |
| TBY2 | 1 | ******************** |
| 4w89 | 1 | ******************** |
| 4w115 | 1 | ******************** |
| 4w77 | 1 | ******************** |
| R20 | 1 | ******************** |
| KAC02 | 1 | ******************** |
| suspension-cultured line BY-2 | 1 | ******************** |
| DOBA | 1 | ******************** |
| VBI-O | 1 | ******************** |
| cell culture (Axelos M., Curie C., Mazzolini L., Bardet | 1 | ******************** |
| X4 | 1 | ******************** |
| L2 | 1 | ******************** |
| embryogenic cells | 1 | ******************** |
| DSMZ Braunschweig PC-1017 | 1 | ******************** |
| kidney | 1 | ******************** |
| B cell | 1 | ******************** |
| MN-1112 | 1 | ******************** |
| B95a | 1 | ******************** |
| IMR-90 | 1 | ******************** |
| KG-1 | 1 | ******************** |
| A549 | 1 | ******************** |
| HeLa 229 cells | 1 | ******************** |
| MRK-nu-1 | 1 | ******************** |
| embryonic carcinoma NCR-G3 | 1 | ******************** |
| WEHI-38 | 1 | ******************** |
| KE-4 | 1 | ******************** |
| U937 | 1 | ******************** |
| MKN28 | 1 | ******************** |
| NCR-G3 | 1 | ******************** |
| HUT102 | 1 | ******************** |
| primary culture | 1 | ******************** |
| KYSE410 | 1 | ******************** |
| NUGC-3 | 1 | ******************** |
| CaSki | 1 | ******************** |
| KSE-1 | 1 | ******************** |
| normal human aortic endothelial cells | 1 | ******************** |
| CMK86 | 1 | ******************** |
| adenocarcinoma COLO 205 | 1 | ******************** |
| UT-7 | 1 | ******************** |
| TAPC301-CL4 | 1 | ******************** |
| erythroleukemic cells | 1 | ******************** |
| KCP4 cells derived from KB cell line | 1 | ******************** |
| PAN07JCK | 1 | ******************** |
| LLC-MK2 | 1 | ******************** |
| KT-3 | 1 | ******************** |
| Molt-4 clone no.8 | 1 | ******************** |
| G-361 | 1 | ******************** |
| KB | 1 | ******************** |
| human gastric cancer cell line MKN-74 | 1 | ******************** |
| bulk | 1 | ******************** |
| LAK cell | 1 | ******************** |
| HEK293 | 1 | ******************** |
| HL-60 cells | 1 | ******************** |
| MDA-MB453 | 1 | ******************** |
| TK-6 | 1 | ******************** |
| LAK | 1 | ******************** |
| 293 cells | 1 | ******************** |
| RA-treated HL-60 | 1 | ******************** |
| teratocarcinoma PA-1 | 1 | ******************** |
| JHH7 | 1 | ******************** |
| erythroleukemia cell | 1 | ******************** |
| Jurkat cells | 1 | ******************** |
| HeLa RCB0007 | 1 | ******************** |
| Lymphoma Raji cell | 1 | ******************** |
| KE4 | 1 | ******************** |
| Y79 | 1 | ******************** |
| THP-1 | 1 | ******************** |
| SK-MEL-37 | 1 | ******************** |
| SW480 | 1 | ******************** |
| SK-LMS-1 | 1 | ******************** |
| HSC-45M2 | 1 | ******************** |
| Jurkat cell | 1 | ******************** |
| primary-peripheral blood granulocytes | 1 | ******************** |
| KOCL-33 | 1 | ******************** |
| HT1376 | 1 | ******************** |
| teratocarcinoma; PA-1 | 1 | ******************** |
| T-LAK cell | 1 | ******************** |
| Ntera-2 RA | 1 | ******************** |
| CHP134 | 1 | ******************** |
| non-small cell lung cancer cell line, Ma29 | 1 | ******************** |
| Human squamous carcinoma cell line | 1 | ******************** |
| U-2 OS | 1 | ******************** |
| HuS-L12 | 1 | ******************** |
| PC-3 | 1 | ******************** |
| Jurkat, HeLa | 1 | ******************** |
| U373MG | 1 | ******************** |
| ACHN/CDDP | 1 | ******************** |
| human promyelocytic leukemia cell line HL-60 | 1 | ******************** |
| SCC-4 | 1 | ******************** |
| WI-38 VA13 | 1 | ******************** |
| TGW | 1 | ******************** |
| PC-14 | 1 | ******************** |
| U87MG | 1 | ******************** |
| ECV 304 | 1 | ******************** |
| CMK cell | 1 | ******************** |
| CMK | 1 | ******************** |
| Panc-1 | 1 | ******************** |
| Panc 1 | 1 | ******************** |
| HeLa, MKN45, MKN28 | 1 | ******************** |
| HCS-2/8 | 1 | ******************** |
| HPLF | 1 | ******************** |
| F36P | 1 | ******************** |
| HEK 293 | 1 | ******************** |
| Molt-4, T98G | 1 | ******************** |
| MOLT3 | 1 | ******************** |
| SKG IIIa | 1 | ******************** |
| Megakaryoblastic leukemia cells (Meg-01) | 1 | ******************** |
| human embryonic lung | 1 | ******************** |
| TIG-1 | 1 | ******************** |
| O-128 | 1 | ******************** |
| NHOst | 1 | ******************** |
| HUVEC | 1 | ******************** |
| SH-SY5Y | 1 | ******************** |
| TE1 | 1 | ******************** |
| KNS60 | 1 | ******************** |
| ARPE19 | 1 | ******************** |
| EBSM | 1 | ******************** |
| SW620 | 1 | ******************** |
| 293 | 1 | ******************** |
| MRC-5 | 1 | ******************** |
| gastric cancer cell line MKN45 | 1 | ******************** |
| Melanoma G-361 | 1 | ******************** |
| Hep3B | 1 | ******************** |
| Huh6 | 1 | ******************** |
| Huh7 | 1 | ******************** |
| SKG-II | 1 | ******************** |
| normal lung tissue | 1 | ******************** |
| THP1 | 1 | ******************** |
| MKN-28 | 1 | ******************** |
| Cos1 | 1 | ******************** |
| PC3 | 1 | ******************** |
| OS-RC-2(RCB0735) | 1 | ******************** |
| gastric cancer cell OKAJIMA | 1 | ******************** |
| HeLa S3 derived | 1 | ******************** |
| KATO III | 1 | ******************** |
| KHM-1B | 1 | ******************** |
| NCI-H929 | 1 | ******************** |
| DU145 | 1 | ******************** |
| HPB-ALL | 1 | ******************** |
| neuroblastoma SH-SY-5Y | 1 | ******************** |
| HEL | 1 | ******************** |
| HO702 | 1 | ******************** |
| Colo205 | 1 | ******************** |
| MRC5 | 1 | ******************** |
| UACC-812 | 1 | ******************** |
| human neuroblastoma SH-SY5Y | 1 | ******************** |
| WI38 | 1 | ******************** |
| human uterine cervical cells | 1 | ******************** |
| HepG 2 | 1 | ******************** |
| FLC4 | 1 | ******************** |
| 293T | 1 | ******************** |
| NAM | 1 | ******************** |
| UOK111 | 1 | ******************** |
| human periodontal ligament cell | 1 | ******************** |
| HEK293, HeLa | 1 | ******************** |
| human colon cancer cell line | 1 | ******************** |
| CMK6 | 1 | ******************** |
| KY-Ra | 1 | ******************** |
| 8305C | 1 | ******************** |
| WI-38 | 1 | ******************** |
| CL4 | 1 | ******************** |
| CTL 55 | 1 | ******************** |
| CTL 589 | 1 | ******************** |
| Karpas 1718 | 1 | ******************** |
| HAEC | 1 | ******************** |
| QGP-1 | 1 | ******************** |
| ARPE-19 | 1 | ******************** |
| Vero African green monkey kidney | 1 | ******************** |
| MRC5, NCI-H82 | 1 | ******************** |
| WiDr | 1 | ******************** |
| VMRC-RCW | 1 | ******************** |
| U-105MG | 1 | ******************** |
| CV-1 | 1 | ******************** |
| HSC-F | 1 | ******************** |
| SKN | 1 | ******************** |
| retinoblastoma | 1 | ******************** |
| Vero E6 | 1 | ******************** |
| LN229 | 1 | ******************** |
| ME-180 | 1 | ******************** |
| TT cell | 1 | ******************** |
| H9 | 1 | ******************** |
| 697 cell | 1 | ******************** |
| GLC-82 | 1 | ******************** |
| T24 | 1 | ******************** |
| interferon-gamma stimulated U937 cell line | 1 | ******************** |
| B cell line | 1 | ******************** |
| Ewing's sarcoma | 1 | ******************** |
| MDA-MB-231 breast cancer cells (adenocarcinoma) | 1 | ******************** |
| pre-B leukaemia cell line G2 | 1 | ******************** |
| M426 | 1 | ******************** |
| Hs68 | 1 | ******************** |
| HUT78 T-cell leukemia | 1 | ******************** |
| UCLA-162 | 1 | ******************** |
| KB-V1 | 1 | ******************** |
| SK-1 | 1 | ******************** |
| huvec; HS913T | 1 | ******************** |
| Epstein-Barr virus-transformed B cells | 1 | ******************** |
| Epstein-Barr virus transformed B cells | 1 | ******************** |
| T-47D | 1 | ******************** |
| leukemia U937 | 1 | ******************** |
| SiSo | 1 | ******************** |
| Burkitt lymphoma cell line | 1 | ******************** |
| HO-1 | 1 | ******************** |
| breast adenocarcinoma MCF7 | 1 | ******************** |
| MDA-MB-231 | 1 | ******************** |
| MCF7; estrogen receptor-expressing | 1 | ******************** |
| LOX | 1 | ******************** |
| KCNR | 1 | ******************** |
| HTLV-1 transformed T cell line, HAT109 | 1 | ******************** |
| human-human hybridoma B9165 | 1 | ******************** |
| CB23 B lymphoblastoid | 1 | ******************** |
| MDA-MB-175 | 1 | ******************** |
| ZR75-1 | 1 | ******************** |
| EBV transformed lymphoblastoid | 1 | ******************** |
| acute myleoid leukemia (AML-M2) cell line HL60 | 1 | ******************** |
| DLD-1; colon cancer cell line | 1 | ******************** |
| L428 | 1 | ******************** |
| NbHOT | 1 | ******************** |
| BT474 | 1 | ******************** |
| NCI H69 | 1 | ******************** |
| IL-2 dependent polyclonal NK | 1 | ******************** |
| KG-1a; KG-1 | 1 | ******************** |
| NCIH292 | 1 | ******************** |
| Ntera-2/RA | 1 | ******************** |
| HCC II | 1 | ******************** |
| EnCa-MZ-3 | 1 | ******************** |
| MES-SA/DxP | 1 | ******************** |
| NCI-H146 | 1 | ******************** |
| MCF-7 and 5Y neuroblastoma cells | 1 | ******************** |
| EBV-transformed B-cell line KT | 1 | ******************** |
| EBV-transformed B-cell line CH | 1 | ******************** |
| COS-7 | 1 | ******************** |
| premyeloid cell line TF-1 | 1 | ******************** |
| chemosensitive PA-1 cells; Wu,G.S. Nat. Med. 2,255-256,1996 | 1 | ******************** |
| MDA-MB-435 | 1 | ******************** |
| lymphoblastoid JY1 cells | 1 | ******************** |
| CMMT | 1 | ******************** |
| 76N | 1 | ******************** |
| HT1080 | 1 | ******************** |
| B98-8 | 1 | ******************** |
| transformed SML cells | 1 | ******************** |
| Mieliki | 1 | ******************** |
| C3-A11N; Nalm-6 | 1 | ******************** |
| HIMeg | 1 | ******************** |
| squamous carcinoma L-78 | 1 | ******************** |
| pancreatic cancer Patu 8988t | 1 | ******************** |
| Patu 8988t | 1 | ******************** |
| HL60 and 293 | 1 | ******************** |
| HBL-100 | 1 | ******************** |
| immortalized first trimester trophoblast cells (HTR-8/SVneo) | 1 | ******************** |
| MDA-468 | 1 | ******************** |
| pancreatic adenocarcinoma | 1 | ******************** |
| lung type-I cell | 1 | ******************** |
| NCI-H82 | 1 | ******************** |
| NCI H82; NCI H345 | 1 | ******************** |
| T47D | 1 | ******************** |
| HAT109 | 1 | ******************** |
| NCI H82 | 1 | ******************** |
| KT3 | 1 | ******************** |
| EBV transformed human B-cell line fused to heteromyeloma | 1 | ******************** |
| HeLa S3; ATCC CCL2.2 | 1 | ******************** |
| Mo7p210 | 1 | ******************** |
| Hs578T | 1 | ******************** |
| Jurkat T-cell | 1 | ******************** |
| Jurkat T cells | 1 | ******************** |
| THP-1; phorbol ester-treated 4 days | 1 | ******************** |
| TIL | 1 | ******************** |
| HeLa-S3 | 1 | ******************** |
| promyelocytic leukemia HL-60 cell line | 1 | ******************** |
| acute leukemia MLA-144 | 1 | ******************** |
| BT-20 | 1 | ******************** |
| Owl IC | 1 | ******************** |
| OM VI-3 | 1 | ******************** |
| D98-H2 HeLa | 1 | ******************** |
| neuroblastoma 4s | 1 | ******************** |
| HL-60 promyelocytic cell-line | 1 | ******************** |
| K-562 | 1 | ******************** |
| 3D5 | 1 | ******************** |
| Jurkat cell line RPMI 1640 | 1 | ******************** |
| endometrial adenocarcinoma cell line HEC1B | 1 | ******************** |
| KG1 | 1 | ******************** |
| CHRF-288-11 | 1 | ******************** |
| Epstein-Barr Virus transformed B cell | 1 | ******************** |
| JEG-3 choriocarcinoma | 1 | ******************** |
| HA1 | 1 | ******************** |
| HTR-8/SVneo | 1 | ******************** |
| Caco 2 | 1 | ******************** |
| NT2/c1.D1 | 1 | ******************** |
| monoclonal cell line Ha5C2.A2 | 1 | ******************** |
| GM10618 | 1 | ******************** |
| GM10354 | 1 | ******************** |
| U2OS | 1 | ******************** |
| NT2 neuronal precursor | 1 | ******************** |
| T84; CaCo-2; HT29 | 1 | ******************** |
| MT2 | 1 | ******************** |
| HOS8603 | 1 | ******************** |
| 8226; H929 | 1 | ******************** |
| WES | 1 | ******************** |
| OMK | 1 | ******************** |
| NZP-60 | 1 | ******************** |
| MM96 | 1 | ******************** |
| ZR-75 | 1 | ******************** |
| HVS transformed | 1 | ******************** |
| AsPC-1 | 1 | ******************** |
| UVB-treated HaCaT | 1 | ******************** |
| U937; ATCCCRL-1593 | 1 | ******************** |
| HeLa S2 | 1 | ******************** |
| EBV-immortalized | 1 | ******************** |
| LNCaP; C4-2 | 1 | ******************** |
| F240 | 1 | ******************** |
| CCL-156 | 1 | ******************** |
| UOC-B1 | 1 | ******************** |
| MDA-MB | 1 | ******************** |
| Mueller | 1 | ******************** |
| Daudi; HeLa | 1 | ******************** |
| myelin basic protein-specific T-cell line | 1 | ******************** |
| promyelocytic leukemia HL-60 | 1 | ******************** |
| HaCaT; TF-1 | 1 | ******************** |
| leukemia TF-1 | 1 | ******************** |
| MCF10A | 1 | ******************** |
| HT29 | 1 | ******************** |
| LS180 | 1 | ******************** |
| monoclonal cell line SN66E3 from Arend Mulder, Leiden, The Netherlands | 1 | ******************** |
| monoclonal cell line MBW1 | 1 | ******************** |
| JEG-3 | 1 | ******************** |
| erythroleukemia K562 | 1 | ******************** |
| SCLC line NCI-H841 | 1 | ******************** |
| UTMC2 | 1 | ******************** |
| cancer cell lines | 1 | ******************** |
| GES-1; MC | 1 | ******************** |
| Met-4A | 1 | ******************** |
| ovarian cancer line C200 | 1 | ******************** |
| NK92.26 | 1 | ******************** |
| HeLa; Jurkat | 1 | ******************** |
| colonic adenocarcinoma SW480 | 1 | ******************** |
| breast cancer cell line, BT474 | 1 | ******************** |
| HMC-1 | 1 | ******************** |
| pancreatc cancer PANC1 | 1 | ******************** |
| SKOV-3; taxol resistant line | 1 | ******************** |
| SS254 | 1 | ******************** |
| C3-A11N; clonally related variant of OCI LY8-C3P | 1 | ******************** |
| Epstein-Barr virus strain B95-8 transformed B lymphoblastoid | 1 | ******************** |
| acyte promyelocytic leukemia HT93A | 1 | ******************** |
| tumor cell line SOJ-6 | 1 | ******************** |
| NT2-D1 | 1 | ******************** |
| KG-1a | 1 | ******************** |
| Wish; HeLa | 1 | ******************** |
| mekakaryocyte | 1 | ******************** |
| CF-PAC1 | 1 | ******************** |
| Gru-1 | 1 | ******************** |
| acute myelogenous leukemia KG-1 | 1 | ******************** |
| MM200 | 1 | ******************** |
| GC | 1 | ******************** |
| OV177 | 1 | ******************** |
| SMMU-7721 | 1 | ******************** |
| H-460 | 1 | ******************** |
| TC7 | 1 | ******************** |
| 1418-1 | 1 | ******************** |
| 1418-16 | 1 | ******************** |
| 1424 | 1 | ******************** |
| T47-D | 1 | ******************** |
| HeLa, D98/AH-2, HPRT- | 1 | ******************** |
| SC-M1 | 1 | ******************** |
| CEM174 | 1 | ******************** |
| ovarian epithelial cancer line SKOV-3 | 1 | ******************** |
| 184B5 | 1 | ******************** |
| PancI | 1 | ******************** |
| 10IHW 9022 | 1 | ******************** |
| 4AOH 100044V | 1 | ******************** |
| 10IHW 9082 | 1 | ******************** |
| 10IHW 9013 | 1 | ******************** |
| 10IHW 9052 | 1 | ******************** |
| 4AOH 100083J | 1 | ******************** |
| 10IHW 9090 | 1 | ******************** |
| 10IHW 9027 | 1 | ******************** |
| 10IHW 9041 | 1 | ******************** |
| 10IHW 9006 | 1 | ******************** |
| 4AOH 100108V | 1 | ******************** |
| HT-29/ino | 1 | ******************** |
| lymphoblast; prepared from SCA2 and SCA7 patients | 1 | ******************** |
| breast cancer cell line 600PE | 1 | ******************** |
| Farage DLCL | 1 | ******************** |
| DU-145; PC-3 | 1 | ******************** |
| Hodgkin cell line L428 | 1 | ******************** |
| U-937 | 1 | ******************** |
| KG1a | 1 | ******************** |
| MCF-7/AdrVp | 1 | ******************** |
| Ntera-2/c1.D1 | 1 | ******************** |
| EBV-B | 1 | ******************** |
| SCC 9 | 1 | ******************** |
| lymphoblastoid B-cell line NC37 | 1 | ******************** |
| JME | 1 | ******************** |
| MCF-7/HER2 | 1 | ******************** |
| EBV-transformed B cell; B-ALL | 1 | ******************** |
| BG9 | 1 | ******************** |
| 786-0 | 1 | ******************** |
| SCC15;SCC25;FaDu | 1 | ******************** |
| SLB-I | 1 | ******************** |
| HTLV-I transformed T-cell line SLB-1 | 1 | ******************** |
| CD8-1 | 1 | ******************** |
| CD8-2 | 1 | ******************** |
| DN1 | 1 | ******************** |
| LDN5 | 1 | ******************** |
| DN.POTT | 1 | ******************** |
| IgM Opp 03 | 1 | ******************** |
| IgM FRI | 1 | ******************** |
| ZR-75-1 | 1 | ******************** |
| IARC-EX1 | 1 | ******************** |
| PMA stimulated HL60 | 1 | ******************** |
| hepatoma | 1 | ******************** |
| ovarian cancer C200 | 1 | ******************** |
| COS | 1 | ******************** |
| Janice | 1 | ******************** |
| COLO-205 | 1 | ******************** |
| glioma U251 | 1 | ******************** |
| Namalwa B cell lymphoma | 1 | ******************** |
| NCR-EW2 | 1 | ******************** |
| Hati | 1 | ******************** |
| Tengku | 1 | ******************** |
| JY | 1 | ******************** |
| DUPRO | 1 | ******************** |
| T84 | 1 | ******************** |
| Jurkat T-cell leukemia | 1 | ******************** |
| E8CASS | 1 | ******************** |
| CCRF-CEM | 1 | ******************** |
| SP49 | 1 | ******************** |
| MDA-MD-468 | 1 | ******************** |
| SOJ-6 | 1 | ******************** |
| HT29-M6 transfected with an activated form of PKC alpha | 1 | ******************** |
| L02 | 1 | ******************** |
| A431 | 1 | ******************** |
| SKOV-3 | 1 | ******************** |
| NCI H157 | 1 | ******************** |
| THP-1 monocyte-macrophage | 1 | ******************** |
| apoptotic HL-60 | 1 | ******************** |
| subtype of SW 480 | 1 | ******************** |
| B95-8 | 1 | ******************** |
| ECV304 | 1 | ******************** |
| SUP-T1 | 1 | ******************** |
| K562, ATCC CCL-243 | 1 | ******************** |
| CCRF-CEM, ATCC CCL-119 | 1 | ******************** |
| KG-1a, ATCC CCL-246.1 | 1 | ******************** |
| MOLT-4, ATCC CRL-1582 | 1 | ******************** |
| glioma LNZ308 | 1 | ******************** |
| 8701-BC; BT-474 | 1 | ******************** |
| HT-29 | 1 | ******************** |
| T84 colonic adenocarcinoma | 1 | ******************** |
| 1973/10-4 | 1 | ******************** |
| HT-29-M6 | 1 | ******************** |
| SV40 virus-transformed embryonic lung fibroblast WI-38/VA13 | 1 | ******************** |
| LAN5 | 1 | ******************** |
| SW626 | 1 | ******************** |
| SCC-9 | 1 | ******************** |
| MDA-MB-453 | 1 | ******************** |
| HLE-B3 | 1 | ******************** |
| leukemic T-cell line | 1 | ******************** |
| AHH-1 | 1 | ******************** |
| melanoma cell line M88 | 1 | ******************** |
| BB90-MEL | 1 | ******************** |
| K562 CML | 1 | ******************** |
| hepatoma Hep3B | 1 | ******************** |
| hepatoma cell line Hep3B | 1 | ******************** |
| 697 | 1 | ******************** |
| MDA MB 453 | 1 | ******************** |
| ARCaP | 1 | ******************** |
| T84; HEk 293 | 1 | ******************** |
| HCT-116 | 1 | ******************** |
| HCC | 1 | ******************** |
| F223 | 1 | ******************** |
| LN319 | 1 | ******************** |
| WERI-1 | 1 | ******************** |
| MV4-11 | 1 | ******************** |
| SLB-1 | 1 | ******************** |
| TSUPr1 | 1 | ******************** |
| S3 | 1 | ******************** |
| HEK293; PC3 | 1 | ******************** |
| Bix3 | 1 | ******************** |
| 1E8 | 1 | ******************** |
| Hs638 | 1 | ******************** |
| myeloma U-266 | 1 | ******************** |
| SS269 | 1 | ******************** |
| pancreatic cancer cell line Suit S2 007 | 1 | ******************** |
| LB373-MEL | 1 | ******************** |
| intestinal epithelial Caco2 | 1 | ******************** |
| fibrosarcoma HT1080 | 1 | ******************** |
| Caco-2; 407 | 1 | ******************** |
| HD3 | 1 | ******************** |
| GM11201 (Coriell) | 1 | ******************** |
| GM11197 (Coriell) | 1 | ******************** |
| GM008333A (Coriell Cell Repositories) | 1 | ******************** |
| Dob1 hybridoma | 1 | ******************** |
| MEL.A-1 | 1 | ******************** |
| A431 epidermoid carcinoma | 1 | ******************** |
| MCF-7; T47D; ZR75-1; MDA-MB-453 | 1 | ******************** |
| CEM x 174 (T-cell/B-cell hybrid) | 1 | ******************** |
| HHCC | 1 | ******************** |
| WCS | 1 | ******************** |
| EBV-transformed B cell | 1 | ******************** |
| MOLT-4 T-cell lymphoblastic leukemia cell line | 1 | ******************** |
| MOLT-4 T-cell lymphoblastic leukemia | 1 | ******************** |
| Mel JuSo | 1 | ******************** |
| MFC-7 | 1 | ******************** |
| Lu-165 | 1 | ******************** |
| Nu-6 | 1 | ******************** |
| ARPE-19; from retina | 1 | ******************** |
| EA.hy926 | 1 | ******************** |
| HEK | 1 | ******************** |
| Burkitt's lymphoma | 1 | ******************** |
| H93D8 T cell | 1 | ******************** |
| Jurkat J6 T cell lymphoma | 1 | ******************** |
| MM5.1 multiple myeloma cell line | 1 | ******************** |
| PPC-1 | 1 | ******************** |
| NB4 treated by ATRA | 1 | ******************** |
| DJM-1 | 1 | ******************** |
| 293EBNA | 1 | ******************** |
| A2780 | 1 | ******************** |
| T-84 | 1 | ******************** |
| Hs578Bst | 1 | ******************** |
| T-cell | 1 | ******************** |
| HM7-F6 | 1 | ******************** |
| SW1088 | 1 | ******************** |
| brain astrocytoma (SW1088) | 1 | ******************** |
| SiHa | 1 | ******************** |
| HeLa; WI38 | 1 | ******************** |
| chondrosarcoma cell line FS | 1 | ******************** |
| RA differentiated Tera2 cl13 | 1 | ******************** |
| YT | 1 | ******************** |
| U2OS; 978SK | 1 | ******************** |
| MARC-145 | 1 | ******************** |
| LP | 1 | ******************** |
| 1362 melanoma | 1 | ******************** |
| WERI Rb-1 | 1 | ******************** |
| Molt 4; HeLa | 1 | ******************** |
| AA/C1 | 1 | ******************** |
| melanoma | 1 | ******************** |
| GT2015; GT1179 | 1 | ******************** |
| IHW9001 SA; IHW9004 JESTHOM | 1 | ******************** |
| IHW9021 RSH; GT1261 | 1 | ******************** |
| GT1060; GT1081 | 1 | ******************** |
| IHW9251 M7 | 1 | ******************** |
| IHW9272 CODI; GT2012 | 1 | ******************** |
| IHW9001 SA | 1 | ******************** |
| IHW9002 MZ070782; Gt1060 | 1 | ******************** |
| IHW9036 SP0010 | 1 | ******************** |
| IHW9107 LKT3; GT321 | 1 | ******************** |
| IHW9234 CRB; GT1183 | 1 | ******************** |
| IHW9021 RSH; GT1083 | 1 | ******************** |
| GT1099; GT1100 | 1 | ******************** |
| GN100 | 1 | ******************** |
| IHW9058 OMW; GT1061 | 1 | ******************** |
| LNCaP prostatic cancer | 1 | ******************** |
| MiaPaCa-2 pancreatic cancer | 1 | ******************** |
| CAKI-1 renal cancer | 1 | ******************** |
| MC | 1 | ******************** |
| Vero 76 | 1 | ******************** |
| MA-104 | 1 | ******************** |
| SY5Y | 1 | ******************** |
| 143B | 1 | ******************** |
| Jurkat T lymphocyte | 1 | ******************** |
| EBV-transformed B cells | 1 | ******************** |
| U937 monocytic | 1 | ******************** |
| WES; ATCC:CRL-1609 | 1 | ******************** |
| CYNOM-K1 | 1 | ******************** |
| myeloid HL-60 | 1 | ******************** |
| ML1260 | 1 | ******************** |
| latently HIV-1-infected CEM | 1 | ******************** |
| SKBR-3 breast cancer cells | 1 | ******************** |
| gingival fibroblasts IMR90 | 1 | ******************** |
| .220 | 1 | ******************** |
| Chang liver | 1 | ******************** |
| MIAPaCa-2 | 1 | ******************** |
| Hodgkin's disease cell line L428 | 1 | ******************** |
| MDA-415 | 1 | ******************** |
| MGC803 | 1 | ******************** |
| MeWo | 1 | ******************** |
| breast cancer ZR-75-1 | 1 | ******************** |
| breast cancer T-47D | 1 | ******************** |
| breast cancer BT-474 | 1 | ******************** |
| breast cancer MCF-7 | 1 | ******************** |
| ATCC CRL-1857 | 1 | ******************** |
| ATCC CRL-1850 | 1 | ******************** |
| ATCC TIB-201 | 1 | ******************** |
| ATCC CRL-1773 | 1 | ******************** |
| from ClonTech Laboratories | 1 | ******************** |
| ANIP973 | 1 | ******************** |
| T47D and MCF7 breast cancer lines | 1 | ******************** |
| ECV-304 | 1 | ******************** |
| LN229 glioma | 1 | ******************** |
| SKNSH neuroblastoma | 1 | ******************** |
| HFL-1; SK-N-SH; K562 | 1 | ******************** |
| PMA-treated HuT 78 | 1 | ******************** |
| EB1 | 1 | ******************** |
| MES-SA/Dx5 | 1 | ******************** |
| FR4 multiple myeloma | 1 | ******************** |
| MES-SA/2B-E3 | 1 | ******************** |
| MES-SA/VL20-4.2 | 1 | ******************** |
| MES-SA/10B-E2 | 1 | ******************** |
| NTera2 cl.D1 | 1 | ******************** |
| HT-29; Caco-2 | 1 | ******************** |
| CV1-B3/13 | 1 | ******************** |
| COS 1 | 1 | ******************** |
| HSC 93 | 1 | ******************** |
| HeLa S3 cell | 1 | ******************** |
| HeLa MR | 1 | ******************** |
| G081 | 1 | ******************** |
| HCV-associated B cell lymphoma | 1 | ******************** |
| NCI-H125; NCI-H23; GLC-A1; GLC-A2; T47D | 1 | ******************** |
| Burkitt's lymphoma BL2 | 1 | ******************** |
| IMR-32 | 1 | ******************** |
| H156-H2 | 1 | ******************** |
| GN044 | 1 | ******************** |
| GN025 | 1 | ******************** |
| GN035 | 1 | ******************** |
| COS I | 1 | ******************** |
| NTera-2D1 | 1 | ******************** |
| MEG-01; HEL | 1 | ******************** |
| IMR-5 | 1 | ******************** |
| A375 melanoma cells overexpressing P15INK4b | 1 | ******************** |
| 7A | 1 | ******************** |
| THP-1; ATCC TIB-202 | 1 | ******************** |
| CaSki; ATCC CRL-1550 | 1 | ******************** |
| PE/CA-PJ15; ECACC 96121230 | 1 | ******************** |
| OE21; ECACC 96062201 | 1 | ******************** |
| A549; ATCC CCL-185 | 1 | ******************** |
| RPMI2650; ATCC 30 | 1 | ******************** |
| C183 | 1 | ******************** |
| T24 transitional-cell carcinoma | 1 | ******************** |
| BL60 | 1 | ******************** |
| cancer | 1 | ******************** |
| B95-8; ATCC CRL-1612 | 1 | ******************** |
| COS-7; ATCC CRL-1651 | 1 | ******************** |
| diploid KMB-17 | 1 | ******************** |
| RD | 1 | ******************** |
| NHEK | 1 | ******************** |
| KMB-17 | 1 | ******************** |
| neuroblastoma LA-N-5 | 1 | ******************** |
| TE671 | 1 | ******************** |
| CaSki (ATCC CCL185) | 1 | ******************** |
| PC-6/SN2-5H | 1 | ******************** |
| C5MJ | 1 | ******************** |
| Jurkat-T | 1 | ******************** |
| Allen | 1 | ******************** |
| Jingjing | 1 | ******************** |
| Minyak | 1 | ******************** |
| Ayer | 1 | ******************** |
| Loklok | 1 | ******************** |
| Lokan | 1 | ******************** |
| Chantek | 1 | ******************** |
| CP81 | 1 | ******************** |
| Ayer, | 1 | ******************** |
| Mikyak | 1 | ******************** |
| Saos-2; ATCC HTB-85 | 1 | ******************** |
| 143B osteosarcoma | 1 | ******************** |
| PHM1-41 | 1 | ******************** |
| multiple myeloma | 1 | ******************** |
| S3 HeLa | 1 | ******************** |
| Beta | 1 | ******************** |
| Oko | 1 | ******************** |
| JinJing | 1 | ******************** |
| 293 HEK | 1 | ******************** |
| liposarcoma 1955/91 | 1 | ******************** |
| SGC7901/VCR | 1 | ******************** |
| K562; HL-60; Meg01; Dami; THP-1; CHRF; U937; KG-1 | 1 | ******************** |
| breast cancer | 1 | ******************** |
| NT2/D1 | 1 | ******************** |
| 105274 | 1 | ******************** |
| MCF-1 | 1 | ******************** |
| H69 | 1 | ******************** |
| GM02756 | 1 | ******************** |
| NK cells | 1 | ******************** |
| H2LCL | 1 | ******************** |
| Me18732 | 1 | ******************** |
| CMD004AN | 1 | ******************** |
| FOB-cells | 1 | ******************** |
| myelocytic leukemia cell-line U937 | 1 | ******************** |
| M10 | 1 | ******************** |
| NALL-1 | 1 | ******************** |
| ME180 | 1 | ******************** |
| 5583S | 1 | ******************** |
| B lymphocyte | 1 | ******************** |
| CCRF-CEM/E1000 | 1 | ******************** |
| CAPAN I | 1 | ******************** |
| RF.BM, YF.PB2 | 1 | ******************** |
| IHKE-1 | 1 | ******************** |
| BC2 | 1 | ******************** |
| BCBL1 | 1 | ******************** |
| HBL6 | 1 | ******************** |
| mammary carcinoma, MDA MB 435 | 1 | ******************** |
| Namalwa Burkitt lymphoma | 1 | ******************** |
| HISM | 1 | ******************** |
| AMA cells | 1 | ******************** |
| CBGA1 | 1 | ******************** |
| MacK | 1 | ******************** |
| LEP2E9 | 1 | ******************** |
| AS30 | 1 | ******************** |
| AS31 | 1 | ******************** |
| AS32 | 1 | ******************** |
| AS33 | 1 | ******************** |
| AS34 | 1 | ******************** |
| AS35 | 1 | ******************** |
| AS36 | 1 | ******************** |
| AS38, AS42, AS44 | 1 | ******************** |
| AS39 | 1 | ******************** |
| AS40 | 1 | ******************** |
| AS41 | 1 | ******************** |
| AS43 | 1 | ******************** |
| LC37 | 1 | ******************** |
| LC38 | 1 | ******************** |
| LC39 | 1 | ******************** |
| LC40 | 1 | ******************** |
| NTERA2-D1 | 1 | ******************** |
| Therad 10 (76/55.1) | 1 | ******************** |
| Therad 24 (174/102.21) | 1 | ******************** |
| SK-RC-10 | 1 | ******************** |
| LB129-SCLC and PBL | 1 | ******************** |
| 530 | 1 | ******************** |
| human malignant glioma cell line MO59J cell | 1 | ******************** |
| GTL-16 | 1 | ******************** |
| 518/IL2.14 | 1 | ******************** |
| 518/IL-2.14 | 1 | ******************** |
| CF Pac1 | 1 | ******************** |
| GM5756T | 1 | ******************** |
| ZR75 breast cancer cell line | 1 | ******************** |
| HCT 116 | 1 | ******************** |
| LB33-MEL.A-1 (tumor cell line) | 1 | ******************** |
| BO2C11 | 1 | ******************** |
| JS1 | 1 | ******************** |
| JS2 | 1 | ******************** |
| JS3 | 1 | ******************** |
| JS4 | 1 | ******************** |
| JS5 | 1 | ******************** |
| JS6 | 1 | ******************** |
| JS7 | 1 | ******************** |
| JS8 | 1 | ******************** |
| JS9 | 1 | ******************** |
| JS10 | 1 | ******************** |
| JS11 | 1 | ******************** |
| JS12 | 1 | ******************** |
| JS13 | 1 | ******************** |
| JS14 | 1 | ******************** |
| JS15 | 1 | ******************** |
| JS16 | 1 | ******************** |
| JS17 | 1 | ******************** |
| JS18 | 1 | ******************** |
| JS19 | 1 | ******************** |
| JS20 | 1 | ******************** |
| JS21 | 1 | ******************** |
| JS22 | 1 | ******************** |
| JS23 | 1 | ******************** |
| JS24 | 1 | ******************** |
| JS25 | 1 | ******************** |
| JS26 | 1 | ******************** |
| JS28 | 1 | ******************** |
| JS29 | 1 | ******************** |
| JS30 | 1 | ******************** |
| JS31 | 1 | ******************** |
| JS32 | 1 | ******************** |
| JS33 | 1 | ******************** |
| JS34 | 1 | ******************** |
| JS35 | 1 | ******************** |
| JS36 | 1 | ******************** |
| JS37 | 1 | ******************** |
| JS38 | 1 | ******************** |
| JS39 | 1 | ******************** |
| JS40 | 1 | ******************** |
| JS41 | 1 | ******************** |
| JS44 | 1 | ******************** |
| JS45 | 1 | ******************** |
| JS46 | 1 | ******************** |
| JS47 | 1 | ******************** |
| JS48 | 1 | ******************** |
| JS49 | 1 | ******************** |
| JS50 | 1 | ******************** |
| LC1 | 1 | ******************** |
| LC2 | 1 | ******************** |
| LC4 | 1 | ******************** |
| LC6 | 1 | ******************** |
| LC7 | 1 | ******************** |
| LC8 | 1 | ******************** |
| LC9 | 1 | ******************** |
| LC11 | 1 | ******************** |
| LC13 | 1 | ******************** |
| LC14 | 1 | ******************** |
| LC15 | 1 | ******************** |
| LC16 | 1 | ******************** |
| LC17 | 1 | ******************** |
| LC18 | 1 | ******************** |
| LC19 | 1 | ******************** |
| LC20 | 1 | ******************** |
| LC21 | 1 | ******************** |
| LC22 | 1 | ******************** |
| LC23 | 1 | ******************** |
| LC24 | 1 | ******************** |
| LC25 | 1 | ******************** |
| LC26 | 1 | ******************** |
| LC27 | 1 | ******************** |
| LC28 | 1 | ******************** |
| LC29 | 1 | ******************** |
| LC30 | 1 | ******************** |
| LC31 | 1 | ******************** |
| LC32 | 1 | ******************** |
| LC33 | 1 | ******************** |
| LC34 | 1 | ******************** |
| LC36 | 1 | ******************** |
| AS1 | 1 | ******************** |
| AS2 | 1 | ******************** |
| AS3 | 1 | ******************** |
| AS5 | 1 | ******************** |
| AS6 | 1 | ******************** |
| AS8 | 1 | ******************** |
| AS9 | 1 | ******************** |
| AS10 | 1 | ******************** |
| AS11 | 1 | ******************** |
| AS12 | 1 | ******************** |
| AS14 | 1 | ******************** |
| AS15 | 1 | ******************** |
| AS17 | 1 | ******************** |
| AS18 | 1 | ******************** |
| AS19 | 1 | ******************** |
| AS20 | 1 | ******************** |
| AS22 | 1 | ******************** |
| AS23 | 1 | ******************** |
| AS24 | 1 | ******************** |
| AS25 | 1 | ******************** |
| AS26 | 1 | ******************** |
| AS27 | 1 | ******************** |
| AS28 | 1 | ******************** |
| AS29 | 1 | ******************** |
| T122.12 | 1 | ******************** |
| T122.12 and peripheral blood monocyte | 1 | ******************** |
| PH63-14, PH63-15 | 1 | ******************** |
| peripheral blood monocyte | 1 | ******************** |
| SP(3,4,18,24,27,42) | 1 | ******************** |
| SP(1,12,14,16,23,35) | 1 | ******************** |
| SP17 | 1 | ******************** |
| SP25 | 1 | ******************** |
| SP6 | 1 | ******************** |
| SP20 | 1 | ******************** |
| SP43 | 1 | ******************** |
| SP2 | 1 | ******************** |
| SP8 | 1 | ******************** |
| SP19 | 1 | ******************** |
| SP(10,18,24,26,27,42) | 1 | ******************** |
| SP4 | 1 | ******************** |
| SP(12,16,23,35) | 1 | ******************** |
| SP7 | 1 | ******************** |
| SV-40 transformed | 1 | ******************** |
| MV3 | 1 | ******************** |
| HSC172 (16PDL) | 1 | ******************** |
| VH-64 | 1 | ******************** |
| SW613-S | 1 | ******************** |
| colon carcinoma SW613-S | 1 | ******************** |
| HDLM-2 | 1 | ******************** |
| Karpas 299 | 1 | ******************** |
| KM-H2 | 1 | ******************** |
| L 1236 | 1 | ******************** |
| L 428 | 1 | ******************** |
| Tera II | 1 | ******************** |
| NK92 | 1 | ******************** |
| YAR | 1 | ******************** |
| TF1 | 1 | ******************** |
| OZB | 1 | ******************** |
| Human hybridoma | 1 | ******************** |
| Epstein Barr Virus-transformed B cells and human hybridoma | 1 | ******************** |
| Epstein Barr-transformed B lymphocyte and human hybridoma | 1 | ******************** |
| Epstein Barr Virus-transformed B lymphocytes and human hybridoma | 1 | ******************** |
| SW 480 | 1 | ******************** |
| AGS and KatoIII | 1 | ******************** |
| adenocarcinoma cell line AGS | 1 | ******************** |
| NB4 cells | 1 | ******************** |
| human medullary thyroid | 1 | ******************** |
| 3C | 1 | ******************** |
| ALBA | 1 | ******************** |
| HeLa (ATCC # CCL2) | 1 | ******************** |
| HOG | 1 | ******************** |
| ROHA, Hairy leukemia cell line | 1 | ******************** |
| weri | 1 | ******************** |
| BV173 | 1 | ******************** |
| Capan1 | 1 | ******************** |
| HEK-293 | 1 | ******************** |
| Thyrocarcinoma cell line ATCC CRL1803 | 1 | ******************** |
| BWTG3 | 1 | ******************** |
| pancreatic adenocarcinoma cell line HPAF | 1 | ******************** |
| VH10SV | 1 | ******************** |
| leukemia cell line JuanaW | 1 | ******************** |
| SW1353 | 1 | ******************** |
| MOLT-4V | 1 | ******************** |
| NT2, undifferentiated teratocarcinoma cell line | 1 | ******************** |
| Fetal lung | 1 | ******************** |
| Lymphoblastoid cell line, testis, fetal lung | 1 | ******************** |
| LB23-SAR | 1 | ******************** |
| A-549 | 1 | ******************** |
| K562, Jurkat, Molt4 | 1 | ******************** |
| 721.45 | 1 | ******************** |
| teratocarcinoma | 1 | ******************** |
| MCF7, T47D, ZR75-1, MDAMB-453 | 1 | ******************** |
| TEM | 1 | ******************** |
| AMALA | 1 | ******************** |
| MI | 1 | ******************** |
| KGU | 1 | ******************** |
| FS | 1 | ******************** |
| FPAF | 1 | ******************** |
| 1F6 | 1 | ******************** |
| AML14.3D10 | 1 | ******************** |
| BS464263 | 1 | ******************** |
| A431, Hep3B, HT1080, T2, SW480, U378 | 1 | ******************** |
| IM1-22 | 1 | ******************** |
| IM1-25 | 1 | ******************** |
| IM2-1 | 1 | ******************** |
| IM2-12 | 1 | ******************** |
| IM2-23 | 1 | ******************** |
| IM3-17 | 1 | ******************** |
| AS4-14 | 1 | ******************** |
| AS4-7 | 1 | ******************** |
| A549 cell line | 1 | ******************** |
| MDA-MB-231 and MCF-7 | 1 | ******************** |
| u937, TPA stimulated | 1 | ******************** |
| UT7 and Jurkat | 1 | ******************** |
| VAL lymphoma | 1 | ******************** |
| Panc-1, poorly-differentiated pancreatic adenocarcinoma cell line | 1 | ******************** |
| adult T cell leukemia cell line JuanaW | 1 | ******************** |
| JuaW | 1 | ******************** |
| RH28 | 1 | ******************** |
| ICB112 | 1 | ******************** |
| C91-PL | 1 | ******************** |
| HTLV-1-transformed C91-PL | 1 | ******************** |
| NTERA2 | 1 | ******************** |
| MZ7-MEL | 1 | ******************** |
| SHEP | 1 | ******************** |
| OAW28 | 1 | ******************** |
| Mcf | 1 | ******************** |
| NSK | 1 | ******************** |
| FLG 29.1 | 1 | ******************** |
| HBL100 | 1 | ******************** |
| HepG2 (hepatocellular carcinoma) | 1 | ******************** |
| HSV33 | 1 | ******************** |
| LC284 | 1 | ******************** |
| HepG2, hepatocellular carcinoma | 1 | ******************** |
| HDLM2 | 1 | ******************** |
| L1236 | 1 | ******************** |
| B-lymphocyte | 1 | ******************** |
| 464b | 1 | ******************** |
| M07e | 1 | ******************** |
| BREP 270898 | 1 | ******************** |
| BREP 73105 | 1 | ******************** |
| SY5Y human neuroblastoma | 1 | ******************** |
| HK-2 | 1 | ******************** |
| AsPC1 | 1 | ******************** |
| hPCPs | 1 | ******************** |
| C5RO | 1 | ******************** |
| T47D cells | 1 | ******************** |
| MR65 | 1 | ******************** |
| BEN | 1 | ******************** |
| SFL004 | 1 | ******************** |
| bulk T cell line | 1 | ******************** |
| JCR | 1 | ******************** |
| JTH | 1 | ******************** |
| SEM | 1 | ******************** |
| KASUMI2 | 1 | ******************** |
| MHH-CALL3 | 1 | ******************** |
| BEL-1 | 1 | ******************** |
| SUP-B15 | 1 | ******************** |
| HPB-NULL | 1 | ******************** |
| MEC1 | 1 | ******************** |
| Karpas-422 | 1 | ******************** |
| SP53 | 1 | ******************** |
| Granta-519 | 1 | ******************** |
| JVM-2 | 1 | ******************** |
| NCEB-1 | 1 | ******************** |
| HBL-2 | 1 | ******************** |
| Jeko-1 | 1 | ******************** |
| NCI-H358 | 1 | ******************** |
| D05-GS melanoma | 1 | ******************** |
| D14-SJR melanoma | 1 | ******************** |
| immortalised B-cells | 1 | ******************** |
| ZR 75 | 1 | ******************** |
| PNT2 | 1 | ******************** |
| SHSY5Y | 1 | ******************** |
| HLE_B3 | 1 | ******************** |
| A549; Calu 6 | 1 | ******************** |
| HCA-7 | 1 | ******************** |
| HeLa; MCF7 | 1 | ******************** |
| ATCC CRL-1651 | 1 | ******************** |
| MCF-7 breast cancer | 1 | ******************** |
| U251 | 1 | ******************** |
| U-373 MG | 1 | ******************** |
| ARH-77 | 1 | ******************** |
| G3361/CDDP melanoma cisplatin-resistant | 1 | ******************** |
| HT-29-MTX | 1 | ******************** |
| HTB-10 | 1 | ******************** |
| THP | 1 | ******************** |
| AMA | 1 | ******************** |
| multiple myeloma cell line ARH-77 | 1 | ******************** |
| BV173 pro-B lymphoma | 1 | ******************** |
| ST98-773 | 1 | ******************** |
| 166931 | 1 | ******************** |
| ST94-114 | 1 | ******************** |
| prostate cancer cell line PC-3 | 1 | ******************** |
| squamous cancer cell line | 1 | ******************** |
| 2BS | 1 | ******************** |
| thyroid adenoma | 1 | ******************** |
| U373 | 1 | ******************** |
| U138-MG | 1 | ******************** |
| diploid line 2BS | 1 | ******************** |
| SML | 1 | ******************** |
| ZR-75-30 | 1 | ******************** |
| HSC93 normal lymphoblast | 1 | ******************** |
| HUVEC-C | 1 | ******************** |
| HCT116 | 1 | ******************** |
| MCF-12A | 1 | ******************** |
| 11.9.14 | 1 | ******************** |
| pooled MCF7, ZR-75-1, SK-BR-3, MDA-MB-231, hTERT-HME1, and LNCaP | 1 | ******************** |
| Int407 | 1 | ******************** |
| Bowes melanoma | 1 | ******************** |
| MGC3 | 1 | ******************** |
| MGC72 | 1 | ******************** |
| MGC17 | 1 | ******************** |
| MGC67 | 1 | ******************** |
| MGC85 | 1 | ******************** |
| A-431 | 1 | ******************** |
| fetal eye UI-E-EO1 | 1 | ******************** |
| DHL16 | 1 | ******************** |
| SNB19 | 1 | ******************** |
| Be(2)C neuroblastoma | 1 | ******************** |
| EOL-1 | 1 | ******************** |
| embryonic stem cell line HSF-6 | 1 | ******************** |
| umbilical vein endothelial cell | 1 | ******************** |
| SKNAS | 1 | ******************** |
| HCC1806 | 1 | ******************** |
| SV40-transformed renal proximal tubular cells (HKC) | 1 | ******************** |
| CF3 | 1 | ******************** |
| SK-BR-3 | 1 | ******************** |
| MDA-MB 231 | 1 | ******************** |
| OVCAR-3 | 1 | ******************** |
| BT-549 | 1 | ******************** |
| MCF-12F | 1 | ******************** |
| H510 | 1 | ******************** |
| DG75 | 1 | ******************** |
| T-cell line derived from donor exposed to HDI occupationally but who did not have asthma based on methacholine and specific inhalation challenge | 1 | ******************** |
| T-cell line derived from non-asthmatic subject who was exposed to HDI occupationally | 1 | ******************** |
| T-cell line derived from occupationally exposed HDI asthmatic (based on specific inhalational challenge testing) | 1 | ******************** |
| T-47D and MCF-7 human breast cancer | 1 | ******************** |
| HITB5 | 1 | ******************** |
| K562; ATCC CCL-243 | 1 | ******************** |
| HEK293; A549 | 1 | ******************** |
| HeLa S3; MOLT4 | 1 | ******************** |
| monochromosomal hybrid GM11712 | 1 | ******************** |
| monochromosomal hybrid GM 11580 | 1 | ******************** |
| monochromosomal hybrid GM13259 | 1 | ******************** |
| monochromosomal hybrid GM10449 | 1 | ******************** |
| monochromosomal hybrid GM 13260 | 1 | ******************** |
| monochromosomal hybrid GM 11712 | 1 | ******************** |
| Herpes papio transformed B cell line | 1 | ******************** |
| LNCaP-1F5 | 1 | ******************** |
| A375SM | 1 | ******************** |
| Tera-1 | 1 | ******************** |
| RB-reconstituted MDA-MB-468; RB-reconstituted Saos-2 | 1 | ******************** |
| B5/589 | 1 | ******************** |
| NCI-H292 | 1 | ******************** |
| Hep 3B; ATCC HB-8064 | 1 | ******************** |
| Caco-2 BBe 5E6L | 1 | ******************** |
| Hep-SK1 | 1 | ******************** |
| U-87 MG | 1 | ******************** |
| H441 | 1 | ******************** |
| IMR90 | 1 | ******************** |
| SPC-A-1/CDDP | 1 | ******************** |
| HVS transformed T lymphocytes | 1 | ******************** |
| A-498 | 1 | ******************** |
| CEM-CM3 | 1 | ******************** |
| HCT-15 | 1 | ******************** |
| 2G9 | 1 | ******************** |
| 9F11 | 1 | ******************** |
| Jurkat T-lymphoma | 1 | ******************** |
| ABd | 1 | ******************** |
| Ramos (Burkitt's Lymphoma) | 1 | ******************** |
| HEK 293; H15; A549 | 1 | ******************** |
| H157; A549 | 1 | ******************** |
| HEK 293; A549 | 1 | ******************** |
| H157 | 1 | ******************** |
| MonoMac-6 | 1 | ******************** |
| 29a | 1 | ******************** |
| 29b | 1 | ******************** |
| BGC-823 | 1 | ******************** |
| SNUhES | 1 | ******************** |
| HEK293: HeLa | 1 | ******************** |
| SB | 1 | ******************** |
| CV1 | 1 | ******************** |
| LLCMK2 | 1 | ******************** |
| hybridoma F428; hybridoma F431 | 1 | ******************** |
| hybridoma F429 | 1 | ******************** |
| hybridoma F431 | 1 | ******************** |
| hybridoma F428; hybridoma F429 | 1 | ******************** |
| FaDu | 1 | ******************** |
| BT 549 | 1 | ******************** |
| ATCC HTB 37 | 1 | ******************** |
| TS-2 ALL | 1 | ******************** |
| Jurkat-T; HeLa | 1 | ******************** |
| owl monkey kidney cells (omk) | 1 | ******************** |
| ARPE-19 + TNFalpha | 1 | ******************** |
| DB-1 | 1 | ******************** |
| COLO 205; ATCC CCL-222 | 1 | ******************** |
| GM11687 | 1 | ******************** |
| CCL-110 (Detroit 551) treated with beta-interferon | 1 | ******************** |
| 293T cells | 1 | ******************** |
| Jurkat/leukemic T-cell | 1 | ******************** |
| 91RD215; VH10 | 1 | ******************** |
| SP-49 | 1 | ******************** |
| CD 8 MS 971 | 1 | ******************** |
| Hub7 | 1 | ******************** |
| NT2N | 1 | ******************** |
| IHW09366, Daudi | 1 | ******************** |
| IHW09049, IBW9 | 1 | ******************** |
| IHW09366, Daudi; IHW09376, FH4; IHW09032, BSM | 1 | ******************** |
| IHW09005, HOM2; IHW09014, MGAR; IHW09051, PITOUT; IHW09095, WIN | 1 | ******************** |
| IHW09021, RSH | 1 | ******************** |
| JRPAY, sample from bone marrow patient | 1 | ******************** |
| IHW09376, FH4 | 1 | ******************** |
| IHW09047, PLH | 1 | ******************** |
| IHW09060, CB6B | 1 | ******************** |
| Hela; HEK293 | 1 | ******************** |
| LTEP-a-2 | 1 | ******************** |
| PC3; PC3M | 1 | ******************** |
| B-cap37 | 1 | ******************** |
| IHW09076; T7526 | 1 | ******************** |
| IHW09291; APD; IHW09373; FH1 | 1 | ******************** |
| IHW09095; WIN | 1 | ******************** |
| IHW09020; QBL | 1 | ******************** |
| heat shocked HeLa | 1 | ******************** |
| UACC-257 | 1 | ******************** |
| melanoma SKmel23 | 1 | ******************** |
| Hep 3B | 1 | ******************** |
| TP31 | 1 | ******************** |
| LCK-Jurkat | 1 | ******************** |
| ATCC CCL-81; Vero | 1 | ******************** |
| ATCC CCL-185; A549 | 1 | ******************** |
| sporadic Burkitt lymphoma | 1 | ******************** |
| SQMK-FP | 1 | ******************** |
| IMR-5; IMR-32; IMR-5/75 | 1 | ******************** |
| CRL-1573; 293 | 1 | ******************** |
| LTED | 1 | ******************** |
| bladder carcinoma | 1 | ******************** |
| bladder carcinoma; pancreatic carcinoma | 1 | ******************** |
| GRB2012722 | 1 | ******************** |
| GRB2024705 | 1 | ******************** |
| GRB2022544 | 1 | ******************** |
| GRB2010154 | 1 | ******************** |
| HEK293T | 1 | ******************** |
| multiple myoloma cell line ANBL6 subline | 1 | ******************** |
| MARC145 | 1 | ******************** |
| human erythroleukemia cell-line (HEL) | 1 | ******************** |
| Vero E6 cells | 1 | ******************** |
| T-lymphoma Jurkat | 1 | ******************** |
| KB cells | 1 | ******************** |
| T cell hybridoma (AC5-8) | 1 | ******************** |
| acute promyelocytic cell (ML3) | 1 | ******************** |
| MGC 1 | 1 | ******************** |
| KU-812F | 1 | ******************** |
| G-401 (ATCC CRL 1441) | 1 | ******************** |
| AKIBA | 1 | ******************** |
| promonocytic cell line U937 | 1 | ******************** |
| JVK-03 | 1 | ******************** |
| RPMI 1788 | 1 | ******************** |
| QGP-1NL | 1 | ******************** |
| 5C10 | 1 | ******************** |
| KB and HeLa | 1 | ******************** |
| RPMI4265 | 1 | ******************** |
| 46JVM-A1 | 1 | ******************** |
| 46JVM-A11 | 1 | ******************** |
| 14MT-B3 | 1 | ******************** |
| 14MT-C5 | 1 | ******************** |
| 14MT-D1 | 1 | ******************** |
| AY29 | 1 | ******************** |
| VS C64.03 | 1 | ******************** |
| VS F41.03 | 1 | ******************** |
| 4-1D4 | 1 | ******************** |
| 341-44 | 1 | ******************** |
| 341-72 | 1 | ******************** |
| AY7 | 1 | ******************** |
| AY28 | 1 | ******************** |
| AY51 | 1 | ******************** |
| 4-1A8 | 1 | ******************** |
| 4-1A7 | 1 | ******************** |
| VS F55.03 | 1 | ******************** |
| Eahy926 and HUVEC | 1 | ******************** |
| KYN-1 | 1 | ******************** |
| PEER | 1 | ******************** |
| hepatoma G2 | 1 | ******************** |
| SW 1116 | 1 | ******************** |
| TIG-3 | 1 | ******************** |
| Kasumi-1 | 1 | ******************** |
| HPB-MLT | 1 | ******************** |
| HOS TE85 | 1 | ******************** |
| HT-1376 | 1 | ******************** |
| SCLC-SA | 1 | ******************** |
| HMV-II melanoma | 1 | ******************** |
| MOLT 4 clone 8 | 1 | ******************** |
| KU812E | 1 | ******************** |
| HPBL MLTC(-) | 1 | ******************** |
| HPBL3x | 1 | ******************** |
| TcHST2 | 1 | ******************** |
| TcSSTW | 1 | ******************** |
| A-172 | 1 | ******************** |
| U118-MG | 1 | ******************** |
| KUT-2 | 1 | ******************** |
| DU145, LNCaP, PC3 | 1 | ******************** |
| MOLT-4 cl. 8 | 1 | ******************** |
| Li21 | 1 | ******************** |
| EoL-1 (butyrate-stimulated) | 1 | ******************** |
| MG-63 | 1 | ******************** |
| TYKnuR | 1 | ******************** |
| M73 | 1 | ******************** |
| RPMI1788 (EB virus-transformed B-cell line) | 1 | ******************** |
| MIY-1 | 1 | ******************** |
| MIY-2 | 1 | ******************** |
| MIY-3 | 1 | ******************** |
| EBV-immortalized peripheral B-lymphocyte | 1 | ******************** |
| RD (CCL 136 human embryonal rhabdomyosarcoma) | 1 | ******************** |
| TE 6 | 1 | ******************** |
| EBV-transformed peripheral B-cell line and Raji cell line | 1 | ******************** |
| BOY | 1 | ******************** |
| SF-HT (ATL cell line) | 1 | ******************** |
| HL60 (promyelocytic leukemia cell) | 1 | ******************** |
| AMS3 | 1 | ******************** |
| YN-1-0-A | 1 | ******************** |
| HPC-Y5 | 1 | ******************** |
| ACHN | 1 | ******************** |
| SAJ022 | 1 | ******************** |
| human glioblastoma cell line, T98G | 1 | ******************** |
| melanoma SK-Mel-28 | 1 | ******************** |
| HepG2 cells | 1 | ******************** |
| GaCa | 1 | ******************** |
| TIG3 | 1 | ******************** |
| CGM1 | 1 | ******************** |
| COLO 201 | 1 | ******************** |
| ATL-16T | 1 | ******************** |
| TIG-1-20 | 1 | ******************** |
| HeLa (RCB0007) | 1 | ******************** |
| NEC14 | 1 | ******************** |
| embryonic carcinoma, NEC14 | 1 | ******************** |
| KD | 1 | ******************** |
| mAb105 producing hybridoma cell | 1 | ******************** |
| mAb107 producing hybridoma cell | 1 | ******************** |
| mAb52 producing hybridoma cell | 1 | ******************** |
| mAb53 producing hybridoma cell | 1 | ******************** |
| mAb55 producing hybridoma cell | 1 | ******************** |
| mAb56 producing hybridoma cell | 1 | ******************** |
| mAb57 producing hybridoma cell | 1 | ******************** |
| mAb58 producing hybridoma cell | 1 | ******************** |
| mAb59 producing hybridoma cell | 1 | ******************** |
| ACC-LC-170 | 1 | ******************** |
| KPB-M15 | 1 | ******************** |
| HepG2 liver tumor | 1 | ******************** |
| primary-cultured | 1 | ******************** |
| 21 | 1 | ******************** |
| HUE4 | 1 | ******************** |
| MCAS | 1 | ******************** |
| SMKT-R3 | 1 | ******************** |
| KM-102 | 1 | ******************** |
| NCC-MS-1 CDDP | 1 | ******************** |
| IKD | 1 | ******************** |
| TPC-1 | 1 | ******************** |
| GM637 | 1 | ******************** |
| MT-2 | 1 | ******************** |
| HeLa cell line KB | 1 | ******************** |
| U937; ATCC CRL-1593.2 | 1 | ******************** |
| MARC-145; MA104 | 1 | ******************** |
| K562 and CD34 positive | 1 | ******************** |
| reticulocyte | 1 | ******************** |
| A549 lung adenocarcinoma | 1 | ******************** |
| HCT 116; ATCC CCL-247 | 1 | ******************** |
| COS7-2 | 1 | ******************** |
| 70N normal breast epithelial cells | 1 | ******************** |
| RF-AN 1983 | 1 | ******************** |
| RF-AN 2004 | 1 | ******************** |
| BSC-1 | 1 | ******************** |
| SupT1 | 1 | ******************** |
| MDA-MB-468 | 1 | ******************** |
| MDA | 1 | ******************** |
| SKOV3 | 1 | ******************** |
| teratocarcinoma cell line, NTera2D1 | 1 | ******************** |
| LCK-deficient Jurkat | 1 | ******************** |
| MDAMB 231 | 1 | ******************** |
| OVCAR | 1 | ******************** |
| T46D | 1 | ******************** |
| PANC28 | 1 | ******************** |
| HPAC | 1 | ******************** |
| PI | 1 | ******************** |
| BxPC3 | 1 | ******************** |
| FG (Colo357 F.S) | 1 | ******************** |
| differentiated Ntera 2D1 | 1 | ******************** |
| drug selected breast cancer cells MCF-7/AdrVp | 1 | ******************** |
| drug selected ovarian cancer cells Igrov1/MX3 | 1 | ******************** |
| drug selected ovarian cancer cells Igrov1/T8 | 1 | ******************** |
| choriocarcinoma cells BeWo | 1 | ******************** |
| choriocarcinoma cells JAR | 1 | ******************** |
| CHME | 1 | ******************** |
| NT2-N | 1 | ******************** |
| NT2-A | 1 | ******************** |
| CMMT 110/C1 | 1 | ******************** |
| Hec50co | 1 | ******************** |
| MCF-10A | 1 | ******************** |
| FaDu, HeLa and SiHa tumor cell lines | 1 | ******************** |
| T cell leukemia | 1 | ******************** |
| BLCL | 1 | ******************** |
| CH521 | 1 | ******************** |
| 96A | 1 | ******************** |
| 4X0200 | 1 | ******************** |
| CH1581 | 1 | ******************** |
| 4X0312 | 1 | ******************** |
| FrhK4 | 1 | ******************** |
| 1328 | 1 | ******************** |
| 10364 | 1 | ******************** |
| 1410 | 1 | ******************** |
| CB0609 | 1 | ******************** |
| 4X0320 | 1 | ******************** |
| LNCaP Hollow Fibre Model | 1 | ******************** |
| IL4- and CD40L-stimulated MedB-1 | 1 | ******************** |
| monoclonal 24.3.1 | 1 | ******************** |
| K562; MM-S1; Ovcar-8 | 1 | ******************** |
| monoclonal 31.1.1 | 1 | ******************** |
| monoclonal 37.2.1 | 1 | ******************** |
| 16HBE-140 | 1 | ******************** |
| CCL-110 | 1 | ******************** |
| SK-MEL 31 | 1 | ******************** |
| KU812 | 1 | ******************** |
| HT29-D4 | 1 | ******************** |
| COS 7 | 1 | ******************** |
| Huh 7 | 1 | ******************** |
| pancreatic adenocarcinoma Bxpc-3 | 1 | ******************** |
| U87-MG | 1 | ******************** |
| HEK-293; HL-60 | 1 | ******************** |
| U937; THP-1 | 1 | ******************** |
| L-1236 | 1 | ******************** |
| L-540 | 1 | ******************** |
| A549; HeLa | 1 | ******************** |
| MB231 | 1 | ******************** |
| HO-8910 | 1 | ******************** |
| MCF-10A-Ras/ErbB2 | 1 | ******************** |
| human neuroblastoma SK-NMC | 1 | ******************** |
| T98G | 1 | ******************** |
| PBL | 1 | ******************** |
| dermal fibroblast | 1 | ******************** |
| ML-1 | 1 | ******************** |
| A875 | 1 | ******************** |
| SJSA-1 | 1 | ******************** |
| SMMC-7721 | 1 | ******************** |
| Vaco432 | 1 | ******************** |
| Mutu III | 1 | ******************** |
| TMX | 1 | ******************** |
| SNB-19 | 1 | ******************** |
| MDA-MB-231 breast adenocarcinoma; HT1080 fibrosarcoma | 1 | ******************** |
| U87 | 1 | ******************** |
| HL1011B | 1 | ******************** |
| SK5 | 1 | ******************** |
| 3B6 | 1 | ******************** |
| IMR-90 leukemic | 1 | ******************** |
| of S.L.C.Woo | 1 | ******************** |
| HPB-ALL ; CEM | 1 | ******************** |
| HL60R | 1 | ******************** |
| Molt 4 | 1 | ******************** |
| neutrophyl | 1 | ******************** |
| HepGT2 | 1 | ******************** |
| BT20 | 1 | ******************** |
| HPAF-CD11 | 1 | ******************** |
| NG9/9.1 hybridoma | 1 | ******************** |
| JM | 1 | ******************** |
| 1027 F57 | 1 | ******************** |
| LS174T | 1 | ******************** |
| BIN-67 | 1 | ******************** |
| hybridoma M7B5 | 1 | ******************** |
| hybridoma T15G1 | 1 | ******************** |
| U1242MG | 1 | ******************** |
| D65MG | 1 | ******************** |
| HL-60 3c5I | 1 | ******************** |
| RD-ES-1, A2095 | 1 | ******************** |
| 102DRF, 139DRD AND 2DLE (CTL CLONES) | 1 | ******************** |
| HeLa cell subclone D98/AH2 | 1 | ******************** |
| NF1002 | 1 | ******************** |
| F3b6 mouse x human | 1 | ******************** |
| 265-695 | 1 | ******************** |
| MD3-4 | 1 | ******************** |
| OST577 | 1 | ******************** |
| ZM1-1 | 1 | ******************** |
| L2B5 | 1 | ******************** |
| L2B8 | 1 | ******************** |
| L2BS1 | 1 | ******************** |
| L2D10 | 1 | ******************** |
| L2E7 | 1 | ******************** |
| L3G11 | 1 | ******************** |
| s4D5 | 1 | ******************** |
| s5A10 | 1 | ******************** |
| s5D11 | 1 | ******************** |
| s5D4 | 1 | ******************** |
| s6A8 | 1 | ******************** |
| s6C8 | 1 | ******************** |
| s6E11 | 1 | ******************** |
| s6H12 | 1 | ******************** |
| s6H7 | 1 | ******************** |
| s6H9 | 1 | ******************** |
| L2A12 | 1 | ******************** |
| L2B10 | 1 | ******************** |
| L2E5 | 1 | ******************** |
| L2E8 | 1 | ******************** |
| L2F10 | 1 | ******************** |
| L2H7 | 1 | ******************** |
| L3A10 | 1 | ******************** |
| L3B2 | 1 | ******************** |
| L3B6 | 1 | ******************** |
| L3G5 | 1 | ******************** |
| s5A9 | 1 | ******************** |
| s5B7 | 1 | ******************** |
| s6A3 | 1 | ******************** |
| s6BG8 | 1 | ******************** |
| s6C9 | 1 | ******************** |
| s6G4 | 1 | ******************** |
| M28 somatic cell hybrid | 1 | ******************** |
| lymphoblastoid cell line | 1 | ******************** |
| HAF10 human-mouse heterohybridoma | 1 | ******************** |
| WI26 VA4 | 1 | ******************** |
| 37GRK | 1 | ******************** |
| 0041 (M. Del Monte) | 1 | ******************** |
| 0041 | 1 | ******************** |
| EBV transformed KY | 1 | ******************** |
| MRC-5 V2 | 1 | ******************** |
| 373 | 1 | ******************** |
| MP-1 | 1 | ******************** |
| BL41/B95-8 | 1 | ******************** |
| ML-1; U-931 | 1 | ******************** |
| TT | 1 | ******************** |
| lymphoblastoid transformed cell line | 1 | ******************** |
| NCI-N417 | 1 | ******************** |
| stratagene E. coli XL1-blue | 1 | ******************** |
| homozygous typing cell line SA | 1 | ******************** |
| differentiated HL60 | 1 | ******************** |
| retinal pigment epithelium (0041 from M. Del Monte) | 1 | ******************** |
| LBUF | 1 | ******************** |
| ATCC TIB 161 | 1 | ******************** |
| HT29-18 | 1 | ******************** |
| CALOGERO (#9084) | 1 | ******************** |
| con A induced PBL | 1 | ******************** |
| B5.62 | 1 | ******************** |
| BS6 | 1 | ******************** |
| B6.6 | 1 | ******************** |
| B5.65 | 1 | ******************** |
| BS2 | 1 | ******************** |
| homozygous typing cell lines MADURA, AMAI | 1 | ******************** |
| GLC-1 | 1 | ******************** |
| AC5 | 1 | ******************** |
| II-23.D7 cells stimulated with PMA for 4 hr | 1 | ******************** |
| Jurkat/Swei | 1 | ******************** |
| A101D | 1 | ******************** |
| THAI742 | 1 | ******************** |
| LEE743 | 1 | ******************** |
| RCE11 | 1 | ******************** |
| Nt2D1 | 1 | ******************** |
| L612 EBV transformed B cell | 1 | ******************** |
| L612 EBV transformed B-cell | 1 | ******************** |
| HSB-2 | 1 | ******************** |
| rhabdomyosarcoma | 1 | ******************** |
| HOB1/VCR1.0 | 1 | ******************** |
| 43D-Cl2 | 1 | ******************** |
| EBV transformed B-cell | 1 | ******************** |
| K562 human erythroleukemia | 1 | ******************** |
| B22 | 1 | ******************** |
| Ann2 | 1 | ******************** |
| IMR-90, U373 (in part) | 1 | ******************** |
| D38 | 1 | ******************** |
| RSA-ND | 1 | ******************** |
| Namalva | 1 | ******************** |
| AGS 1-6-30-1 | 1 | ******************** |
| W7079 | 1 | ******************** |
| G2 | 1 | ******************** |
| 35020 | 1 | ******************** |
| A2058 | 1 | ******************** |
| CMK11-5 | 1 | ******************** |
| EBV-transformed cell line | 1 | ******************** |
| U1-Mel | 1 | ******************** |
| B-LCL CODI | 1 | ******************** |
| CAKI-2 | 1 | ******************** |
| PA-1 | 1 | ******************** |
| 19148 | 1 | ******************** |
| EBC transformed B cell line SS713 | 1 | ******************** |
| Jurkai | 1 | ******************** |
| BL-29 | 1 | ******************** |
| CRL-1262 | 1 | ******************** |
| EBV transformed | 1 | ******************** |
| EBV transformed cell line | 1 | ******************** |
| THP-1 (Phorbol ester activated) | 1 | ******************** |
| U118 | 1 | ******************** |
| MLH (EBV transformed B cell line) | 1 | ******************** |
| RSA (EBV transformed B cell line) | 1 | ******************** |
| RS4;11 | 1 | ******************** |
| Namalwa and UOC-B1 | 1 | ******************** |
| B3 | 1 | ******************** |
| DPSO 114/74 | 1 | ******************** |
| Human Lopez natural killer cell leukemia | 1 | ******************** |
| HGT-1 | 1 | ******************** |
| 417.32F4.8.5 | 1 | ******************** |
| 416.F2.2.34 | 1 | ******************** |
| 417.F25 | 1 | ******************** |
| 417.F21.5 | 1 | ******************** |
| 417.F14 | 1 | ******************** |
| 417.F22 | 1 | ******************** |
| 417.F1.1.35 | 1 | ******************** |
| 417.F23 | 1 | ******************** |
| 417.7.3.1 | 1 | ******************** |
| 417.F29 | 1 | ******************** |
| 417.32.F24.7 | 1 | ******************** |
| 417.F33.3 | 1 | ******************** |
| 417.F32.36 | 1 | ******************** |
| 417.F32.26 | 1 | ******************** |
| 417.F28 | 1 | ******************** |
| 417.F9.5 | 1 | ******************** |
| 418.F63.35 | 1 | ******************** |
| Tera-2, U937, HL-60 | 1 | ******************** |
| GM 639 | 1 | ******************** |
| DLD-1 | 1 | ******************** |
| IMR91 and CF150-6 | 1 | ******************** |
| JM101 | 1 | ******************** |
| Tera 2 | 1 | ******************** |
| 032891 | 1 | ******************** |
| PBMC | 1 | ******************** |
| 5E1 | 1 | ******************** |
| RPMI 8402 | 1 | ******************** |
| BH1 | 1 | ******************** |
| lymphoblastoma | 1 | ******************** |
| lymphocyte | 1 | ******************** |
| MO53 | 1 | ******************** |
| MO58 | 1 | ******************** |
| MO81 | 1 | ******************** |
| MO61 | 1 | ******************** |
| HCV-2 | 1 | ******************** |
| HCV-3 | 1 | ******************** |
| HCV-63 | 1 | ******************** |
| HCV-65 | 1 | ******************** |
| C304 | 1 | ******************** |
| Hela 3T3-L1 | 1 | ******************** |
| B-LCL | 1 | ******************** |
| Daudi Burkitt's lymphoma cell line | 1 | ******************** |
| CCF-STTG1 | 1 | ******************** |
| erythroleukemic K562 | 1 | ******************** |
| LBR 295 | 1 | ******************** |
| LBR 962 | 1 | ******************** |
| LBR 1045 | 1 | ******************** |
| LBR 1189 | 1 | ******************** |
| PHB 1213 | 1 | ******************** |
| KES 643 | 1 | ******************** |
| LBR 150 | 1 | ******************** |
| LBR 271 | 1 | ******************** |
| LBR 1104 | 1 | ******************** |
| E. coli DH5 (pjptHUMB) | 1 | ******************** |
| EBV-transformed 3104 B cell line | 1 | ******************** |
| KK | 1 | ******************** |
| DOND | 1 | ******************** |
| HT29 cl-CIII | 1 | ******************** |
| Tera-2 (EC) | 1 | ******************** |
| M426, WI38 | 1 | ******************** |
| Tera-2 | 1 | ******************** |
| HEL; MLT; Daudi | 1 | ******************** |
| 9500 | 1 | ******************** |
| 9604 | 1 | ******************** |
| 9702 | 1 | ******************** |
| B122-2 | 1 | ******************** |
| B6204 | 1 | ******************** |
| B8801 | 1 | ******************** |
| B8807 | 1 | ******************** |
| B8815 | 1 | ******************** |
| C119 | 1 | ******************** |
| C471 | 1 | ******************** |
| MRE 148 | 1 | ******************** |
| GEE018 | 1 | ******************** |
| 123AV16-1 | 1 | ******************** |
| platelet | 1 | ******************** |
| KAS116 | 1 | ******************** |
| EMJ | 1 | ******************** |
| KAS011 | 1 | ******************** |
| E418 1324 | 1 | ******************** |
| MOU | 1 | ******************** |
| BOLETH | 1 | ******************** |
| DKB, YT | 1 | ******************** |
| SPACH | 1 | ******************** |
| BM16 | 1 | ******************** |
| LUY | 1 | ******************** |
| DkB | 1 | ******************** |
| AMAI | 1 | ******************** |
| OMW | 1 | ******************** |
| keratinocytes | 1 | ******************** |
| CTL 100GRK | 1 | ******************** |
| CTL 11.8SLG | 1 | ******************** |
| CTL 11SRY, CTL 40SRY | 1 | ******************** |
| CTL 122GRK | 1 | ******************** |
| CTLs 12SRF, 12SLG, 60SLG, 4S15, 11S15, 37SLG | 1 | ******************** |
| CTL 13SLG | 1 | ******************** |
| CTL 13SRC | 1 | ******************** |
| CTL 20.8GRK | 1 | ******************** |
| CTL 21S69 | 1 | ******************** |
| CTL 27S69 | 1 | ******************** |
| CTL 2SRZ | 1 | ******************** |
| CTL 31GRK | 1 | ******************** |
| CTL 33.8S15 | 1 | ******************** |
| CTL 33S69 | 1 | ******************** |
| CTL 3SRF | 1 | ******************** |
| CTL 47S69 | 1 | ******************** |
| CTL 58GRK | 1 | ******************** |
| CTL 74GRK | 1 | ******************** |
| CTL 74GRKB | 1 | ******************** |
| CTL 7S15 | 1 | ******************** |
| CTL 93S15 | 1 | ******************** |
| CTL 116GRK | 1 | ******************** |
| CTL 11SRY | 1 | ******************** |
| CTL 12SRF | 1 | ******************** |
| CTL 116.8GRK | 1 | ******************** |
| CTL 58GRK, CTL 20.8 GRK | 1 | ******************** |
| A2058; established from brain metastasis | 1 | ******************** |
| 316 | 1 | ******************** |
| E51 | 1 | ******************** |
| BD10 | 1 | ******************** |
| FLEB14-14 | 1 | ******************** |
| HGOM | 1 | ******************** |
| SUP T1 lymphoblast | 1 | ******************** |
| JAP-NF | 1 | ******************** |
| HT-H | 1 | ******************** |
| ITC88 | 1 | ******************** |
| CHP100 | 1 | ******************** |
| AP630 | 1 | ******************** |
| AP630 EBV-transformed B cell line | 1 | ******************** |
| TC106 EBV transformed B cell line | 1 | ******************** |
| Tcc UA-S2 | 1 | ******************** |
| short ragweed pollen allergen-specific T-cell clone, AP1.2. | 1 | ******************** |
| RL95-2 | 1 | ******************** |
| NV | 1 | ******************** |
| ZR-75-1 0) | 1 | ******************** |
| Kitty, Epstein-Barr virus transformed B lymphoblastoid | 1 | ******************** |
| Matata, Epstein-Barr virus transformed B lymphoblastoid | 1 | ******************** |
| hybridoma 87-2 | 1 | ******************** |
| 26CB-1 | 1 | ******************** |
| E4181324 | 1 | ******************** |
| EBV-transformed | 1 | ******************** |
| EBV- transformed | 1 | ******************** |
| NK3.3, natural killer-like cell line | 1 | ******************** |
| K562 cell line | 1 | ******************** |
| HUVE | 1 | ******************** |
| RC654. EBV transformed | 1 | ******************** |
| ebv-cell line | 1 | ******************** |
| Osteosarcoma cell line, MS | 1 | ******************** |
| Daudi/Molt4 | 1 | ******************** |
| MO6 | 1 | ******************** |
| LH92 | 1 | ******************** |
| LH114 | 1 | ******************** |
| PHA/PMA stimulated Jurkat cells | 1 | ******************** |
| KAS116(9003), EMJ(9097), KAS011(9009) and E4181324(9011) | 1 | ******************** |
| EK(9054) | 1 | ******************** |
| AK93007 | 1 | ******************** |
| MOU(9050), BOLETH(9031) and YT | 1 | ******************** |
| DKB(9075) | 1 | ******************** |
| SPACH(9072) and LUY(9070) | 1 | ******************** |
| VAVY(9023), BM16(9038) and AMALA(9064) | 1 | ******************** |
| HepG2, HeLa | 1 | ******************** |
| kidney cell line | 1 | ******************** |
| B20 | 1 | ******************** |
| B9601 | 1 | ******************** |
| MF8 | 1 | ******************** |
| EBV cell line | 1 | ******************** |
| EBV-transformed B cell lymphoblast | 1 | ******************** |
| EBV-transformed B lymphoblast | 1 | ******************** |
| GF-D8 | 1 | ******************** |
| Jujkat | 1 | ******************** |
| EBV-tramsformed B-cell line | 1 | ******************** |
| EBV B-cell line | 1 | ******************** |
| IF-HVS | 1 | ******************** |
| HS 766T | 1 | ******************** |
| interferon-induced HeLa cell | 1 | ******************** |
| Burkitt lymphoma KK124 | 1 | ******************** |
| B lymphoblastoid HPB-MLT | 1 | ******************** |
| Li-7 | 1 | ******************** |
| promyelocytic leukemia cell line HL60 | 1 | ******************** |
| promyelocytic leukemia cell line HL-60 | 1 | ******************** |
| DR4 | 1 | ******************** |
| IM9 | 1 | ******************** |
| Epstein-Barr virus transformed lymphoblastoid cell line LCL | 1 | ******************** |
| acute promyelocytic leukemia cell lines HL-60 and PLB-985 | 1 | ******************** |
| HLC-1 | 1 | ******************** |
| DS6 | 1 | ******************** |
| HuT-14 | 1 | ******************** |
| neuroblastoma IMR-32 | 1 | ******************** |
| SUP-T8 | 1 | ******************** |
| AG 1518 | 1 | ******************** |
| DT | 1 | ******************** |
| EK4 | 1 | ******************** |
| J5 | 1 | ******************** |
| 4B4 | 1 | ******************** |
| Epstein-Barr transformed B cell line DBB | 1 | ******************** |
| U-373MG | 1 | ******************** |
| HEC | 1 | ******************** |
| GM6804 (Human Mutant Cell Repository, Camden NJ | 1 | ******************** |
| CB6B(10w9064) | 1 | ******************** |
| AMALA(10w9064) | 1 | ******************** |
| EBV-transformed LCL | 1 | ******************** |
| T-CEMB | 1 | ******************** |
| COLO320 | 1 | ******************** |
| intestinal mucosa teratocarcinoma cell line hTera2D | 1 | ******************** |
| MO30 | 1 | ******************** |
| UCLA-P3 | 1 | ******************** |
| U | 1 | ******************** |
| CEM-ON | 1 | ******************** |
| MeWo melanoma DNA, and cDNA to mRNA | 1 | ******************** |
| LLICRF | 1 | ******************** |
| HERLUFF | 1 | ******************** |
| Bristol 8 | 1 | ******************** |
| Maja | 1 | ******************** |
| Kim4.6 | 1 | ******************** |
| mononuclear cord blood cells stimulated with EL4 supernatants | 1 | ******************** |
| VAVY, RSH,BH, DBB | 1 | ******************** |
| YTN-10 | 1 | ******************** |
| retinoblastoma cell line Y79, and normal retinoblastoma cell line | 1 | ******************** |
| RPMI 4265 | 1 | ******************** |
| FS-4 | 1 | ******************** |
| IFIO-D3 | 1 | ******************** |
| IFN-alpha-2 treated cell line T98G | 1 | ******************** |
| chronic myelogenous leukemia cell line K562 | 1 | ******************** |
| chronic myelogenous leukemia cell line EM2 | 1 | ******************** |
| simian virus 80 transformed fibroblast cell line | 1 | ******************** |
| WI26-VA4 | 1 | ******************** |
| SW948 | 1 | ******************** |
| LG2 | 1 | ******************** |
| F6-2 | 1 | ******************** |
| UC/HeLa2-5 | 1 | ******************** |
| hystiocytic lymphoma monocyte-like cell line U937 | 1 | ******************** |
| breast cancer cell line MDA-MB 231 | 1 | ******************** |
| Li7 | 1 | ******************** |
| RPMI 6410 | 1 | ******************** |
| W38 and U2-OS | 1 | ******************** |
| T61 transplantable braet tumor | 1 | ******************** |
| 3T3-VMCUB2-1 | 1 | ******************** |
| TE-89 osteosarcoma | 1 | ******************** |
| leukemia K562 | 1 | ******************** |
| AG 1523 | 1 | ******************** |
| Capan-2 | 1 | ******************** |
| FS-2 | 1 | ******************** |
| H647 | 1 | ******************** |
| 86-226 | 1 | ******************** |
| HS913T | 1 | ******************** |
| HLA-homozygous B | 1 | ******************** |
| xenograft D245MG | 1 | ******************** |
| B21 | 1 | ******************** |
| SK-Hep-1 | 1 | ******************** |
| CML K562 | 1 | ******************** |
| OXEN | 1 | ******************** |
| IM-9-P derived from IM-9 | 1 | ******************** |
| IFN-gamma-induced U937 | 1 | ******************** |
| HeLa and keratinocyte | 1 | ******************** |
| 2708 | 1 | ******************** |
| 2013 | 1 | ******************** |
| 2012 | 1 | ******************** |
| 1125 | 1 | ******************** |
| JY + DAUDI | 1 | ******************** |
| blood platelet cell line HEL | 1 | ******************** |
| A631 | 1 | ******************** |
| 86081 | 1 | ******************** |
| GM3299; GM637 | 1 | ******************** |
| HMy2.DRN | 1 | ******************** |
| HMy2.A3m | 1 | ******************** |
| HEL 92.1.7 | 1 | ******************** |
| HeLa D98/AH-2 | 1 | ******************** |
| promyelocytic tumor cell line HL60 | 1 | ******************** |
| VA13 | 1 | ******************** |
| A204 | 1 | ******************** |
| cultured human keratinocytes | 1 | ******************** |
| CTL/NK cell | 1 | ******************** |
| TC79-842 | 1 | ******************** |
| human erythroleukemic (Hel) cells | 1 | ******************** |
| G401 | 1 | ******************** |
| KT2 | 1 | ******************** |
| GM2.11 | 1 | ******************** |
| LG37 | 1 | ******************** |
| AL4.1 | 1 | ******************** |
| M-07 | 1 | ******************** |
| SHJO; 32/37; KRC032 | 1 | ******************** |
| PA-1, teratocarcinoma | 1 | ******************** |
| HTB119 | 1 | ******************** |
| human breast carcinoma MCF-7; human lung fibroblast IMR-90 | 1 | ******************** |
| EBV-transformed B cell line RPMI 8866 | 1 | ******************** |
| peripheral blood T cell | 1 | ******************** |
| Meg-01, human platelets | 1 | ******************** |
| HL 60 | 1 | ******************** |
| SPL | 1 | ******************** |
| NCI-H345 | 1 | ******************** |
| ATCC A253 | 1 | ******************** |
| MG-63 osteosarcoma, (ATCC CRL 1427) | 1 | ******************** |
| 184N | 1 | ******************** |
| Human glioblastoma U118 | 1 | ******************** |
| BeWo choriocarcinoma | 1 | ******************** |
| F4 | 1 | ******************** |
| Dauidi | 1 | ******************** |
| BM-16 | 1 | ******************** |
| BM-18 | 1 | ******************** |
| MB-19 | 1 | ******************** |
| Kelly | 1 | ******************** |
| cervical cancer cell line cc-7T | 1 | ******************** |
| UMSCC2 | 1 | ******************** |
| homopoietic TF-1 | 1 | ******************** |
| EVB transformed B cell line | 1 | ******************** |
| PER-225 | 1 | ******************** |
| SC2 | 1 | ******************** |
| RPM 4265 | 1 | ******************** |
| PCR IM9 lymphocyte | 1 | ******************** |
| U937, cAMP induced | 1 | ******************** |
| 23.411+ genomic transfectant | 1 | ******************** |
| delta 6 from MIA PaCa (ATCC CRL 1420); B3-3 from BT-20 (ATCC HTB 19) | 1 | ******************** |
| human erytholeukemia (HEL) | 1 | ******************** |
| EBV Transformed B Cell line, B*5401 cDNA clones were obtained (and identical) from the LKT3 and TTL cell lines. | 1 | ******************** |
| ENA is an EBV Transformed B Cell line, B*5602 was cloned from the Australian Aboriginal ENA cell line.es. | 1 | ******************** |
| EBV Transformed B Cell line, B*5401 cDNA clones were obtained (and identical) from the LKT3 and TTLcell lines. | 1 | ******************** |
| EBV TransformeAPA is an EBV Transformed B Cell line, B*5502 was cloned from the Oriental APA cell line. | 1 | ******************** |
| EBV TransformeVEN is an EBV Transformed B Cell line, B*5501 was cloned from the caucasian VEN cell line. | 1 | ******************** |
| FS4 | 1 | ******************** |
| HeLa and HPB-ALL | 1 | ******************** |
| HT-144 | 1 | ******************** |
| HT144 | 1 | ******************** |
| hybridoma RC3 | 1 | ******************** |
| hybridoma LSF2 | 1 | ******************** |
| hybridoma JB21 | 1 | ******************** |
| hybridoma RAY4 | 1 | ******************** |
| hybridoma SB5/D6 | 1 | ******************** |
| hybridoma JB32 | 1 | ******************** |
| hybridoma ED6.1 | 1 | ******************** |
| hybridoma 16M3C8 | 1 | ******************** |
| BH | 1 | ******************** |
| jurkat T-lymphocytes | 1 | ******************** |
| 8B3 | 1 | ******************** |
| Hmy2 and C1R | 1 | ******************** |
| LSH6 | 1 | ******************** |
| gamma-interferon-induced HeLa | 1 | ******************** |
| PMN | 1 | ******************** |
| GM03560 | 1 | ******************** |
| IM-9 | 1 | ******************** |
| HUT-102 | 1 | ******************** |
| placenta cDNA | 1 | ******************** |
| AML-193 | 1 | ******************** |
| LK63 | 1 | ******************** |
| MCH 200.3 | 1 | ******************** |
| AP | 1 | ******************** |
| LWAGS | 1 | ******************** |
| 2627 American Indian Tribe | 1 | ******************** |
| HH-16 | 1 | ******************** |
| KRC033 | 1 | ******************** |
| GRC138 | 1 | ******************** |
| GRC138; JY | 1 | ******************** |
| GRC212 | 1 | ******************** |
| T98G, CCF-STTG1, U87MG | 1 | ******************** |
| T CELL | 1 | ******************** |
| CB33 | 1 | ******************** |
| human glioma explant HS 683 (ATCC # HTB 138) | 1 | ******************** |
| D98/AH-2 | 1 | ******************** |
| 2E7 | 1 | ******************** |
| WiDr; CRL 1262 | 1 | ******************** |
| COS-7 (SV40-transformed African green monkey kidney) | 1 | ******************** |
| neuroblastoma IMR32 | 1 | ******************** |
| 16M3C8 | 1 | ******************** |
| Hib JB32 | 1 | ******************** |
| RC3 | 1 | ******************** |
| YT2C2 | 1 | ******************** |
| pBluescript | 1 | ******************** |
| SV40-transformed cell line MRC-5 | 1 | ******************** |
| HeLa (D98/AH-2) | 1 | ******************** |
| SIV-infected CTL | 1 | ******************** |
| NCC-IT | 1 | ******************** |
| CTL 139DRD | 1 | ******************** |
| CTL 64.8P | 1 | ******************** |
| CTL 22DAG | 1 | ******************** |
| CTL 5A2 | 1 | ******************** |
| CTL 140 | 1 | ******************** |
| CTL 28 | 1 | ******************** |
| CTL 67DRF | 1 | ******************** |
| CCRF-HSB-2 | 1 | ******************** |
| K562 human erythro leukemia cell line | 1 | ******************** |
| HMMA2.11TG/0 | 1 | ******************** |
| CCD-16Lu | 1 | ******************** |
| EBV-transformed peripheral blood lymphocytes | 1 | ******************** |
| Nalm6 pre-B cell and RIC2 retinal cell | 1 | ******************** |
| CTL 102DRF | 1 | ******************** |
| CTL 168DRF | 1 | ******************** |
| CTL GM7 | 1 | ******************** |
| CTL 2DLE | 1 | ******************** |
| CTL 212DRD | 1 | ******************** |
| H3347 | 1 | ******************** |
| RH | 1 | ******************** |
| SSH23 | 1 | ******************** |
| 184 (from M. Stampfer) | 1 | ******************** |
| U937/Dyl | 1 | ******************** |
| HuH-6 | 1 | ******************** |
| unfractionated non-cultured keratinocyte | 1 | ******************** |
| BH, VH, GTI3, GTI4 | 1 | ******************** |
| WS8 | 1 | ******************** |
| BJA | 1 | ******************** |
| W138 | 1 | ******************** |
| Molt13 | 1 | ******************** |
| AL61.102 | 1 | ******************** |
| S3 (ATTC) | 1 | ******************** |
| Hela S3 (ATTC) | 1 | ******************** |
| hybridoma cell line, mAb-57 | 1 | ******************** |
| K562/ADM | 1 | ******************** |
| hepatocellular carcinoma; FOCUS | 1 | ******************** |
| KT14 | 1 | ******************** |
| GM06141A | 1 | ******************** |
| GM 4672 | 1 | ******************** |
| GRC 150 | 1 | ******************** |
| KRC 110 | 1 | ******************** |
| LNCaP-ATCC | 1 | ******************** |
| OR8 | 1 | ******************** |
| CEM C7 | 1 | ******************** |
| A375 | 1 | ******************** |
| Ble | 1 | ******************** |
| TTC466 | 1 | ******************** |
| TTC633 | 1 | ******************** |
| lymphoid cell line B95.8 | 1 | ******************** |
| i37-4 | 1 | ******************** |
| MC4100E3 | 1 | ******************** |
| TIL A42 | 1 | ******************** |
| RPMI1788 | 1 | ******************** |
| pre-acute lymphocytic leukemia (pre-ALP) | 1 | ******************** |
| Jurkat J6 | 1 | ******************** |
| CB STL-1 hybridoma | 1 | ******************** |
| hybridoma AEE111F | 1 | ******************** |
| RF1; RF48 | 1 | ******************** |
| neuroblastoma x glioma hybrid NG108-15 cells | 1 | ******************** |
| CD8+ T-cell clone BF-C13 | 1 | ******************** |
| differentiated HL-60 cell | 1 | ******************** |
| BL979 | 1 | ******************** |
| T cell clone | 1 | ******************** |
| T cell line | 1 | ******************** |
| b cell clone | 1 | ******************** |
| TE85 | 1 | ******************** |
| melanoma H3606 | 1 | ******************** |
| 293, Akata, Nalm-6, HeLa | 1 | ******************** |
| A-704 cells (ATCC HTB 45) | 1 | ******************** |
| Hs294T cells (ATCC HTB 140) | 1 | ******************** |
| RH30 | 1 | ******************** |
| U188-MG | 1 | ******************** |
| Kcl22 | 1 | ******************** |
| K-562 human erythroleukemia | 1 | ******************** |
| CV1/EBNA | 1 | ******************** |
| MG-63, osteosarcoma cell line | 1 | ******************** |
| PL-1 | 1 | ******************** |
| M7 | 1 | ******************** |
| HPB-ALL T cells | 1 | ******************** |
| MGAR (9014) | 1 | ******************** |
| clone 22 (T cell) | 1 | ******************** |
| PP | 1 | ******************** |
| MonoMac 6 | 1 | ******************** |
| GM6061B | 1 | ******************** |
| AMc | 1 | ******************** |
| cc102 | 1 | ******************** |
| CL170 | 1 | ******************** |
| 20015 | 1 | ******************** |
| 10243 | 1 | ******************** |
| JY EBV B lymphoblastoid line | 1 | ******************** |
| colon carcinoma LIM 1215 | 1 | ******************** |
| LK707 | 1 | ******************** |
| SV48 thymic stroma | 1 | ******************** |
| SU-DHL-1 | 1 | ******************** |
| M426 cells | 1 | ******************** |
| melanoma cell line, 501mel | 1 | ******************** |
| H929 | 1 | ******************** |
| WDV | 1 | ******************** |
| DO208915 | 1 | ******************** |
| LK | 1 | ******************** |
| human x mouse heterohybridoma CA4 | 1 | ******************** |
| RSH | 1 | ******************** |
| olga (9071) | 1 | ******************** |
| Hs683 | 1 | ******************** |
| Culture 10 | 1 | ******************** |
| Culture 5 | 1 | ******************** |
| CF/T43 | 1 | ******************** |
| PHA Blast ST-EMO | 1 | ******************** |
| RSH 9021 | 1 | ******************** |
| HSB2 | 1 | ******************** |
| Culture 5(Vb17+/Va2.3+) | 1 | ******************** |
| Culture 5(Vb17+/Va2.3-) | 1 | ******************** |
| CCRF-CEM acute lymphoblastic leukemia | 1 | ******************** |
| hepatoma G2 cell line | 1 | ******************** |
| ALL-1, KCL-22 | 1 | ******************** |
| cell line IM-9, ATCC CCl159 | 1 | ******************** |
| Burkitt's lymphoma-derived cell line Davdi (ATCC CCL 213) | 1 | ******************** |
| Human lymphoma-derived cell line MC116 (ATCC CRL 1649) | 1 | ******************** |
| myeloma-derived cell line IM9 (ATCC CCL 159) | 1 | ******************** |
| lymphoma-derived cell line MC116 (ATCC CRL 1649) | 1 | ******************** |
| myeloma-derived cell line RPMI 8226 (ATCC CCL 155) | 1 | ******************** |
| Jurkat T cell leukemia line | 1 | ******************** |
| YT (natural killer-like) | 1 | ******************** |
| 22-12b (human met-transformed NIH3T3 cell line) | 1 | ******************** |
| LBF (LBUF, 10W9048) | 1 | ******************** |
| gingival fibroblast | 1 | ******************** |
| HRPE cell line #165 | 1 | ******************** |
| ATCC CCL136 | 1 | ******************** |
| CCRF-HSB2 (ATCC CCL 120.1) | 1 | ******************** |
| YT, HUT-78 | 1 | ******************** |
| LB33-MELc1 | 1 | ******************** |
| DM150 | 1 | ******************** |
| PA-1 human teratocarcinoma | 1 | ******************** |
| BJAB human B lymphocyte cell line cDNA library | 1 | ******************** |
| A3.01 | 1 | ******************** |
| B lymphoblastoid | 1 | ******************** |
| Gw144 | 1 | ******************** |
| normal human peripheral blood-derived neutrophils | 1 | ******************** |
| HL-60 neutrophils | 1 | ******************** |
| JC11 | 1 | ******************** |
| HeLa, subclone D98/AH-2 | 1 | ******************** |
| CEM T-cells | 1 | ******************** |
| BM14 | 1 | ******************** |
| DD18 | 1 | ******************** |
| DD2 | 1 | ******************** |
| DD22 | 1 | ******************** |
| DD30 | 1 | ******************** |
| HD22 | 1 | ******************** |
| HD40 | 1 | ******************** |
| HD47 | 1 | ******************** |
| HD51 | 1 | ******************** |
| HD53 | 1 | ******************** |
| HD54 | 1 | ******************** |
| HD56 | 1 | ******************** |
| JC14 | 1 | ******************** |
| JC16 | 1 | ******************** |
| JC18 | 1 | ******************** |
| JC2 | 1 | ******************** |
| JC3 | 1 | ******************** |
| JC5 | 1 | ******************** |
| JC9 | 1 | ******************** |
| JD22 | 1 | ******************** |
| JD5 | 1 | ******************** |
| MC13 | 1 | ******************** |
| MC14 | 1 | ******************** |
| MC19 | 1 | ******************** |
| MC36 | 1 | ******************** |
| MD28 | 1 | ******************** |
| MD30 | 1 | ******************** |
| MD31 | 1 | ******************** |
| MD32 | 1 | ******************** |
| SC24 | 1 | ******************** |
| SC28 | 1 | ******************** |
| SC3 | 1 | ******************** |
| SC30 | 1 | ******************** |
| SC31 | 1 | ******************** |
| SC32 | 1 | ******************** |
| SC33 | 1 | ******************** |
| SC34 | 1 | ******************** |
| SD15 | 1 | ******************** |
| SD19 | 1 | ******************** |
| SD21 | 1 | ******************** |
| IMTLH | 1 | ******************** |
| PC-3 prostate carcinoma | 1 | ******************** |
| megakaryoblastic cell line M07e | 1 | ******************** |
| human keratinocyte cell line SCC 12-F: subclone c12c2 | 1 | ******************** |
| GM5424 | 1 | ******************** |
| GM0435 | 1 | ******************** |
| Y-79 retinoblastoma | 1 | ******************** |
| EBV transformed B lymphoblastoid | 1 | ******************** |
| GN032 | 1 | ******************** |
| GN037,GN041 | 1 | ******************** |
| GN033 | 1 | ******************** |
| ODM-2SV40 | 1 | ******************** |
| A8496 | 1 | ******************** |
| interferon-treated U cells | 1 | ******************** |
| HC10 | 1 | ******************** |
| MZ2-MEL.43 | 1 | ******************** |
| ATCC TERA-1 | 1 | ******************** |
| ASKMN | 1 | ******************** |
| K562 erythroleukemia | 1 | ******************** |
| K562.4CF | 1 | ******************** |
| ZR-75-1 (ATCC#CRL 1500) | 1 | ******************** |
| 888 mel | 1 | ******************** |
| mAb 10.2.3 | 1 | ******************** |
| lymphoblastoid JY cell line | 1 | ******************** |
| NCI-H157 NCI-H889 | 1 | ******************** |
| NCI-H157 | 1 | ******************** |
| Jurkat T-cell leukemia line | 1 | ******************** |
| BL29 Burkitt's lymphoma | 1 | ******************** |
| LB33-MEL.A-1 | 1 | ******************** |
| CF | 1 | ******************** |
| BPot | 1 | ******************** |
| osteoblast primary culture | 1 | ******************** |
| BT-20 breast cancer cell line | 1 | ******************** |
| K562 leukemia cell line; HEL leukemia cell line | 1 | ******************** |
| U-937 histiocytic lymphoma | 1 | ******************** |
| MV1 | 1 | ******************** |
| A10 | 1 | ******************** |
| NK3.3 | 1 | ******************** |
| Hep 3B hepatocellular carcinoma | 1 | ******************** |
| Hela D98 | 1 | ******************** |
| EBV-transformed lymphoblastoid cell line AD7563 | 1 | ******************** |
| DMS-79 small cell lung cancer line | 1 | ******************** |
| PFAT-MT | 1 | ******************** |
| HeLa S3, exponentially growing, ATCC #CCL 2.2 | 1 | ******************** |
| SCC83-01-82 | 1 | ******************** |
| breast cancer cell line ZR75-1 | 1 | ******************** |
| RPMI 8226 | 1 | ******************** |
| 2E9 anti-cryptococcal monoclonal antibody | 1 | ******************** |
| 3B6 anti-cryptococcal monoclonal antibody | 1 | ******************** |
| EBV-transformed cell line DH | 1 | ******************** |
| THP-1, an acute monocitic human cell-line | 1 | ******************** |
| ST90-375 | 1 | ******************** |
| ST93-724 | 1 | ******************** |
| HL-60 promyelocytic cell line | 1 | ******************** |
| HeLa S3 cells; grown to semi-confluency | 1 | ******************** |
| RD105 and RD105U | 1 | ******************** |
| RD105 | 1 | ******************** |
| Ad-312/SV40 cell line established from primary pleomorphic adenoma of the salivary gland | 1 | ******************** |
| Li-538/SV40 lipoma cell line | 1 | ******************** |
| LM-30.1/SV40 leiomyoma derived cell line | 1 | ******************** |
| Li-14/SV40 lipoma derived cell line | 1 | ******************** |
| SKBR3 and ZR-75-1 | 1 | ******************** |
| 143,2 | 1 | ******************** |
| myeloma, U266 | 1 | ******************** |
| T84 cell line | 1 | ******************** |
| acute promyelocytic leukemia HL60 | 1 | ******************** |
| HT-29 carcinoma | 1 | ******************** |
| MGR-1 | 1 | ******************** |
| EBV transfected cell line RB22 | 1 | ******************** |
| melanoma 530 | 1 | ******************** |
| WI-26 VA4 | 1 | ******************** |
| gn045 | 1 | ******************** |
| hepetoblastoma HepG2 | 1 | ******************** |
| RJ2.2.5 | 1 | ******************** |
| CLL 1.19 | 1 | ******************** |
| CLL 1.32 | 1 | ******************** |
| CLL 1.69 | 1 | ******************** |
| CTM 8958127 | 1 | ******************** |
| Mz-ChA-1 cholangiocarcinoma cell line derived from gallbladder | 1 | ******************** |
| SMS-KAN | 1 | ******************** |
| GN097 | 1 | ******************** |
| LA1-5S | 1 | ******************** |
| HUT-78 T cell library | 1 | ******************** |
| SW480, SW1463, SW1417, SW837, SW948, SW620, SW403, SW116, T84, HTC15, LS123, HT29, Caco-2 | 1 | ******************** |
| HeLa S3, exponentially growing, ATCC# CCL 2.2 | 1 | ******************** |
| non-small cell lung carcinoma cell line | 1 | ******************** |
| acute promyelocytic leukemia NB4 | 1 | ******************** |
| HL60 cells | 1 | ******************** |
| Lopez (NK cell leukemia) | 1 | ******************** |
| 8477 | 1 | ******************** |
| EBC transformed cell line LIE | 1 | ******************** |
| EBV-infected cell line: ML108 | 1 | ******************** |
| TC-206 | 1 | ******************** |
| Raji Burkitt's lymphoma | 1 | ******************** |
| EBV-transformed, monoclonal B cells, C108G | 1 | ******************** |
| EBV-transformed, monoclonal B cell line, C108G | 1 | ******************** |
| EC8712 | 1 | ******************** |
| T-cell line Jurkat | 1 | ******************** |
| EBV transformed B cell line G1 | 1 | ******************** |
| FM454 | 1 | ******************** |
| MAME | 1 | ******************** |
| CTL 11DCJ | 1 | ******************** |
| CTL 12DCJ | 1 | ******************** |
| CTL 15DLH | 1 | ******************** |
| CTL 13DCJ, CTL 31DCJ | 1 | ******************** |
| CTL 18DLH | 1 | ******************** |
| CTL 23GLM | 1 | ******************** |
| CTL 28DLH | 1 | ******************** |
| CTL 49GCP, CTL54GCP | 1 | ******************** |
| CTL 36DLH | 1 | ******************** |
| CTL 37DCJ | 1 | ******************** |
| CTL 39GLM | 1 | ******************** |
| CTL 3.8DLH | 1 | ******************** |
| CTL 42GCP | 1 | ******************** |
| CTL 42.8GLM, 71GCP | 1 | ******************** |
| CTL 43DCJ | 1 | ******************** |
| CTL 5DLL | 1 | ******************** |
| CTL 48GLM | 1 | ******************** |
| CTL 56GLM | 1 | ******************** |
| CTL 5DCJ | 1 | ******************** |
| CTL 62GCP, 63GLM | 1 | ******************** |
| CTL 70DCI | 1 | ******************** |
| CTL 81DCJ | 1 | ******************** |
| CTL 74GCP | 1 | ******************** |
| CTL 77GCP | 1 | ******************** |
| CTL 7DCI | 1 | ******************** |
| CTL 81GCP | 1 | ******************** |
| CTL 26GCP | 1 | ******************** |
| CTL 29GCP, 54GCP | 1 | ******************** |
| CTL 42.8GLM, 71GCP, 74.8GCP | 1 | ******************** |
| CTL 62GCP, CTL 63GLM | 1 | ******************** |
| lymphoblastoid; normal diploid fibroblast | 1 | ******************** |
| NCI-H441 lung adenocarcinoma | 1 | ******************** |
| SV-80: fibroblastic cell-line transformed by SV40 | 1 | ******************** |
| KB, HeLa, OVCAR-3 | 1 | ******************** |
| LB96-SAR | 1 | ******************** |
| Jurkat T-cell line | 1 | ******************** |
| BEN cell line, Moseley, J.M. et al. (1987), Proc. Natl. Acad. Sci. USA 84: 5048-5052 | 1 | ******************** |
| EBV transfected cell line AA859 | 1 | ******************** |
| MCF-7 human breast cancer cell line | 1 | ******************** |
| HT1080 fibrosarcoma | 1 | ******************** |
| EBV transformed cell line TC106 | 1 | ******************** |
| EBV transformed cell line, TC106 | 1 | ******************** |
| MDA-MB-468 mammary epithelial carcinoma | 1 | ******************** |
| MDA-MB-468 mammary epithelial carcinoma cells | 1 | ******************** |
| hybridoma Ann23 | 1 | ******************** |
| human glioma cell line G61 | 1 | ******************** |
| megakaryocyte lines CMK11-5 and DAMI | 1 | ******************** |
| Jurkat T cell line | 1 | ******************** |
| Jurkat T | 1 | ******************** |
| Hela S3, exponentially growing (ATCC# CCL2.2) | 1 | ******************** |
| Jurkat T-cell line, ATCC E6-1 | 1 | ******************** |
| neo6/C8161.1 | 1 | ******************** |
| heterohybridoma:43f10 | 1 | ******************** |
| heterohybridoma:28e4 | 1 | ******************** |
| heterohybridoma:26c1 | 1 | ******************** |
| heterohybridoma:25f5 | 1 | ******************** |
| heterohybridoma:24a5 | 1 | ******************** |
| heterohybridoma:21h9 | 1 | ******************** |
| heterohybridoma:19a5 | 1 | ******************** |
| heterohybridoma:13e10 | 1 | ******************** |
| heterohybridoma:13d2 | 1 | ******************** |
| breast cancer cell line | 1 | ******************** |
| IMR 90 | 1 | ******************** |
| ALL cell line HB11;19 | 1 | ******************** |
| Jurkatt T cell line | 1 | ******************** |
| B6B7 | 1 | ******************** |
| Jurkat leukemic T cell line | 1 | ******************** |
| EBV transfected cell line ML108 | 1 | ******************** |
| EBV transformed B-cell line GN090 | 1 | ******************** |
| Daudi and CCRF-CEM | 1 | ******************** |
| peripheral blood T cell line stimulated by Staphylococal enterotoxin A | 1 | ******************** |
| MT-2, HTLV-1-infected lymphoid cell line | 1 | ******************** |
| breast carcinoma cell line ZR-75-1 (ATCC CRL 1500) | 1 | ******************** |
| SH-EP1 neuroblastoma cell line | 1 | ******************** |
| HeLa, RL95 | 1 | ******************** |
| mammary tumor (ductal carcinoma) cell line: ZR-75-1 | 1 | ******************** |
| MCF-7 human mammary | 1 | ******************** |
| mammary epithelial cancer cell line MCF-7 | 1 | ******************** |
| Chromosome 6 Suppressed Melanoma Cell Line UACC 903 (+6) | 1 | ******************** |
| SCLC line MM-1 | 1 | ******************** |
| mammary epithelial cancer MCF-7 | 1 | ******************** |
| W652D, Epstein-Barr transformed | 1 | ******************** |
| leukemia cell line HL60 | 1 | ******************** |
| normal human primary keratinocyte culture | 1 | ******************** |
| choriocarcinoma cell line, JAR | 1 | ******************** |
| SKH1 | 1 | ******************** |
| lung adenocarcinoma A549 stably transfected with the E1A gene of adenovirus 5 | 1 | ******************** |
| oral cancer cell lines SCC15, SCC25.Hu | 1 | ******************** |
| HeLa cell R19 | 1 | ******************** |
| CEM human T cell | 1 | ******************** |
| B-lymphoblastoid cell line AZH | 1 | ******************** |
| CAL44 cervix uteri carcinoma cell line | 1 | ******************** |
| RPMI 8392 B lymphoblastoid | 1 | ******************** |
| EBV-cell lines ML108 and ML108U | 1 | ******************** |
| MDA-MB-231 breast carcinoma cell line | 1 | ******************** |
| megakaryocytic cell line MO7e | 1 | ******************** |
| ML108; ML108U | 1 | ******************** |
| CEM cells | 1 | ******************** |
| HAL-01; B-cell progenitor cell line | 1 | ******************** |
| hepatoma HepG2 | 1 | ******************** |
| astrocytoma cell line | 1 | ******************** |
| CHRF288-11 | 1 | ******************** |
| Jurkat E6 cells | 1 | ******************** |
| teratocarcinoma NTera2D1 cell line | 1 | ******************** |
| THP-1 cells | 1 | ******************** |
| BJA-B | 1 | ******************** |
| glioblastoma cell line | 1 | ******************** |
| adenocarcinoma Caco-2 | 1 | ******************** |
| 232132/87 from gastric cancer | 1 | ******************** |
| MGR3 | 1 | ******************** |
| 21PT | 1 | ******************** |
| 370 glyoma | 1 | ******************** |
| osteosarcoma cell line | 1 | ******************** |
| GN015 | 1 | ******************** |
| HEpG2; HUVEC | 1 | ******************** |
| Epstein-Barr transformed B-cell | 1 | ******************** |
| MCF7; ATCC HTB22 | 1 | ******************** |
| EBV transformed B cell line 19662 | 1 | ******************** |
| LB33-MEL.A | 1 | ******************** |
| U118 glioblastoma | 1 | ******************** |
| H146 | 1 | ******************** |
| WI-38; K562 | 1 | ******************** |
| A70 | 1 | ******************** |
| 437.3 | 1 | ******************** |
| EBV transformed cells | 1 | ******************** |
| PCI-O6A | 1 | ******************** |
| MCF-7 breast cancer cell line | 1 | ******************** |
| G292 | 1 | ******************** |
| PHA-PBL | 1 | ******************** |
| pancreatic cancer cell line Patu8988t | 1 | ******************** |
| HT-29 and Caco-2 | 1 | ******************** |
| EBV cell line WAI047 | 1 | ******************** |
| HeLa S3 cell line | 1 | ******************** |
| Patu8988s | 1 | ******************** |
| amelanotic melanoma; LOX | 1 | ******************** |
| LIM 1863 | 1 | ******************** |
| cisplatin resistant cell A2780 E(80) derived from A2780 (human ovarian carcinoma cell line) | 1 | ******************** |
| cisplatin resistant cell line A2780 E(80) derived from A2780 cell line( human ovarian carcinoma) | 1 | ******************** |
| KLE | 1 | ******************** |
| Epstein-Barr virus-transformed B-cell LAZ-388 | 1 | ******************** |
| Manca B cell lymphoma | 1 | ******************** |
| LIM1215 | 1 | ******************** |
| t(15;17) acute promyelocytic leukemia NB4 | 1 | ******************** |
| Namalwa B | 1 | ******************** |
| EB virus-transformed human B cell line | 1 | ******************** |
| CD34+ | 1 | ******************** |
| C1R | 1 | ******************** |
| Raji; B cell line | 1 | ******************** |
| Epstein-Barr transformed cell line | 1 | ******************** |
| breast carcinoma line MDAMB435 | 1 | ******************** |
| EBV transformed B cell line | 1 | ******************** |
| T antigen-transformed diploid fibroblast | 1 | ******************** |
| MCF7 human breast carcinoma cell line | 1 | ******************** |
| DM0 | 1 | ******************** |
| DM1 | 1 | ******************** |
| DMId3 | 1 | ******************** |
| DMId5 | 1 | ******************** |
| MBW1 | 1 | ******************** |
| NCI-H322 | 1 | ******************** |
| C8161 | 1 | ******************** |
| Raji cell line | 1 | ******************** |
| OVCA432 | 1 | ******************** |
| S594; infected with herpesvirus papio | 1 | ******************** |
| U87 MG | 1 | ******************** |
| leukemia H9 | 1 | ******************** |
| BON | 1 | ******************** |
| HS74 | 1 | ******************** |
| L55 | 1 | ******************** |
| U937 histiocytic cell line | 1 | ******************** |
| FCCM-9 | 1 | ******************** |
| EBV-transformed Korean B-cell line CH | 1 | ******************** |
| EBV-transformed Korean B-cell line KT | 1 | ******************** |
| EBV-transformed Korean B-cell line JS | 1 | ******************** |
| EBV-transformed Korean B-cell line (K-KT) | 1 | ******************** |
| hybridoma 1C9 | 1 | ******************** |
| immortalized first trimester human trophoblast cells (HTR-8/SVneo) | 1 | ******************** |
| monoclonal cell line 3.B6 | 1 | ******************** |
| monoclonal cell line 1.H9 | 1 | ******************** |
| monoclonal cell line 1.C8 | 1 | ******************** |
| monoclonal cell line 5.G3 | 1 | ******************** |
| monoclonal cell line 10.2.5 | 1 | ******************** |
| PaTu8988t | 1 | ******************** |
| U937, histiocytic lymphoma | 1 | ******************** |
| diploid fibroblast cell line VGS | 1 | ******************** |
| NH17 | 1 | ******************** |
| T-cell leukemia JURKAT | 1 | ******************** |
| TCL-Na1 | 1 | ******************** |
| HT29-18C(1) | 1 | ******************** |
| ATL-2 | 1 | ******************** |
| HEP G2 hepatoma | 1 | ******************** |
| rhabdomyosarcoma line A204 | 1 | ******************** |
| B-lymphoblast RPMI 8866 | 1 | ******************** |
| HL-60 promyelocytic leukemia cells | 1 | ******************** |
| AH2 | 1 | ******************** |
| NIH3T3 | 1 | ******************** |
| HT 1080 | 1 | ******************** |
| MIA PaCa-2 | 1 | ******************** |
| ML3 (acute promyelocytic cells) | 1 | ******************** |
| CRL 1106 | 1 | ******************** |
| HeLa-cells | 1 | ******************** |
| PLC/PRF/5 (Alexander) | 1 | ******************** |
| COLO201 | 1 | ******************** |
| U-2OS osteosarcoma cells | 1 | ******************** |
| foetal lung fibroblast HFL-1, ATCC CCL153 | 1 | ******************** |
| NIH/MDA-2 | 1 | ******************** |
| NIH 3T3, MDA-MB231 | 1 | ******************** |
| CLL B lymphocytes | 1 | ******************** |
| MOLT17 | 1 | ******************** |
| glioblastoma ATCC HTB14 | 1 | ******************** |
| MOLT-4, clone=M4-117 | 1 | ******************** |
| acute lymphocytic leukemia T cell line HPB-ALL | 1 | ******************** |
| D-259 MG | 1 | ******************** |
| ALL-1 | 1 | ******************** |
| GM1380 fibroblast cells | 1 | ******************** |
| SV80 | 1 | ******************** |
| WM 1158 | 1 | ******************** |
| Hs294T melanoma | 1 | ******************** |
| RAJI human lymphoma | 1 | ******************** |
| rescue fusion 2a12. | 1 | ******************** |
| rescue fusion 1h1. | 1 | ******************** |
| rescue fusion 2c12. | 1 | ******************** |
| rescue fusion 1b11. | 1 | ******************** |
| rescue fusion k6h6. | 1 | ******************** |
| rescue fusion k4h8. | 1 | ******************** |
| rescue fusion k5b8 | 1 | ******************** |
| rescue fusion k6f5 | 1 | ******************** |
| rescue fusion k5c7. | 1 | ******************** |
| K.LIE-EBV | 1 | ******************** |
| Hugo-EBV | 1 | ******************** |
| Clara | 1 | ******************** |
| MCF-7.2.2 | 1 | ******************** |
| Burkitt lymphoma Daudi. | 1 | ******************** |
| CGL | 1 | ******************** |
| T-cell clone LB117 | 1 | ******************** |
| T-cell clone LB210 | 1 | ******************** |
| T-cell clone LB207 | 1 | ******************** |
| T-cell clone WM14 | 1 | ******************** |
| C10-MJ2 | 1 | ******************** |
| CLL leukemia | 1 | ******************** |
| A172 glioblastoma | 1 | ******************** |
| JIMM-69 | 1 | ******************** |
| Jurkat-111 | 1 | ******************** |
| 4G12 | 1 | ******************** |
| 4G12 hybridoma | 1 | ******************** |
| KBM-5 | 1 | ******************** |
| U105MG | 1 | ******************** |
| LOVO (ATCC CCl 229) | 1 | ******************** |
| MANN | 1 | ******************** |
| pheochromocytoma | 1 | ******************** |
| CII. | 1 | ******************** |
| CII | 1 | ******************** |
| rescue fusion k5g5 | 1 | ******************** |
| Hep62 | 1 | ******************** |
| multidrug resistant Adr(R) MCF cells | 1 | ******************** |
| NTERA-2/D1. | 1 | ******************** |
| 1.Hepatoma, 2.GM637 fibroblast, 3.HeLa | 1 | ******************** |
| BC-10 | 1 | ******************** |
| Jurkat III | 1 | ******************** |
| 23.4 11+, HT-29. | 1 | ******************** |
| LS 180 | 1 | ******************** |
| primary human skeletal muscle culture | 1 | ******************** |
| peripheral blood leucocytes | 1 | ******************** |
| human-mouse hybridoma | 1 | ******************** |
| monocytes U937 (nt 1-917) | 1 | ******************** |
| myogenic cells | 1 | ******************** |
| FIS | 1 | ******************** |
| HL60 (1) | 1 | ******************** |
| thymic | 1 | ******************** |
| KG-1, ML-1, MCF-7 | 1 | ******************** |
| KG-1 (ATCC CCL 229) | 1 | ******************** |
| lymphoma 201 | 1 | ******************** |
| ML-2 | 1 | ******************** |
| peripheral blood mononuclear cells | 1 | ******************** |
| HEL cell (Flow 2000) | 1 | ******************** |
| AML,KG-1 | 1 | ******************** |
| S7 | 1 | ******************** |
| MG63, HL60 | 1 | ******************** |
| SK-MEL-19 | 1 | ******************** |
| ROF-NL | 1 | ******************** |
| CTL 172DRF | 1 | ******************** |
| CTL 17A2 | 1 | ******************** |
| CTL 40 | 1 | ******************** |
| CTL 64DRF | 1 | ******************** |
| CTL G36 | 1 | ******************** |
| K 562, Meg 01, Jurkat | 1 | ******************** |
| MKN-45 | 1 | ******************** |
| Fog-B | 1 | ******************** |
| Pag-1 | 1 | ******************** |
| HeLa and testis | 1 | ******************** |
| PHA/PMA stimulated T cell | 1 | ******************** |
| T47D breast tumour | 1 | ******************** |
| Jurcat | 1 | ******************** |
| SSK41 | 1 | ******************** |
| BL Ly47 | 1 | ******************** |
| BL Ly91 | 1 | ******************** |
| BL JBL2 | 1 | ******************** |
| E29.1 | 1 | ******************** |
| LS174T. | 1 | ******************** |
| 600 PEII | 1 | ******************** |
| HePTP | 1 | ******************** |
| HepG2 hepatocarcinoma | 1 | ******************** |
| FG | 1 | ******************** |
| 3D6. | 1 | ******************** |
| F55IIIE5 | 1 | ******************** |
| AB12 | 1 | ******************** |
| A549, ATCC #CCL185 | 1 | ******************** |
| ARM/BC11 (human-human hybridoma) | 1 | ******************** |
| HN.F1BB5 (human-human hybridoma) | 1 | ******************** |
| Ly66 | 1 | ******************** |
| Ly47 | 1 | ******************** |
| HEP G2. | 1 | ******************** |
| Raji (Mer+) | 1 | ******************** |
| KU-812-F | 1 | ******************** |
| Kelly. | 1 | ******************** |
| Burkitt lymphoma Daudi | 1 | ******************** |
| Ab 60 | 1 | ******************** |
| Ab 61 | 1 | ******************** |
| Ab 63 | 1 | ******************** |
| Ab 65 | 1 | ******************** |
| Ab 67 | 1 | ******************** |
| genomic DNA | 1 | ******************** |
| GIN-1 | 1 | ******************** |
| GTL16 | 1 | ******************** |
| T-cell lymphoma PEER | 1 | ******************** |
| NK B22 | 1 | ******************** |
| A2058 melanoma | 1 | ******************** |
| hepatocellular carcinoma (FOCUS) | 1 | ******************** |
| HeLa. | 1 | ******************** |
| Wish cell | 1 | ******************** |
| BeWo | 1 | ******************** |
| GM6061B lymphoblast cell line | 1 | ******************** |
| NIH3T3 cells transformed by human DNA | 1 | ******************** |
| HF_21/28 | 1 | ******************** |
| hybridoma Ray 4 | 1 | ******************** |
| hybridoma ED8.4 | 1 | ******************** |
| hybridoma SB1/D8 | 1 | ******************** |
| EBU transformed: T14 | 1 | ******************** |
| EBU transformed;T14 | 1 | ******************** |
| IW6 | 1 | ******************** |
| HMP2 | 1 | ******************** |
| HepG2 and MOLT-4 | 1 | ******************** |
| breast carcinoma ZR-75-1 | 1 | ******************** |
| M432 | 1 | ******************** |
| EJ bladder carcinoma | 1 | ******************** |
| transformed human amnion cell line (AMA) | 1 | ******************** |
| SV40 transformed MRC-5 fibroblasts (MRC-5 V2) | 1 | ******************** |
| transformed human amnion cells (AMA) | 1 | ******************** |
| A2058 (ATCC) | 1 | ******************** |
| primary myoblast/myotube culture | 1 | ******************** |
| GM2132 | 1 | ******************** |
| RML | 1 | ******************** |
| reticulocytes | 1 | ******************** |
| synovial T-lymphocyte | 1 | ******************** |
| HEP G 2 | 1 | ******************** |
| CLL-12 | 1 | ******************** |
| CLL-27 EBV | 1 | ******************** |
| LAZZ-21 | 1 | ******************** |
| EBV-21 | 1 | ******************** |
| GLC28 | 1 | ******************** |
| Nalm-1 | 1 | ******************** |
| IGR3 | 1 | ******************** |
| serum starved CEM | 1 | ******************** |
| cytoplasmic extract from Raji (Burkitts lymphoma) | 1 | ******************** |
| GLC 28, Kelly | 1 | ******************** |
| L1 | 1 | ******************** |
| D1 | 1 | ******************** |
| C32 | 1 | ******************** |
| CB233 | 1 | ******************** |
| Jurkat and HPB-ALL | 1 | ******************** |
| AMA amniotic epithelial | 1 | ******************** |
| AKATA | 1 | ******************** |
| IARC/BL2 | 1 | ******************** |
| IARC/BL30 | 1 | ******************** |
| IARC/BL37 | 1 | ******************** |
| IARC/BL41 | 1 | ******************** |
| P3HR1 | 1 | ******************** |
| HeLa, bone arrow | 1 | ******************** |
| Lymphoblastoid cells lines | 1 | ******************** |
| NTERA2-1 | 1 | ******************** |
| liver | 1 | ******************** |
| NTERA1-D1 | 1 | ******************** |
| Calabar B lymphoblastoid cell line | 1 | ******************** |
| Oko B lymphoblastoid cell line | 1 | ******************** |
| Banga B lymphoblastoid cell line | 1 | ******************** |
| Inaki B lymphoblastoid cell line | 1 | ******************** |
| cultured foetal human lung fibroblast | 1 | ******************** |
| Kime | 1 | ******************** |
| HPBALL | 1 | ******************** |
| UD53 | 1 | ******************** |
| human-mouse-heterohybridoma P61B27 | 1 | ******************** |
| CH4-25 hybridoma | 1 | ******************** |
| EBV transformed Human peripheral lymphocyte (B-cell) | 1 | ******************** |
| T cell clone Mb11 | 1 | ******************** |
| MASCH | 1 | ******************** |
| CC | 1 | ******************** |
| CR-B | 1 | ******************** |
| ENA | 1 | ******************** |
| WWAI | 1 | ******************** |
| SH.JO | 1 | ******************** |
| 3232 | 1 | ******************** |
| 25-1501 | 1 | ******************** |
| MALS | 1 | ******************** |
| primary fibroblast culture | 1 | ******************** |
| K562 and human T-lymphocytes | 1 | ******************** |
| B5-589 | 1 | ******************** |
| E.coli dM105 | 1 | ******************** |
| AIDS-KS 3 cells | 1 | ******************** |
| CEM, U937 (gamma interferon induced) | 1 | ******************** |
| LCLC97 | 1 | ******************** |
| NBC | 1 | ******************** |
| RB2 | 1 | ******************** |
| NF861 | 1 | ******************** |
| 721.180 | 1 | ******************** |
| Total human foetal liver | 1 | ******************** |
| KB100 cyt1 | 1 | ******************** |
| HA1.7 | 1 | ******************** |
| transfected NIH 3T3 cell | 1 | ******************** |
| hTera2D | 1 | ******************** |
| patient #22 cells | 1 | ******************** |
| patient #8 cells | 1 | ******************** |
| patient #30 cells | 1 | ******************** |
| patient #31 cells | 1 | ******************** |
| patient #13 cells | 1 | ******************** |
| patient #32 cells | 1 | ******************** |
| patient #28 cells | 1 | ******************** |
| IARC 171 | 1 | ******************** |
| TT cells | 1 | ******************** |
| SKW6.4 | 1 | ******************** |
| Ly91 | 1 | ******************** |
| peripheral blood from CLL patient P46 | 1 | ******************** |
| Jac-10 | 1 | ******************** |
| Brad-3 | 1 | ******************** |
| Fog-1 | 1 | ******************** |
| Fog-3 | 1 | ******************** |
| Fom-1 | 1 | ******************** |
| HAM-B | 1 | ******************** |
| Oak-3 | 1 | ******************** |
| Og-31 | 1 | ******************** |
| Reg-A | 1 | ******************** |
| Gad-2 | 1 | ******************** |
| Mad-2 | 1 | ******************** |
| peripheral blood from CLL patient P30 | 1 | ******************** |
| peripheral blood from CLL patient P32 | 1 | ******************** |
| peripheral blood from CLL patient P34 | 1 | ******************** |
| peripheral blood from CLL patient P53 | 1 | ******************** |
| peripheral blood from CLL patient P28 | 1 | ******************** |
| peripheral blood from CLL patient P4 | 1 | ******************** |
| peripheral blood from CLL patient P29 | 1 | ******************** |
| peripheral blood from CLL patient P2 | 1 | ******************** |
| peripheral blood from CLL patient P48 | 1 | ******************** |
| peripheral blood from CLL patient P7 | 1 | ******************** |
| bLcL(B-cell) | 1 | ******************** |
| HeLa, CHP100 | 1 | ******************** |
| COLO-16 | 1 | ******************** |
| U937 and peripheral blood mononuclear leukocytes | 1 | ******************** |
| human liver | 1 | ******************** |
| THP.1 - acute monocytic leukemia | 1 | ******************** |
| T-cell lymphoma (PEER) | 1 | ******************** |
| CH4-14 hybridoma | 1 | ******************** |
| A9A2Br | 1 | ******************** |
| adenovirus transformed retinal cells, Nalm-6 pre-B cell line, HOS osteosarcoma e | 1 | ******************** |
| normal human duodenum | 1 | ******************** |
| haemopoetic | 1 | ******************** |
| Raji: burkitt lymphoma cell line | 1 | ******************** |
| HT1080 and M426 | 1 | ******************** |
| CCL186 | 1 | ******************** |
| KB cell line | 1 | ******************** |
| mAb 61 | 1 | ******************** |
| Colon carcinoma cell line CaCO2 (ATTC HTB37) | 1 | ******************** |
| Hela (nucleotides residues 1-200 only) | 1 | ******************** |
| human epididymis tissue | 1 | ******************** |
| 2085(HLA-A1,29 Cw6sh,BL B52,61 DR14,15 DQ5,6) | 1 | ******************** |
| EBV transformed B cell line R 149 | 1 | ******************** |
| T23-9 | 1 | ******************** |
| T24-3 | 1 | ******************** |
| T21-9 | 1 | ******************** |
| T34-1 | 1 | ******************** |
| T20-24 | 1 | ******************** |
| T20-11 | 1 | ******************** |
| IARC-BL64 | 1 | ******************** |
| IMR 32 | 1 | ******************** |
| EK 4 | 1 | ******************** |
| Ishikawa | 1 | ******************** |
| EpG2 | 1 | ******************** |
| RHEK-1 | 1 | ******************** |
| lambda gt11 cDNA | 1 | ******************** |
| IN 157 | 1 | ******************** |
| U937 Lymphoma | 1 | ******************** |
| SW-1573/1R50b | 1 | ******************** |
| HL60 cDNA library | 1 | ******************** |
| T33-1 | 1 | ******************** |
| T33-2 | 1 | ******************** |
| T33-4 | 1 | ******************** |
| T33-16 | 1 | ******************** |
| T33-17 | 1 | ******************** |
| T24-9 | 1 | ******************** |
| T33-20 | 1 | ******************** |
| human fetal liver | 1 | ******************** |
| Raji, Mann | 1 | ******************** |
| SHSY-5Y | 1 | ******************** |
| THP-1 (ATCC TiB 202) | 1 | ******************** |
| SW613S c13 | 1 | ******************** |
| HBL100/RAS1 | 1 | ******************** |
| LT5-1 melanoma cell line / normal melanocytes | 1 | ******************** |
| 2085 | 1 | ******************** |
| 2088 | 1 | ******************** |
| human keratinocyte | 1 | ******************** |
| foetal spinal cord RNA | 1 | ******************** |
| NF1032 | 1 | ******************** |
| 11-50 | 1 | ******************** |
| 11050 | 1 | ******************** |
| HMST-1 | 1 | ******************** |
| human brain poly(A)+ RNA | 1 | ******************** |
| ZR 75-1 | 1 | ******************** |
| nasopharyngeal carcinoma | 1 | ******************** |
| CO47 | 1 | ******************** |
| PAR HLA phenotype A11/24, B27 /48, DR11 /15, DQ5/7 | 1 | ******************** |
| RF-KL5 | 1 | ******************** |
| SW613-S clone 3 | 1 | ******************** |
| HEP-3B | 1 | ******************** |
| Human 293S from Dr. B.Stillman (NY,USA) | 1 | ******************** |
| Human 293S from Dr. B.Stilliman (NY,USA) | 1 | ******************** |
| PBL clone 119 | 1 | ******************** |
| TIL clone A21 | 1 | ******************** |
| PBL clone A81 | 1 | ******************** |
| PBL clone A96 | 1 | ******************** |
| TIL clone A36 | 1 | ******************** |
| TIL clone A25 | 1 | ******************** |
| MCF7 breast cancer | 1 | ******************** |
| pituitary adenoma | 1 | ******************** |
| WM266-4 | 1 | ******************** |
| white blood cells | 1 | ******************** |
| F1.1 | 1 | ******************** |
| G1.1 | 1 | ******************** |
| T1.1 | 1 | ******************** |
| J2.2 | 1 | ******************** |
| Daudi Burkitt lymphoma cell line | 1 | ******************** |
| EBV transformed cell line H2LCL typed (HLA-A3,3; B7,7; Cw7,7; DR2,2; Dw,2.2 DQwl,1; DPw4,4) | 1 | ******************** |
| EBV transformed cell line H2LCL typed (HLA-A3,3; B7,7; Cw7,7 DR2,2; Dw2,2; DQw1,1; DPw4,4) | 1 | ******************** |
| PLC/PRF/5 (Alexander cells) | 1 | ******************** |
| human thymus | 1 | ******************** |
| human thymus 3 year caucasian male | 1 | ******************** |
| NT9D1 | 1 | ******************** |
| 9F12 (ATCC no. MB 8177) | 1 | ******************** |
| melanoma HTZ19 | 1 | ******************** |
| WI-38 human lung fibroblast | 1 | ******************** |
| LNCaP, human prostate carcinoma cell line | 1 | ******************** |
| PC3, human prostate carcinoma cell line | 1 | ******************** |
| DU145, human prostate carcinoma cell line | 1 | ******************** |
| HEP-G2 | 1 | ******************** |
| TAN | 1 | ******************** |
| IARC-EW11 | 1 | ******************** |
| tera 2 /clone13 | 1 | ******************** |
| normal adult and fetal brain | 1 | ******************** |
| EW-1 Ewings sarcoma cells | 1 | ******************** |
| C073, HLA phenotype A2/29, Cw2 /Cw6.2, B44/51, DRA4/15, DQ6/8 | 1 | ******************** |
| human medullary thyroid carcinoma cells hMTC | 1 | ******************** |
| hMTC cells (human medullary thyroid carcinoma cells) | 1 | ******************** |
| human thymocytes | 1 | ******************** |
| KM-3 | 1 | ******************** |
| MH6 | 1 | ******************** |
| SH-SY5Y cells | 1 | ******************** |
| ATL-2 (human HTLV-I transformed T cell line) | 1 | ******************** |
| SCC25 | 1 | ******************** |
| LE023 HLA phenotype A26,32; Cw1,-; B51,73; DR13,13; DQ6,6 | 1 | ******************** |
| HEC-1-B (ATCC) | 1 | ******************** |
| OVCA-432 ovarian carcinoma cell line | 1 | ******************** |
| B12.F8 | 1 | ******************** |
| D10.E6 | 1 | ******************** |
| HER XC2 (retina) | 1 | ******************** |
| AMA (transformed human anion cells) | 1 | ******************** |
| primary human foreskin keratinocytes | 1 | ******************** |
| tertiary tumor from transfected NIH3T3 cells | 1 | ******************** |
| GLC4/ADR | 1 | ******************** |
| RT112 (bladder carcinoma) | 1 | ******************** |
| LEO23 HLA phenotype A26,32; Cw1; B51,73; DR13,13; DQ6,6 | 1 | ******************** |
| human leukemia cell line | 1 | ******************** |
| Namalwa line NM864, NM878 | 1 | ******************** |
| human epidermal cylindroma | 1 | ******************** |
| human Tera-2 (EC) | 1 | ******************** |
| hybridoma cell line: GAN4B.5 | 1 | ******************** |
| NSO transfectant 10B3 | 1 | ******************** |
| human (fresh) thymocytes | 1 | ******************** |
| non fractionated non cultures normal keratinocytes | 1 | ******************** |
| non fractionated non cultured normal keratinocytes | 1 | ******************** |
| hematopoietic | 1 | ******************** |
| human placenta, human colon carcinome | 1 | ******************** |
| human fetal muscle | 1 | ******************** |
| HT1080 /Dr4 | 1 | ******************** |
| IMR32 human neuroblastoma | 1 | ******************** |
| PHA activated PBL | 1 | ******************** |
| HT29 colon carcinoma cell line | 1 | ******************** |
| AG1518 | 1 | ******************** |
| RSP-1 | 1 | ******************** |
| RSP-4 | 1 | ******************** |
| human breast cancer cells | 1 | ******************** |
| human periferal lymphocytes | 1 | ******************** |
| human peripheral lymphocytes | 1 | ******************** |
| 1-gt11-library | 1 | ******************** |
| NTERA2-cloneD1 | 1 | ******************** |
| IM-9 (ATCC CCL159) | 1 | ******************** |
| SBD4 | 1 | ******************** |
| human blood | 1 | ******************** |
| HT29-D4 colon carcinoma | 1 | ******************** |
| FLEB14-14 and HL60 | 1 | ******************** |
| GB002 | 1 | ******************** |
| purified high endothelial cells | 1 | ******************** |
| ALL1 | 1 | ******************** |
| HT-1080 (ATCC CCL121) | 1 | ******************** |
| Human teratocarcinoma | 1 | ******************** |
| diploid dermal fibroblasts | 1 | ******************** |
| PDL 27 | 1 | ******************** |
| Bonnet monkey ovary | 1 | ******************** |
| UM-SSC-22A | 1 | ******************** |
| medullary thyroid carcinoma | 1 | ******************** |
| CM3.B6 | 1 | ******************** |
| neutrophil granulocyte | 1 | ******************** |
| KRO3 /4 (IHW 8w141) | 1 | ******************** |
| fetal bone marrow | 1 | ******************** |
| U266BL | 1 | ******************** |
| CLL001 x HMMA 2.1 heterohybridoma | 1 | ******************** |
| CLL030 x HMMA 2.1 heterohybridoma | 1 | ******************** |
| CLL033 x HMMA 2.1 heterohybridoma | 1 | ******************** |
| CLL039 x HMMA 2.1 heterohybridoma | 1 | ******************** |
| CLL040 x HMMA 2.1 heterohybridoma | 1 | ******************** |
| CLL055 x HMMA 2.1 heterohybridoma | 1 | ******************** |
| CLL057 x HMMA 2.1 heterohybridoma | 1 | ******************** |
| peripheral blood B cells | 1 | ******************** |
| GO85 | 1 | ******************** |
| SSC25 | 1 | ******************** |
| HEC-1B | 1 | ******************** |
| bone marrow | 1 | ******************** |
| HT 1080 (fibrosarcoma, ATCC CCL 121) | 1 | ******************** |
| NEC | 1 | ******************** |
| T cell clone (TCC) 4:2.15 | 1 | ******************** |
| T cell clone (TCC) 4:2.20 | 1 | ******************** |
| T cell clone (TCC) 4:3.1 | 1 | ******************** |
| T cell clone (TCC) 4:1.1 | 1 | ******************** |
| T cell clone (TCC) 4:7.4 | 1 | ******************** |
| T cell clone (TCC) 4:14.4 | 1 | ******************** |
| DAUDI B*5802 | 1 | ******************** |
| DAUDI B*4102 | 1 | ******************** |
| fetal brain | 1 | ******************** |
| teratocarcinoma NTERA2 | 1 | ******************** |
| J6 and CEM | 1 | ******************** |
| transformed amnion cells (AMA) | 1 | ******************** |
| BL29 | 1 | ******************** |
| BL31 | 1 | ******************** |
| BL36 | 1 | ******************** |
| BL41 | 1 | ******************** |
| CA46 | 1 | ******************** |
| CW698 | 1 | ******************** |
| JI | 1 | ******************** |
| JIJOYE | 1 | ******************** |
| tumor material JN | 1 | ******************** |
| tumor material KD | 1 | ******************** |
| tumor material MM | 1 | ******************** |
| ST486 | 1 | ******************** |
| 5637 | 1 | ******************** |
| hybridoma derived from peripheral blood lymphocytes | 1 | ******************** |
| CA2 | 1 | ******************** |
| HT1080/Dr4 | 1 | ******************** |
| HOC-8 (ovarian carcinoma) | 1 | ******************** |
| hepatoma G2, leukaemia Molt4 | 1 | ******************** |
| ATCC HTB 17 U-373 MG | 1 | ******************** |
| GB92 | 1 | ******************** |
| fetal lung cDNA | 1 | ******************** |
| AH-2 | 1 | ******************** |
| DA3 | 1 | ******************** |
| UK4 | 1 | ******************** |
| LJ 1 | 1 | ******************** |
| MAD61 | 1 | ******************** |
| Hela, IMR90 | 1 | ******************** |
| Jurkat leukaemic T cell | 1 | ******************** |
| tumor cell line U251-MG | 1 | ******************** |
| primary foreskin keratinocytes cell line | 1 | ******************** |
| immunoglobulin phage display library | 1 | ******************** |
| SKBR-3 | 1 | ******************** |
| PBL clone 26-331 | 1 | ******************** |
| PBL clone 81-20 | 1 | ******************** |
| PBL clone 25-244 | 1 | ******************** |
| PBL clone 82-1 | 1 | ******************** |
| PBL clone 82-82 | 1 | ******************** |
| PC-3 (ATCC CRL 1435) | 1 | ******************** |
| NCIH69 | 1 | ******************** |
| NCIH82 | 1 | ******************** |
| KLO | 1 | ******************** |
| WT51 | 1 | ******************** |
| EPG85-257RNOV | 1 | ******************** |
| Tera2 cl13 | 1 | ******************** |
| HUT-78, ATCC #TIB161 | 1 | ******************** |
| lymphoblastoid cell line DCH013 | 1 | ******************** |
| lymphoblastoid cell line DCH036 | 1 | ******************** |
| U937-B | 1 | ******************** |
| RH 14 | 1 | ******************** |
| KT30 | 1 | ******************** |
| GB2 | 1 | ******************** |
| HIgMXL AO-EBV B | 1 | ******************** |
| A2243 synovial sarcoma | 1 | ******************** |
| ARMS282A | 1 | ******************** |
| A375met | 1 | ******************** |
| Raji lymphoma | 1 | ******************** |
| Ca. SW850 | 1 | ******************** |
| 594S (Idzerda et al., 1989, Proc. Natl. Acad. Sci. USA, 86: 4659-4663) | 1 | ******************** |
| T47D, mammary carcinoma | 1 | ******************** |
| 5583-S | 1 | ******************** |
| cancer cell line HT-29/M6 | 1 | ******************** |
| M54672 | 1 | ******************** |
| continuous clone GL37 of AGMK cells | 1 | ******************** |
| GB86 | 1 | ******************** |
| Manca B | 1 | ******************** |
| NK 3.3 | 1 | ******************** |
| Small Cell Lung Cancer-10 | 1 | ******************** |
| SCLC-10 | 1 | ******************** |
| SCLC-6 | 1 | ******************** |
| LCL | 1 | ******************** |
| IB4 (human B cell, human tonsil) | 1 | ******************** |
| glioblastoma 308 | 1 | ******************** |
| qm637 | 1 | ******************** |
| HepG2 Hepatoma cells | 1 | ******************** |
| Melanoma cell (Bowes) | 1 | ******************** |
| K937 | 1 | ******************** |
| 22-12b (murine NIH3T3 cell line) transformed | 1 | ******************** |
| medulloblastoma TE761 | 1 | ******************** |
| MOLT13 leukemia | 1 | ******************** |
| EBV transformed lymphoblastoid B cell line H2LCL | 1 | ******************** |
| preB cell | 1 | ******************** |
| GSW002 | 1 | ******************** |
| MCF-7ADR | 1 | ******************** |
| 4251 astrocytoma | 1 | ******************** |
| GMO3299 | 1 | ******************** |
| BL2 | 1 | ******************** |
| adenocarcinoma cell line | 1 | ******************** |
| HeLa S3 (ATCC #CCL2.2) | 1 | ******************** |
| E6SM (embryonic strain - skin and muscle) | 1 | ******************** |
| ewing | 1 | ******************** |
| B-lymphoblastoid, NDS-DG | 1 | ******************** |
| WM1361C | 1 | ******************** |
| GB32 | 1 | ******************** |
| primary resting T-cells | 1 | ******************** |
| primary T-cell culture | 1 | ******************** |
| MV3 melanoma | 1 | ******************** |
| HeLa S3 ATCC CCL 2.2 | 1 | ******************** |
| LE-9211RC | 1 | ******************** |
| purified primary HEV endothelial cells | 1 | ******************** |
| BM21 (1othIHW No.9043) | 1 | ******************** |
| uninduced male teratocarcinoma, NT2 /D1 | 1 | ******************** |
| COS-3 | 1 | ******************** |
| NDS-JD | 1 | ******************** |
| 3nbHPG | 1 | ******************** |
| MKN45 (gastric) | 1 | ******************** |
| HIV/U937 | 1 | ******************** |
| foetal liver spleen 1NFLS | 1 | ******************** |
| KT30 (CD4+ T cell line) | 1 | ******************** |
| MG63 (osteosarcoma) | 1 | ******************** |
| uninduced male teratocarcinoma cell line | 1 | ******************** |
| ZR-75-1; breast cancer cell line | 1 | ******************** |
| human /mouse (NS-0) hetero-hybridoma cell line ESD-1 (THERAD 03) | 1 | ******************** |
| human /mouse (NS-0) hetero-hybridoma cell line LHM70/45.3 (THERAD 06) | 1 | ******************** |
| K562 erythroleukemic | 1 | ******************** |
| LB831-BLC | 1 | ******************** |
| uninduced teratocarcinoma | 1 | ******************** |
| MG63 ostosarcoma | 1 | ******************** |
| RT6 hybridoma | 1 | ******************** |
| human lymphoid cell line | 1 | ******************** |
| Primary explant, passage 4 to 10 | 1 | ******************** |
| SK-ES-1 | 1 | ******************** |
| EBV transformed B-cell lymphoblastoid cell line | 1 | ******************** |
| A | 1 | ******************** |
| CB-201 | 1 | ******************** |
| Daudi cell line | 1 | ******************** |
| HeLa cell line | 1 | ******************** |
| Epstein-Barr transformed lymphoblastoid cell line | 1 | ******************** |
| EBV383 | 1 | ******************** |
| AG 1518 human foreskin fibroblasts | 1 | ******************** |
| erythroleukemia (HEL) cells | 1 | ******************** |
| L540, YT, K562 | 1 | ******************** |
| DX3 | 1 | ******************** |
| DE49 | 1 | ******************** |
| DH15 | 1 | ******************** |
| DE26 | 1 | ******************** |
| DH12 | 1 | ******************** |
| DD11 | 1 | ******************** |
| ZR-75-1 (human breast carcinoma) | 1 | ******************** |
| XLI | 1 | ******************** |
| ZR-75-1, ATCC CCL119 | 1 | ******************** |
| Colon Carcinoma CaCo2 | 1 | ******************** |
| HT29-M6 | 1 | ******************** |
| SLUGEO | 1 | ******************** |
| T15-42 | 1 | ******************** |
| T33-5 | 1 | ******************** |
| T33-14 | 1 | ******************** |
| human hepatoma cell line,Hep G2,ATCC HB 8065 | 1 | ******************** |
| RPMI 8226 and U266 | 1 | ******************** |
| normal adult human epidermal melanocyte | 1 | ******************** |
| PLC/PRF/5 | 1 | ******************** |
| Ci | 1 | ******************** |
| P54 | 1 | ******************** |
| Burkitt's lymphoma cell line BL-29 | 1 | ******************** |
| CRL 1475 (ATCC) | 1 | ******************** |
| Heteromyeloma | 1 | ******************** |
| RF-SJ5 | 1 | ******************** |
| RF-TS7 | 1 | ******************** |
| RF-MR13 | 1 | ******************** |
| RF-MR16 | 1 | ******************** |
| RF-MR2 | 1 | ******************** |
| RF-MR1 | 1 | ******************** |
| RF-MR14 | 1 | ******************** |
| RF-MR25 | 1 | ******************** |
| RF-MR28 | 1 | ******************** |
| RF-MR30 | 1 | ******************** |
| RF-MR33 | 1 | ******************** |
| RF-MR37 | 1 | ******************** |
| K422 | 1 | ******************** |
| Reh (ATCC #CRL 8286) | 1 | ******************** |
| PATU 8988s (pancreatic adenocarcinoma) | 1 | ******************** |
| SPAZ 4 | 1 | ******************** |
| heterohybridoma | 1 | ******************** |
| EA.hy926 (human hybrid endothelial cell line) | 1 | ******************** |
| TUBO | 1 | ******************** |
| LCL721 | 1 | ******************** |
| MICA 1 | 1 | ******************** |
| MICA 2 | 1 | ******************** |
| MICA 3 | 1 | ******************** |
| MICA 4 | 1 | ******************** |
| MICA 5 | 1 | ******************** |
| MICA 6 | 1 | ******************** |
| MICA 7 | 1 | ******************** |
| Clones A,B,C,D,E,F + Line A.1-CD8 | 1 | ******************** |
| TF-1, KG1a | 1 | ******************** |
| LUY (IHW 9070) | 1 | ******************** |
| HT29-MTX | 1 | ******************** |
| U937 PMA stimulated | 1 | ******************** |
| U937 PMA-stimulated | 1 | ******************** |
| melanoma cell line SK29-MEL-1 | 1 | ******************** |
| HepG2, liver tumor stimulated with IL-1 | 1 | ******************** |
| Farage | 1 | ******************** |
| HL-60, Y-79 | 1 | ******************** |
| BJA-B Burkitt lymphoma B-cell line | 1 | ******************** |
| islet-specific T cell line | 1 | ******************** |
| breast cancer cell line SKBR-III | 1 | ******************** |
| BTII 180, BTIV 13 | 1 | ******************** |
| BTII 36 | 1 | ******************** |
| BTIII 65 | 1 | ******************** |
| BTIII 56 | 1 | ******************** |
| BTIII 60 | 1 | ******************** |
| BTIV 58 | 1 | ******************** |
| BTII 102, BTII176, BTIII 1, BTIII 13, BTIV 54 | 1 | ******************** |
| BTII 175, BTIII 44, BTIV 32 | 1 | ******************** |
| BTII 158 | 1 | ******************** |
| BTII 68 | 1 | ******************** |
| BTII 141 | 1 | ******************** |
| BTIII 53 | 1 | ******************** |
| BTIII 85, BTIV47 | 1 | ******************** |
| activated HUT78 cells | 1 | ******************** |
| ANDP | 1 | ******************** |
| FOB fetal osteoblasts | 1 | ******************** |
| rat 3Y1 | 1 | ******************** |
| 3Y1 | 1 | ******************** |
| ECA2 | 1 | ******************** |
| Pam | 1 | ******************** |
| IMS32 | 1 | ******************** |
| PC12 | 1 | ******************** |
| CTLL-2 | 1 | ******************** |
| PC-12 | 1 | ******************** |
| K-1735 M2 | 1 | ******************** |
| C2 | 1 | ******************** |
| RCN-9 | 1 | ******************** |
| FD2M | 1 | ******************** |
| APU-6 | 1 | ******************** |
| APU-1 | 1 | ******************** |
| MIN6 | 1 | ******************** |
| betaHC9 and MIN6 | 1 | ******************** |
| BCL1 | 1 | ******************** |
| MC3T3-E1 | 1 | ******************** |
| ST2 | 1 | ******************** |
| CHO-9 | 1 | ******************** |
| BaF3 | 1 | ******************** |
| ATDC5 | 1 | ******************** |
| MC3T3-G2-PA6 | 1 | ******************** |
| ROS-17-2.8-5 | 1 | ******************** |
| WR19L | 1 | ******************** |
| EL-4 | 1 | ******************** |
| FM3A | 1 | ******************** |
| newborn rat keratinocyte | 1 | ******************** |
| aorta endothelail cell | 1 | ******************** |
| SX-9 | 1 | ******************** |
| MSS62 | 1 | ******************** |
| erythroleukemia 745a cells | 1 | ******************** |
| CMS5j | 1 | ******************** |
| ES | 1 | ******************** |
| P19EC cells | 1 | ******************** |
| SCC-131 | 1 | ******************** |
| C6 glioma | 1 | ******************** |
| BHK | 1 | ******************** |
| hybridoma FU-MK-1 | 1 | ******************** |
| FU-MK-1 hybridoma | 1 | ******************** |
| NSC-19 | 1 | ******************** |
| SR-1 | 1 | ******************** |
| SX9 | 1 | ******************** |
| PT-18 | 1 | ******************** |
| NIH 3T3 | 1 | ******************** |
| SCGR-11 | 1 | ******************** |
| P19 | 1 | ******************** |
| J774A.1 | 1 | ******************** |
| CRA1 | 1 | ******************** |
| CRA5 | 1 | ******************** |
| NRK-49F | 1 | ******************** |
| FTL43 | 1 | ******************** |
| NRK49F | 1 | ******************** |
| MC12 | 1 | ******************** |
| FRSK | 1 | ******************** |
| B6TNC | 1 | ******************** |
| E14TG2a | 1 | ******************** |
| BMS2.4 | 1 | ******************** |
| MIN6 or betaHC9 | 1 | ******************** |
| UMR106 | 1 | ******************** |
| OP9 | 1 | ******************** |
| 129Sv | 1 | ******************** |
| LO | 1 | ******************** |
| L-G | 1 | ******************** |
| FE-3 | 1 | ******************** |
| RAW 264.7 | 1 | ******************** |
| hybridoma 5.2 | 1 | ******************** |
| BW5147 | 1 | ******************** |
| TT2 | 1 | ******************** |
| PC 12 | 1 | ******************** |
| RBL-2H3 | 1 | ******************** |
| M1 | 1 | ******************** |
| F9 | 1 | ******************** |
| C3H10T1-2 | 1 | ******************** |
| MC/9.IL-4 | 1 | ******************** |
| F9 cell | 1 | ******************** |
| H4-II-E | 1 | ******************** |
| 34N | 1 | ******************** |
| 3T3-L1 | 1 | ******************** |
| microglia | 1 | ******************** |
| COMMA1d | 1 | ******************** |
| CHO K1 | 1 | ******************** |
| B16-BL6 | 1 | ******************** |
| CHO | 1 | ******************** |
| 63-12 | 1 | ******************** |
| M3E3/C3 | 1 | ******************** |
| J1 | 1 | ******************** |
| Hamster kidney BHK | 1 | ******************** |
| Mouse MC3T3-E1 | 1 | ******************** |
| RBL-1 | 1 | ******************** |
| hybridoma F106-88 | 1 | ******************** |
| hybridoma F33-104 | 1 | ******************** |
| hybridoma 6G9 | 1 | ******************** |
| hybridoma 9D5 | 1 | ******************** |
| hybridoma 1D6 | 1 | ******************** |
| hybridoma 10G1 | 1 | ******************** |
| hybridoma 1D3 | 1 | ******************** |
| hybridoma 9H8 | 1 | ******************** |
| hybridoma 10B2 | 1 | ******************** |
| hybridoma 2C | 1 | ******************** |
| NRK-52E | 1 | ******************** |
| BHK21/13 | 1 | ******************** |
| MMC2 | 1 | ******************** |
| A-10 | 1 | ******************** |
| L5178Y | 1 | ******************** |
| Ehrlich | 1 | ******************** |
| Friend MEL | 1 | ******************** |
| Ra2 | 1 | ******************** |
| XC | 1 | ******************** |
| E14.1 | 1 | ******************** |
| AtT20 | 1 | ******************** |
| GBaSM-4 | 1 | ******************** |
| Embryonic stem cell | 1 | ******************** |
| 30F1 | 1 | ******************** |
| 30F3 | 1 | ******************** |
| AB2.2 embryonic stem cells | 1 | ******************** |
| IEC6 | 1 | ******************** |
| BHK21 | 1 | ******************** |
| SV40T2 | 1 | ******************** |
| CG-4 | 1 | ******************** |
| hybridoma GA2-20-6 | 1 | ******************** |
| AL3D5 | 1 | ******************** |
| AL11 | 1 | ******************** |
| AKL3H6 | 1 | ******************** |
| AKL5C1 | 1 | ******************** |
| Konishi-9 | 1 | ******************** |
| Konishi-A | 1 | ******************** |
| Konishi-4 | 1 | ******************** |
| Konishi-6 | 1 | ******************** |
| MH134 | 1 | ******************** |
| sebocytes | 1 | ******************** |
| Meth A | 1 | ******************** |
| HIT-T15 | 1 | ******************** |
| CCE#28 | 1 | ******************** |
| MLT2-23 hybridoma | 1 | ******************** |
| MLT40-4 hybridoma | 1 | ******************** |
| BBA-2187 hybridoma | 1 | ******************** |
| BBA-2617 hybridoma | 1 | ******************** |
| BTE-3456 hybridoma | 1 | ******************** |
| BKE-3430 hybridoma | 1 | ******************** |
| AP-14 hybridoma | 1 | ******************** |
| MOF3-139 hybridoma | 1 | ******************** |
| SMT3110 hybridoma | 1 | ******************** |
| 3SB | 1 | ******************** |
| CCE28 | 1 | ******************** |
| TL7 | 1 | ******************** |
| TL10 | 1 | ******************** |
| TL52 | 1 | ******************** |
| beta-TC-6 | 1 | ******************** |
| dRLh84 | 1 | ******************** |
| Chinese hamster ovary | 1 | ******************** |
| RAW-D (a derivative of RAW264.7) | 1 | ******************** |
| CGR8 | 1 | ******************** |
| 5-5B hybridoma | 1 | ******************** |
| CCE | 1 | ******************** |
| PC12h | 1 | ******************** |
| RBL-2H3 cell | 1 | ******************** |
| BCL1-5B1b | 1 | ******************** |
| BCL1-B20 | 1 | ******************** |
| BCL1-CW13.20 | 1 | ******************** |
| MP4 | 1 | ******************** |
| MIN6 cell | 1 | ******************** |
| MH1C1 | 1 | ******************** |
| E14 | 1 | ******************** |
| PC12 cell_line | 1 | ******************** |
| BP1 | 1 | ******************** |
| 2Y-5o2b | 1 | ******************** |
| NIH/3T3 | 1 | ******************** |
| P53LMACO1 | 1 | ******************** |
| CRL-1830 Hepa1-6 | 1 | ******************** |
| C6 | 1 | ******************** |
| TA3-Ha | 1 | ******************** |
| Chainese hamster ovary (CHO-K1) | 1 | ******************** |
| A3-1 | 1 | ******************** |
| Chinese hamster ovary (CHO) cell | 1 | ******************** |
| RAW264 | 1 | ******************** |
| Chinese hamster ovary K1 | 1 | ******************** |
| 2H3 | 1 | ******************** |
| 1452c11 | 1 | ******************** |
| 500A2 | 1 | ******************** |
| WEHI-3B | 1 | ******************** |
| K-1735 M-2 mouse melanoma | 1 | ******************** |
| 3T3 | 1 | ******************** |
| hybridoma cell line A1 | 1 | ******************** |
| T-cell Hybridoma 3D0 | 1 | ******************** |
| Ki-4 | 1 | ******************** |
| NMuMG1 | 1 | ******************** |
| 2E11 | 1 | ******************** |
| 28B4 | 1 | ******************** |
| 18R.136 | 1 | ******************** |
| AZ-42 | 1 | ******************** |
| AZ-12 | 1 | ******************** |
| AZ-14 | 1 | ******************** |
| AZ-3 | 1 | ******************** |
| AZ-4 | 1 | ******************** |
| AZ-6 | 1 | ******************** |
| AZ-7 | 1 | ******************** |
| AZ-20 | 1 | ******************** |
| AZ-28 | 1 | ******************** |
| AZ-30 | 1 | ******************** |
| AZ-34 | 1 | ******************** |
| AZ-40 | 1 | ******************** |
| S91 | 1 | ******************** |
| (10)1 | 1 | ******************** |
| RBL | 1 | ******************** |
| Rat 6 | 1 | ******************** |
| murine erythroleukemia (MEL) | 1 | ******************** |
| spleen hybridoma cell line 64.22.2 | 1 | ******************** |
| spleen hybridoma cell line 70.1.4 | 1 | ******************** |
| spleen hybridoma cell line 70.3.1 | 1 | ******************** |
| spleen hybridoma cell line 64.3AII | 1 | ******************** |
| spleen hybridoma cell line 64.18AI | 1 | ******************** |
| spleen hybridoma cell line 64.8DI | 1 | ******************** |
| spleen hybridoma cell line A.24.7 | 1 | ******************** |
| spleen hybridoma cell line 3.4.1 | 1 | ******************** |
| spleen hybridoma cell line A.18.13 | 1 | ******************** |
| spleen hybridoma cell line 8.46.2 | 1 | ******************** |
| spleen hybridoma cell line 8.3.6 | 1 | ******************** |
| spleen hybridoma cell line A.1.11 | 1 | ******************** |
| spleen hybridoma cell line 27.3EIa | 1 | ******************** |
| neuron | 1 | ******************** |
| ROS17/2.8 | 1 | ******************** |
| IEC-6; ATCC CRL1592 | 1 | ******************** |
| corticotrope tumor cell line AtT-20 | 1 | ******************** |
| preadipocyte 30A5 | 1 | ******************** |
| 11F8 | 1 | ******************** |
| 22D6 | 1 | ******************** |
| J3D | 1 | ******************** |
| 70Z/3 pre-B lymphocyte; CD1 newborn kidney | 1 | ******************** |
| T cell hybridoma KMls-8.3.5 | 1 | ******************** |
| G28-5 | 1 | ******************** |
| 9.3 | 1 | ******************** |
| DDT1 MF2 | 1 | ******************** |
| MHSV-12; immortalized | 1 | ******************** |
| Ba/F3-gp55 | 1 | ******************** |
| Ureteric bud cell line derived from SV40 transgenic mouse | 1 | ******************** |
| Rat2 | 1 | ******************** |
| MN12H2 | 1 | ******************** |
| BRL3A | 1 | ******************** |
| GHFT1-5 | 1 | ******************** |
| 10T1/2 quiescent cells | 1 | ******************** |
| clonal L cell line LTA clone 1A (described in Shworak et. al., 1996, J. Biol. Chem. 271:27071-82) | 1 | ******************** |
| CHO-7 | 1 | ******************** |
| gene trapped R140 embryonic stem cell | 1 | ******************** |
| BXH2-4S | 1 | ******************** |
| 43.1 | 1 | ******************** |
| 266-6 | 1 | ******************** |
| EWS/FLI1 transformed NIH 3T3 | 1 | ******************** |
| E11-NMT | 1 | ******************** |
| alphaTN4 | 1 | ******************** |
| BWEM | 1 | ******************** |
| Ba/F3 (IL-3 dependent pro-B cell line) | 1 | ******************** |
| MC3T3-E1 osteoblast cells (this is not an embryo cell line) | 1 | ******************** |
| GH4C1 | 1 | ******************** |
| B5T | 1 | ******************** |
| WEHI 231 | 1 | ******************** |
| MIN 6 beta | 1 | ******************** |
| AS-30D | 1 | ******************** |
| 32Dcl3 | 1 | ******************** |
| 32D.3 | 1 | ******************** |
| 2G12 | 1 | ******************** |
| 4F10 | 1 | ******************** |
| T560.2.F7 | 1 | ******************** |
| B lymphoma T560.2.F7 | 1 | ******************** |
| Mouse erythroleukemia (MEL) cell line | 1 | ******************** |
| Ras-transformed NIH 3T3 cells | 1 | ******************** |
| ALAK | 1 | ******************** |
| CCC4 | 1 | ******************** |
| RS-4 | 1 | ******************** |
| neuroblastoma x glioma cell line NH15-CA2 | 1 | ******************** |
| J2E | 1 | ******************** |
| KLN205 and 3LL | 1 | ******************** |
| gene-trap line CT 45 | 1 | ******************** |
| gene-trap line CT 143 | 1 | ******************** |
| gene-trap line CT 146 | 1 | ******************** |
| gene-trap line CT 37 | 1 | ******************** |
| gene-trap line CT 82 | 1 | ******************** |
| IC-12 | 1 | ******************** |
| BAP-1 | 1 | ******************** |
| BT | 1 | ******************** |
| 5 | 1 | ******************** |
| 11 | 1 | ******************** |
| IOPS-6 | 1 | ******************** |
| IOPS-7 | 1 | ******************** |
| IOPS-8 | 1 | ******************** |
| T3 | 1 | ******************** |
| AA8 and CHO9 | 1 | ******************** |
| NIH-3T3 | 1 | ******************** |
| prolactin-independent Nb2-Sp lymphoma T cell line | 1 | ******************** |
| NIH3T3 cells | 1 | ******************** |
| Raphe nucleus derived RN33 | 1 | ******************** |
| 3T3-F442A | 1 | ******************** |
| insulinoma RIN-m5F | 1 | ******************** |
| L1210 variant | 1 | ******************** |
| hybridoma SM3 | 1 | ******************** |
| immortalized olfactory neuroepithelial cells | 1 | ******************** |
| EML | 1 | ******************** |
| MEL | 1 | ******************** |
| hepatoma Reuber H35 | 1 | ******************** |
| Hepa1c1c7 | 1 | ******************** |
| H-mAbB55 | 1 | ******************** |
| H-mAbB128 | 1 | ******************** |
| V13 | 1 | ******************** |
| T-25-Adh; derivative of a S49 BALB/c T-cell lymphoma cell line | 1 | ******************** |
| CHO-K1; ATCC CCL61 | 1 | ******************** |
| spleen cell hybridoma | 1 | ******************** |
| ds19 | 1 | ******************** |
| HIB 1B | 1 | ******************** |
| C15 | 1 | ******************** |
| PCC4 teratocarcinoma | 1 | ******************** |
| alpha-TC6 | 1 | ******************** |
| F9 teratocarcinoma | 1 | ******************** |
| L1210 | 1 | ******************** |
| R2BFL | 1 | ******************** |
| Ba/F3 | 1 | ******************** |
| hybridoma 12A1 | 1 | ******************** |
| hybridoma 13F1 | 1 | ******************** |
| SPGM1 | 1 | ******************** |
| ROS 17/2.8 | 1 | ******************** |
| G5 | 1 | ******************** |
| G7 | 1 | ******************** |
| P2.6 | 1 | ******************** |
| P2.48 | 1 | ******************** |
| P2.76 | 1 | ******************** |
| TKtsA6 | 1 | ******************** |
| L6 | 1 | ******************** |
| adenocarcinoma VMR-Liv | 1 | ******************** |
| NIH/3T3; ATCCCRL-1658 | 1 | ******************** |
| F.495-123-2-1 | 1 | ******************** |
| F.495-129-7-2 | 1 | ******************** |
| F.495-131-2-1 | 1 | ******************** |
| F.495-15-7-1 | 1 | ******************** |
| F.495-54-2-1 | 1 | ******************** |
| F.495-61-1-14 | 1 | ******************** |
| F.495-66-2-7 | 1 | ******************** |
| F.495-68-2-2 | 1 | ******************** |
| F.495-79-3-1 | 1 | ******************** |
| F.495-82-1-2 | 1 | ******************** |
| F.495-87-2-1 | 1 | ******************** |
| F.413-A10C-1-6 | 1 | ******************** |
| F.413-A10D-3 S | 1 | ******************** |
| F.413-A9d-4-5 | 1 | ******************** |
| F.413-B8E-5 | 1 | ******************** |
| M-NBT-II (Bellusci, S. et al, 1994, J. Cell Sci. 107, 1277-87) | 1 | ******************** |
| PB-3c | 1 | ******************** |
| hybridoma C106-1C11 | 1 | ******************** |
| Fu5-5 | 1 | ******************** |
| MEL-C19 | 1 | ******************** |
| GC pituitary tumor | 1 | ******************** |
| NB41A3 | 1 | ******************** |
| IEC-8 | 1 | ******************** |
| TS2 | 1 | ******************** |
| MPLRB5 | 1 | ******************** |
| ATCC CRL-1658 | 1 | ******************** |
| growth hormone secreting GC | 1 | ******************** |
| B cell lymphoma 70Z/3 | 1 | ******************** |
| F9; AtT20 | 1 | ******************** |
| ATCC CCL-107 | 1 | ******************** |
| T28 T hybridoma | 1 | ******************** |
| NSC-34 (Cashman et al., Dev. Dyn., 1992) | 1 | ******************** |
| 375.3 | 1 | ******************** |
| 375.22 | 1 | ******************** |
| 375.23 | 1 | ******************** |
| 375.257 | 1 | ******************** |
| 375.81 | 1 | ******************** |
| 375.96 | 1 | ******************** |
| 375.105 | 1 | ******************** |
| 375.108 | 1 | ******************** |
| 375.112 | 1 | ******************** |
| 375.57 | 1 | ******************** |
| B.21 | 1 | ******************** |
| B.26 | 1 | ******************** |
| B.43 | 1 | ******************** |
| B.51 | 1 | ******************** |
| B.121 | 1 | ******************** |
| B.128 | 1 | ******************** |
| B.143 | 1 | ******************** |
| B.203 | 1 | ******************** |
| B.117 | 1 | ******************** |
| Ig(5a)7.2; ATCC No. TIB 149 | 1 | ******************** |
| MEL-C88 | 1 | ******************** |
| S9 | 1 | ******************** |
| type II pneumocytes | 1 | ******************** |
| WIHI | 1 | ******************** |
| MIN6N8a; NOD mouse-derived insulin-producing beta-cell line | 1 | ******************** |
| NIH/3T3 (ATCC CRL-1658) | 1 | ******************** |
| M291 | 1 | ******************** |
| BC3 | 1 | ******************** |
| 70Z/3 | 1 | ******************** |
| D2N B-cell lymphoid | 1 | ******************** |
| NFS/N1.H7 | 1 | ******************** |
| IL-3 dependent NFS/N1.H7 cells | 1 | ******************** |
| rat1 (3T3-like) | 1 | ******************** |
| parietal endoderm L-2 | 1 | ******************** |
| CFTL-15 | 1 | ******************** |
| BHK-21 C-13 | 1 | ******************** |
| BHK RicR14 | 1 | ******************** |
| mevIIB4 | 1 | ******************** |
| PCC3 | 1 | ******************** |
| RIN 38A insulinoma | 1 | ******************** |
| F111 | 1 | ******************** |
| 7-15 | 1 | ******************** |
| insulinoma cell line | 1 | ******************** |
| myeloma MPC-11; 4T00.1 | 1 | ******************** |
| HAR-BA3 | 1 | ******************** |
| HAR-ID12 | 1 | ******************** |
| HAR-EG11 | 1 | ******************** |
| HAR-QG6 | 1 | ******************** |
| C57MG | 1 | ******************** |
| beta TC3 | 1 | ******************** |
| NIH/3T3; ATCC:CRL-1658 | 1 | ******************** |
| endothelial SVEC | 1 | ******************** |
| RW4 | 1 | ******************** |
| L929 | 1 | ******************** |
| IN insulinoma | 1 | ******************** |
| renal cell carcinoma | 1 | ******************** |
| INS-1 insulinoma | 1 | ******************** |
| F10.6.6 | 1 | ******************** |
| BHK-21 | 1 | ******************** |
| hybridoma lineage 5C3 | 1 | ******************** |
| A31 | 1 | ******************** |
| DREG-200 | 1 | ******************** |
| DREG-55 | 1 | ******************** |
| hybridoma 1F11 | 1 | ******************** |
| hybridoma 5G3 | 1 | ******************** |
| hybridoma 1E8 | 1 | ******************** |
| hybridoma 4F8 | 1 | ******************** |
| hybridoma 5F2 | 1 | ******************** |
| hybridoma 2D4 | 1 | ******************** |
| hybridoma 8E2 | 1 | ******************** |
| hybridoma 2A10 | 1 | ******************** |
| hybridoma Y1-4D12 | 1 | ******************** |
| hybridoma Y1-5G3 | 1 | ******************** |
| hybridoma Y6-4B5 | 1 | ******************** |
| hybridoma Y6-8G3 | 1 | ******************** |
| hybridoma Y6-9G3 | 1 | ******************** |
| hybridoma 4D8 | 1 | ******************** |
| hybridoma 2G10 | 1 | ******************** |
| hybridoma 7C10 | 1 | ******************** |
| hybridoma 8D12 | 1 | ******************** |
| hybridoma 7G4 | 1 | ******************** |
| hybridoma 22-27 | 1 | ******************** |
| hybridoma 31-1 | 1 | ******************** |
| hybridoma 2E8 | 1 | ******************** |
| hybridoma Y1-8G3 | 1 | ******************** |
| hybridoma Y1-9G3 | 1 | ******************** |
| RA6.3 | 1 | ******************** |
| MTSC4 | 1 | ******************** |
| MPRO | 1 | ******************** |
| E13 | 1 | ******************** |
| AE0002 | 1 | ******************** |
| AE0010 | 1 | ******************** |
| AE0012 | 1 | ******************** |
| AE0015 | 1 | ******************** |
| AE0016 | 1 | ******************** |
| AE0018 | 1 | ******************** |
| AE0019 | 1 | ******************** |
| AE0062 | 1 | ******************** |
| AE0063 | 1 | ******************** |
| AE0064 | 1 | ******************** |
| AE0067 | 1 | ******************** |
| AE0070 | 1 | ******************** |
| AE0071 | 1 | ******************** |
| AE0072 | 1 | ******************** |
| AE0073 | 1 | ******************** |
| AE0074 | 1 | ******************** |
| AE0077 | 1 | ******************** |
| AE0078 | 1 | ******************** |
| AE0079 | 1 | ******************** |
| AE0080 | 1 | ******************** |
| AE0081 | 1 | ******************** |
| AE0082 | 1 | ******************** |
| AE0132B | 1 | ******************** |
| AE0134 | 1 | ******************** |
| AE0138 | 1 | ******************** |
| AE0139 | 1 | ******************** |
| AE0140 | 1 | ******************** |
| AE0168 | 1 | ******************** |
| AE0188 | 1 | ******************** |
| AE0190 | 1 | ******************** |
| AE0191 | 1 | ******************** |
| AE0194 | 1 | ******************** |
| AE0195 | 1 | ******************** |
| AE0196 | 1 | ******************** |
| AE0197 | 1 | ******************** |
| AE0198 | 1 | ******************** |
| AE0199 | 1 | ******************** |
| AE0200 | 1 | ******************** |
| AE0201 | 1 | ******************** |
| AE0203 | 1 | ******************** |
| AE0204 | 1 | ******************** |
| AE0206 | 1 | ******************** |
| AE0229 | 1 | ******************** |
| AG0002 | 1 | ******************** |
| AG0010 | 1 | ******************** |
| AG0013 | 1 | ******************** |
| AG0016X | 1 | ******************** |
| AG0018 | 1 | ******************** |
| AG0029 | 1 | ******************** |
| AG0030 | 1 | ******************** |
| AG0032 | 1 | ******************** |
| AG0033 | 1 | ******************** |
| AG0034 | 1 | ******************** |
| AG0082 | 1 | ******************** |
| AG0085 | 1 | ******************** |
| AG0087 | 1 | ******************** |
| AG0088 | 1 | ******************** |
| AG0089B | 1 | ******************** |
| AG0091 | 1 | ******************** |
| AG0111 | 1 | ******************** |
| AG0112 | 1 | ******************** |
| AG0113 | 1 | ******************** |
| AG0114 | 1 | ******************** |
| AG0401 | 1 | ******************** |
| AG0402 | 1 | ******************** |
| AG0403 | 1 | ******************** |
| AG0406S | 1 | ******************** |
| AG0413 | 1 | ******************** |
| AG0467 | 1 | ******************** |
| AG0468 | 1 | ******************** |
| AG0469 | 1 | ******************** |
| AG0470 | 1 | ******************** |
| AG0471 | 1 | ******************** |
| AG0473 | 1 | ******************** |
| AG0479 | 1 | ******************** |
| AG0480 | 1 | ******************** |
| AG0484 | 1 | ******************** |
| AG0551 | 1 | ******************** |
| AG0553 | 1 | ******************** |
| AG0554 | 1 | ******************** |
| AH0002 | 1 | ******************** |
| AH0030 | 1 | ******************** |
| AH0032 | 1 | ******************** |
| AH0033AB | 1 | ******************** |
| AH0077 | 1 | ******************** |
| AH0079 | 1 | ******************** |
| AH0080 | 1 | ******************** |
| AH0081BB | 1 | ******************** |
| AH0097 | 1 | ******************** |
| AH0100 | 1 | ******************** |
| AH0189B | 1 | ******************** |
| AH0190AB | 1 | ******************** |
| AH0191 | 1 | ******************** |
| AH0192 | 1 | ******************** |
| AH0193 | 1 | ******************** |
| AH0194 | 1 | ******************** |
| AH0221 | 1 | ******************** |
| AH0223 | 1 | ******************** |
| AH0224 | 1 | ******************** |
| AH0291 | 1 | ******************** |
| AH0316 | 1 | ******************** |
| AH0320 | 1 | ******************** |
| AH0321 | 1 | ******************** |
| AH0322BC | 1 | ******************** |
| AH0325 | 1 | ******************** |
| AH0363 | 1 | ******************** |
| AH0364 | 1 | ******************** |
| AH0365 | 1 | ******************** |
| AH0366 | 1 | ******************** |
| AH0368 | 1 | ******************** |
| 3H1 | 1 | ******************** |
| A20 | 1 | ******************** |
| EML-C1 | 1 | ******************** |
| LXA1 | 1 | ******************** |
| LXB2 | 1 | ******************** |
| B4-2-1 CHO | 1 | ******************** |
| INS-1 | 1 | ******************** |
| embryonic stem cell line R1 | 1 | ******************** |
| anti-CD40 plus IL-4 induced, RAG-2 deficient, bcl-2 transgenic (R2BFL) pro-B | 1 | ******************** |
| FDC-P1 | 1 | ******************** |
| CHOpro-5 | 1 | ******************** |
| ATCC CCL-61; CHO-K1 | 1 | ******************** |
| RIN 5AH | 1 | ******************** |
| AR4-2J | 1 | ******************** |
| SC-1 | 1 | ******************** |
| ATCC CCL-158 | 1 | ******************** |
| 2BBLC811.2 | 1 | ******************** |
| 2BBLC854.5 | 1 | ******************** |
| CBL166.10 | 1 | ******************** |
| H25B10 | 1 | ******************** |
| hybridoma 6.7 | 1 | ******************** |
| J774 | 1 | ******************** |
| MCA1315 | 1 | ******************** |
| 5B4D6 | 1 | ******************** |
| malignant mesothelioma cell line AB1 | 1 | ******************** |
| BC3H1 | 1 | ******************** |
| Baf3 pro-B cell line | 1 | ******************** |
| MC615 | 1 | ******************** |
| SCGR11 | 1 | ******************** |
| IMCD | 1 | ******************** |
| PbR1 | 1 | ******************** |
| 3T3L1 | 1 | ******************** |
| ATCC:CRL-1658 | 1 | ******************** |
| EJ | 1 | ******************** |
| PCC4 | 1 | ******************** |
| endothelioma cells bEND5 | 1 | ******************** |
| hybridoma DNPc 08.03 | 1 | ******************** |
| hybridoma TNPc A1 | 1 | ******************** |
| hybridoma DNPc 06.25 | 1 | ******************** |
| hybridoma DNPc 07.08 | 1 | ******************** |
| V79-4 | 1 | ******************** |
| betaTC1 | 1 | ******************** |
| MTEC1 | 1 | ******************** |
| Ealpha 6 T cell | 1 | ******************** |
| E18 | 1 | ******************** |
| W16 | 1 | ******************** |
| 29-3 | 1 | ******************** |
| 36-3 | 1 | ******************** |
| 26-20 | 1 | ******************** |
| 37g | 1 | ******************** |
| 18-1 | 1 | ******************** |
| 31-26 | 1 | ******************** |
| 12-16 | 1 | ******************** |
| 23-7 | 1 | ******************** |
| 29-5 | 1 | ******************** |
| 16-9 | 1 | ******************** |
| 19-43 | 1 | ******************** |
| 8-3 | 1 | ******************** |
| 39-9 | 1 | ******************** |
| 2-4 | 1 | ******************** |
| 25-30 | 1 | ******************** |
| 32-13 | 1 | ******************** |
| 20-1 | 1 | ******************** |
| 15-16 | 1 | ******************** |
| 18-18 | 1 | ******************** |
| 38-11 | 1 | ******************** |
| 16-19 | 1 | ******************** |
| 5-1 | 1 | ******************** |
| 5-16 | 1 | ******************** |
| 19-19 | 1 | ******************** |
| JB6 | 1 | ******************** |
| HTC | 1 | ******************** |
| muscle cell line provided by Carl Blobel (Sloan-Kettering, NY, USA) | 1 | ******************** |
| parathyroid | 1 | ******************** |
| mpkCCDc14 | 1 | ******************** |
| 32D cl3 | 1 | ******************** |
| JS1 schwannoma | 1 | ******************** |
| N1-S1 | 1 | ******************** |
| insulinoma CRI-G1 | 1 | ******************** |
| PAM 212 | 1 | ******************** |
| embryonal carcinoma cell F9 | 1 | ******************** |
| C6 glioma; ATCC number CCL-107 | 1 | ******************** |
| thymic epithelial cell line 1 | 1 | ******************** |
| RA-treated embryonic carcinoma p19 | 1 | ******************** |
| MS-5 stromal cells | 1 | ******************** |
| AV29 | 1 | ******************** |
| AV12 hybridoma | 1 | ******************** |
| erythroleukemia | 1 | ******************** |
| Neuro-2a; ATCC CCL-131 | 1 | ******************** |
| JB6 P+ | 1 | ******************** |
| leukemic cell-line DA-24 | 1 | ******************** |
| thymic dendritic; MTDC | 1 | ******************** |
| cholinergic interneurons | 1 | ******************** |
| CB7 | 1 | ******************** |
| BICR1 | 1 | ******************** |
| UMR 106-1 osteosarcoma cells | 1 | ******************** |
| EL-4; RMA; MBL-2 | 1 | ******************** |
| MN29D9B1D8 | 1 | ******************** |
| MN29DB1D8 | 1 | ******************** |
| MN29D9B1G7 | 1 | ******************** |
| SKT6-EE372 | 1 | ******************** |
| REL | 1 | ******************** |
| hematopoietic progenitor cell line FDCP | 1 | ******************** |
| CTL line specific for HSV-1 gB498-505 determinant | 1 | ******************** |
| T cell line specific for HSV-1 gB498-505 determinant | 1 | ******************** |
| mIMCD-3 | 1 | ******************** |
| GH3 | 1 | ******************** |
| 3DO | 1 | ******************** |
| T cell hybridoma 3DO | 1 | ******************** |
| S194 | 1 | ******************** |
| Lu | 1 | ******************** |
| UMR 106 | 1 | ******************** |
| XS52 | 1 | ******************** |
| pre-B lymphocyte 22-D6 | 1 | ******************** |
| monocytic cell line Wehi-274.1 | 1 | ******************** |
| H4IIE hepatoma | 1 | ******************** |
| NS-1 non-secreting myeloma cells; ATCC TIB-18 | 1 | ******************** |
| NFS36; NFS58; NFS78 | 1 | ******************** |
| 9A8 | 1 | ******************** |
| W3 | 1 | ******************** |
| AKO3 | 1 | ******************** |
| EL4/Karolinska | 1 | ******************** |
| EL4/Salk | 1 | ******************** |
| RMA | 1 | ******************** |
| RMA/S | 1 | ******************** |
| ham2 | 1 | ******************** |
| mtp2 | 1 | ******************** |
| E50.16+ | 1 | ******************** |
| RBL5 | 1 | ******************** |
| EfemaleK1 | 1 | ******************** |
| EmaleG2 | 1 | ******************** |
| CG4 | 1 | ******************** |
| MLg | 1 | ******************** |
| MBL2 | 1 | ******************** |
| M104E myeloma | 1 | ******************** |
| C3H/RV | 1 | ******************** |
| XS52 DC | 1 | ******************** |
| C3H10T1/2 | 1 | ******************** |
| NS-1 | 1 | ******************** |
| Reuber H35 hepatoma | 1 | ******************** |
| monocyte-macrophage line RAW 264.7 | 1 | ******************** |
| WR19L12a | 1 | ******************** |
| P253 | 1 | ******************** |
| MC3T3-G2/PA6 | 1 | ******************** |
| 2D6; IL-12 dependent | 1 | ******************** |
| 1D10 | 1 | ******************** |
| CGR8 ES cells; F9 embryocarcinoma cells | 1 | ******************** |
| V79 | 1 | ******************** |
| Nb2 lymphoma cell line | 1 | ******************** |
| AKR-2B | 1 | ******************** |
| 3T3-F44A | 1 | ******************** |
| RU5 | 1 | ******************** |
| mA9-11-5 | 1 | ******************** |
| B10BR | 1 | ******************** |
| insulinoma b-TC-1 | 1 | ******************** |
| malignant H5 | 1 | ******************** |
| H4-II-E-C3 | 1 | ******************** |
| NR8383 | 1 | ******************** |
| bone marrow-derived early B cell line | 1 | ******************** |
| MC3T3 | 1 | ******************** |
| T-cell lymphoma | 1 | ******************** |
| Cl.MC.C57 | 1 | ******************** |
| R2L1 | 1 | ******************** |
| salivary gland-derived epithelial RSMG-1 cells | 1 | ******************** |
| A23 | 1 | ******************** |
| D3 | 1 | ******************** |
| PS120 | 1 | ******************** |
| PC12; ATCC CRL-1721 | 1 | ******************** |
| 32D myeloid progenitor | 1 | ******************** |
| P815 | 1 | ******************** |
| ARIP | 1 | ******************** |
| UMR 201 preosteoblast; UMR 106 osteoblast-like cells | 1 | ******************** |
| embryonic fibroblast rat-1 cells | 1 | ******************** |
| myeloid precursor cell line 32Dcl3 | 1 | ******************** |
| HT4 | 1 | ******************** |
| Rab1-5-8 | 1 | ******************** |
| lymphoma cell line 164T2 | 1 | ******************** |
| S49 | 1 | ******************** |
| AT-1 | 1 | ******************** |
| R210.RCY3 | 1 | ******************** |
| Lec1A CHO mutant | 1 | ******************** |
| RAW-264.7 | 1 | ******************** |
| colon 38 | 1 | ******************** |
| PGMD1 | 1 | ******************** |
| oligodendroglial cells | 1 | ******************** |
| HiB5 | 1 | ******************** |
| 3T6 | 1 | ******************** |
| FRTL-5 | 1 | ******************** |
| Th1 | 1 | ******************** |
| 13762 MAT | 1 | ******************** |
| P19; derived from matings between C3H/He females and male animals carrying an X chromosome derived from a feral mouse (McBurney & Rogers, Dev. Biol., 89, 503) | 1 | ******************** |
| OP6 | 1 | ******************** |
| L-6 myogenic cells | 1 | ******************** |
| L-6 | 1 | ******************** |
| WEHI 7.2 | 1 | ******************** |
| 707 | 1 | ******************** |
| T-cell hybridoma | 1 | ******************** |
| Morris hepatoma 3924A | 1 | ******************** |
| Chinese hamster ovary cells; CHO | 1 | ******************** |
| melan-a | 1 | ******************** |
| B104 | 1 | ******************** |
| primary vascular smooth muscle cells | 1 | ******************** |
| P29 | 1 | ******************** |
| DC-3F | 1 | ******************** |
| J558L | 1 | ******************** |
| BetaTC | 1 | ******************** |
| A20; MEL | 1 | ******************** |
| basophilic leukemia cells (RBL-2H3) | 1 | ******************** |
| pancreatic A InR1-G9 | 1 | ******************** |
| AML12 | 1 | ******************** |
| Da-1; BaF3 | 1 | ******************** |
| GC-1spg | 1 | ******************** |
| pccl3 | 1 | ******************** |
| 10E10 | 1 | ******************** |
| P-19 | 1 | ******************** |
| ES D3 | 1 | ******************** |
| Chinese hamster ovary; CHO | 1 | ******************** |
| BH3-1 | 1 | ******************** |
| CHO Lec1.3C | 1 | ******************** |
| CHO Lec1.1N | 1 | ******************** |
| CHO Lec9.1.3C | 1 | ******************** |
| CHO Lec3.2.8.1 | 1 | ******************** |
| CHO Lec1.1C | 1 | ******************** |
| differentiated 3T3-L1 | 1 | ******************** |
| Y1 adrenocortical tumor | 1 | ******************** |
| temperature-sensitive SV40 immortalized proximal tubule cell line | 1 | ******************** |
| E12.5 | 1 | ******************** |
| 3T3NIH | 1 | ******************** |
| A1-5 | 1 | ******************** |
| 208F | 1 | ******************** |
| Chinese hamster ovary cells (CHO) | 1 | ******************** |
| SRD-5 | 1 | ******************** |
| FRTL-5; PC CL3 | 1 | ******************** |
| P19 EC cells | 1 | ******************** |
| S17 | 1 | ******************** |
| regressor | 1 | ******************** |
| DA-3 | 1 | ******************** |
| hematopoietic progenitor FDCP-mix | 1 | ******************** |
| 2C7 | 1 | ******************** |
| T52 Hepatocarcinoma | 1 | ******************** |
| germline precursor of VI24 | 1 | ******************** |
| DyB | 1 | ******************** |
| F142-63/ST40 | 1 | ******************** |
| 18 | 1 | ******************** |
| TFP10 | 1 | ******************** |
| embryonal carcinoma | 1 | ******************** |
| WEHI-231 | 1 | ******************** |
| 5T33 B cell lymphoma | 1 | ******************** |
| 5T33 B cell myeloma | 1 | ******************** |
| SV52 | 1 | ******************** |
| NS0 (ECACC 85110503) | 1 | ******************** |
| WEHI | 1 | ******************** |
| NTW8 | 1 | ******************** |
| H4IIE rat hepatoma cells (ATCC; CRL 1600) | 1 | ******************** |
| FDCP1 | 1 | ******************** |
| Val5 | 1 | ******************** |
| 210-RCY3-Ag.1.2.3 | 1 | ******************** |
| F124 | 1 | ******************** |
| RNK-16 | 1 | ******************** |
| (X-63 Ag.8.653 x BALB/c spleen) | 1 | ******************** |
| (X-63 Ag.8.653 x BALB.c spleen) | 1 | ******************** |
| MTE 4.14 | 1 | ******************** |
| pre-T cell line KKF | 1 | ******************** |
| BAL17 | 1 | ******************** |
| MCA16 | 1 | ******************** |
| insulinoma cell line INS-1 | 1 | ******************** |
| DL-3 | 1 | ******************** |
| FREJ4 | 1 | ******************** |
| WOL-1 | 1 | ******************** |
| hybridoma 1A4 | 1 | ******************** |
| hybridoma 3B11 | 1 | ******************** |
| MN14C11.6 | 1 | ******************** |
| Novikoff hepatoma | 1 | ******************** |
| murine hematopoietic, 32D | 1 | ******************** |
| PDV | 1 | ******************** |
| HET-SR | 1 | ******************** |
| H2KtsA58 | 1 | ******************** |
| AX-high venule | 1 | ******************** |
| MAT-LyLu | 1 | ******************** |
| AT-2 | 1 | ******************** |
| PC12, MTLn3 | 1 | ******************** |
| C2C12 myoblast | 1 | ******************** |
| 13B8.2 | 1 | ******************** |
| NS/O | 1 | ******************** |
| LB | 1 | ******************** |
| baby hamster kidney-21 (BHK-21) | 1 | ******************** |
| microglial | 1 | ******************** |
| 5a19 | 1 | ******************** |
| CHO, V79-4 | 1 | ******************** |
| Z12 B cell hybridoma | 1 | ******************** |
| PAM212 | 1 | ******************** |
| V79B | 1 | ******************** |
| V8 | 1 | ******************** |
| MR-2 | 1 | ******************** |
| Olineu | 1 | ******************** |
| 91c | 1 | ******************** |
| MN16C13F4 | 1 | ******************** |
| L-929 | 1 | ******************** |
| glioma C6 (ATCC) | 1 | ******************** |
| 18-81 | 1 | ******************** |
| AR42J | 1 | ******************** |
| F9 embryo teratocarcinoma | 1 | ******************** |
| IgG-secreting murine hybridoma 9012.2 | 1 | ******************** |
| DDT1MF2 | 1 | ******************** |
| NIH 3T3-L1 | 1 | ******************** |
| Raw 264.7; ATCC TIB-71 | 1 | ******************** |
| mesenchymal cell line MBA-13 | 1 | ******************** |
| mpkCCDcl4 | 1 | ******************** |
| TAC-2 | 1 | ******************** |
| BML1-ME | 1 | ******************** |
| AKR1010 | 1 | ******************** |
| KS483 | 1 | ******************** |
| C3H.RV | 1 | ******************** |
| C3H/He | 1 | ******************** |
| dhfr- | 1 | ******************** |
| OLF442 | 1 | ******************** |
| neuroblastoma 2A | 1 | ******************** |
| IEC4.1 | 1 | ******************** |
| NRP-152 | 1 | ******************** |
| 410.4 | 1 | ******************** |
| EB6 | 1 | ******************** |
| EF10B | 1 | ******************** |
| DA5-4A11 | 1 | ******************** |
| 7F5 | 1 | ******************** |
| 1B9 | 1 | ******************** |
| melanoma M3 | 1 | ******************** |
| ATCC CRL-9096 | 1 | ******************** |
| E4B7 | 1 | ******************** |
| L | 1 | ******************** |
| CRL-1600 | 1 | ******************** |
| AT6.1 | 1 | ******************** |
| HT22 | 1 | ******************** |
| MEL-745A cl. DS19 | 1 | ******************** |
| murine erythroleukemia; MEL | 1 | ******************** |
| IEC-6 | 1 | ******************** |
| INS1-E | 1 | ******************** |
| Rat1 | 1 | ******************** |
| T-cell leukemia RL-12 | 1 | ******************** |
| immature NK | 1 | ******************** |
| RS485 | 1 | ******************** |
| CCL 107 C6 | 1 | ******************** |
| osteosarcoma cell line ROS 17/2 | 1 | ******************** |
| AT2 | 1 | ******************** |
| ST1 | 1 | ******************** |
| ZHTc6 | 1 | ******************** |
| RFL-6 | 1 | ******************** |
| REF52.2 | 1 | ******************** |
| AtT-20/D1 | 1 | ******************** |
| SY5Y, N1E-115 | 1 | ******************** |
| H4IIE | 1 | ******************** |
| M1 mutant | 1 | ******************** |
| M2 mutant | 1 | ******************** |
| alpha-T3 | 1 | ******************** |
| 9L glioma | 1 | ******************** |
| F98 glioma | 1 | ******************** |
| SPOC1 | 1 | ******************** |
| alpha TC1.6 | 1 | ******************** |
| LbetaT2 | 1 | ******************** |
| SP2/0-BALB/c spleen cells fusion hybridoma | 1 | ******************** |
| P19 teratocarcinoma | 1 | ******************** |
| C50 | 1 | ******************** |
| TR-PCT1 | 1 | ******************** |
| FL5.12 | 1 | ******************** |
| AC29 | 1 | ******************** |
| Rcho-1 trophoblast | 1 | ******************** |
| H9c2 (2-1) | 1 | ******************** |
| murine anti-human cTnI antibody hybridoma | 1 | ******************** |
| RC2.E10 | 1 | ******************** |
| LTR6 | 1 | ******************** |
| B-cell line A20 | 1 | ******************** |
| J774.1 | 1 | ******************** |
| insulinoma Rin-5F | 1 | ******************** |
| sub-line of Ba/F3 | 1 | ******************** |
| REF52 | 1 | ******************** |
| TNF-R2 | 1 | ******************** |
| TNFR2 | 1 | ******************** |
| CRL-9606 | 1 | ******************** |
| 9G2D3 | 1 | ******************** |
| 11A12F5 | 1 | ******************** |
| GPC-16 | 1 | ******************** |
| N1E-115 | 1 | ******************** |
| AH130W1 | 1 | ******************** |
| HC11 | 1 | ******************** |
| hybridoma cell line B105 | 1 | ******************** |
| IMCD3 | 1 | ******************** |
| LEC12 CHO | 1 | ******************** |
| LEC29 CHO | 1 | ******************** |
| F9; ATCC CRL-1720 | 1 | ******************** |
| hybridoma P135H-74/4 | 1 | ******************** |
| hybridoma P135H-99/518 | 1 | ******************** |
| C166 | 1 | ******************** |
| 12F6 | 1 | ******************** |
| MEL DS-19 | 1 | ******************** |
| P19 embryonal carcinoma | 1 | ******************** |
| mRNA | 1 | ******************** |
| 3C10; ATCC TIB-228 | 1 | ******************** |
| 3E5 | 1 | ******************** |
| 4H3 | 1 | ******************** |
| FDCP-mix A4; P338; Mel-1; pre-T EL4 | 1 | ******************** |
| DC-3F/9-OH-E | 1 | ******************** |
| RBL2H3 | 1 | ******************** |
| hybridoma 5/4E8 | 1 | ******************** |
| C8-B4 | 1 | ******************** |
| mouse erythroleukemia cell; MELC | 1 | ******************** |
| B16F1 | 1 | ******************** |
| hybridoma CP3 23-24, CP4 9-9, CP4 12-18(mouse NZB peritoneal cells fused with BALB/c myeloma cells), CP5 B5-3, CP5 A23-3, CP5 A21-1(mouse CBA/J peritoneal cells fused with BALB/c myeloma cells) | 1 | ******************** |
| TM10 | 1 | ******************** |
| Balb/c3T3 | 1 | ******************** |
| anti-NP-hybridoma (A6) | 1 | ******************** |
| anti-NP-hybridoma (E3) | 1 | ******************** |
| V79-UF cells | 1 | ******************** |
| OTT 6050 | 1 | ******************** |
| AT-3-44-16 | 1 | ******************** |
| Ax cells | 1 | ******************** |
| B16 | 1 | ******************** |
| embryonic-fibroblast 3T3, lymphoma RL-12 | 1 | ******************** |
| SPL2-1-2-12 | 1 | ******************** |
| mastocytoma P-815 | 1 | ******************** |
| ECA2(a line of embryonal carcinoma cells) | 1 | ******************** |
| revertant cell derived from ras-transformed NIH 3T3 cells | 1 | ******************** |
| BHK21 cell line | 1 | ******************** |
| LFD14 | 1 | ******************** |
| SC-3 | 1 | ******************** |
| SC2G | 1 | ******************** |
| SN-H | 1 | ******************** |
| OHP101.B11.1 | 1 | ******************** |
| OHP138.H8.1 | 1 | ******************** |
| OHP1E9.3.1 | 1 | ******************** |
| OHP57.G6.1 | 1 | ******************** |
| OHP7D7.2.3 | 1 | ******************** |
| SB14-31 | 1 | ******************** |
| BL4L-23 | 1 | ******************** |
| BL4L-30 | 1 | ******************** |
| F5-5 | 1 | ******************** |
| OTT6050 | 1 | ******************** |
| H4TG | 1 | ******************** |
| BALB/c-3T3 (A31) | 1 | ******************** |
| mouse B-cell lymphoblastoid A-20 | 1 | ******************** |
| SV-T2(SV-40-transformed Balb/3T3) | 1 | ******************** |
| NIH3T3 transformed with c-Ha-ras | 1 | ******************** |
| 1G3 | 1 | ******************** |
| 2B11.3 | 1 | ******************** |
| 7B6.8 | 1 | ******************** |
| BL16-F10 | 1 | ******************** |
| END-D | 1 | ******************** |
| 14-2 | 1 | ******************** |
| Nb2 | 1 | ******************** |
| IL-3-dependent leukemia cell line | 1 | ******************** |
| AH60 | 1 | ******************** |
| AH7974F | 1 | ******************** |
| PA6 | 1 | ******************** |
| Ehrlich ascites carcinoma | 1 | ******************** |
| NG108-15 | 1 | ******************** |
| 1F7 | 1 | ******************** |
| PYS-2 | 1 | ******************** |
| P-815 | 1 | ******************** |
| cFTL53 | 1 | ******************** |
| NIH3T3-ras | 1 | ******************** |
| E17 | 1 | ******************** |
| TYH-C4 | 1 | ******************** |
| TRLEC-03 | 1 | ******************** |
| Id-F2 | 1 | ******************** |
| 18.81 | 1 | ******************** |
| C3H/10T1/2 | 1 | ******************** |
| MRK | 1 | ******************** |
| FG1H5 | 1 | ******************** |
| McA-RH8994 HTC | 1 | ******************** |
| NRK | 1 | ******************** |
| SV40-transformed 3Y1 | 1 | ******************** |
| RPC-C2A | 1 | ******************** |
| RINn5F | 1 | ******************** |
| HIT T15 | 1 | ******************** |
| HepaI | 1 | ******************** |
| TARL-2 | 1 | ******************** |
| CAK4.4 | 1 | ******************** |
| smooth muscle cell line | 1 | ******************** |
| AKR-stroma | 1 | ******************** |
| colon 26 | 1 | ******************** |
| normal rat kidney (NRK) | 1 | ******************** |
| F9 embryonal carcinoma | 1 | ******************** |
| B8 | 1 | ******************** |
| LyD9 | 1 | ******************** |
| CC1.2 | 1 | ******************** |
| RS-A | 1 | ******************** |
| B16-F1 | 1 | ******************** |
| NS20Y | 1 | ******************** |
| K1E6 | 1 | ******************** |
| K1F12 | 1 | ******************** |
| K2C3 | 1 | ******************** |
| K2F7 | 1 | ******************** |
| K3F10 | 1 | ******************** |
| K4B4 | 1 | ******************** |
| K4F5 | 1 | ******************** |
| K4H11 | 1 | ******************** |
| K5D1 | 1 | ******************** |
| K5E1 | 1 | ******************** |
| K5G5 | 1 | ******************** |
| MIN6 cells | 1 | ******************** |
| ST-2 | 1 | ******************** |
| B16 melanoma F10 | 1 | ******************** |
| Lewis-S1 | 1 | ******************** |
| mebryonal carcinoma cell, F9 | 1 | ******************** |
| Friend erythroleukemia cell DS19/3 | 1 | ******************** |
| SC3VA4(SCID lung fibroblast established by SV40 infection) | 1 | ******************** |
| murine colon 26 | 1 | ******************** |
| A54 preadipocyte | 1 | ******************** |
| F10 | 1 | ******************** |
| SC3VA4 | 1 | ******************** |
| Mm-P | 1 | ******************** |
| anti-CD3 monoclonal antibody OKT3 | 1 | ******************** |
| FM3A HA1 | 1 | ******************** |
| MEL (Friend) cell 745A | 1 | ******************** |
| MEL 745A | 1 | ******************** |
| Hybridoma MEK-1 | 1 | ******************** |
| 3Y1-B clone1-6 | 1 | ******************** |
| SIA.TB.4.8.2 | 1 | ******************** |
| C-6 | 1 | ******************** |
| Konishi-7 | 1 | ******************** |
| 3Y1 fibroblast | 1 | ******************** |
| 3D5 and 6B11 hybridomas | 1 | ******************** |
| 3D5 hybridoma | 1 | ******************** |
| 6B11 hybridoma | 1 | ******************** |
| 6B11 | 1 | ******************** |
| erythroleukemia (MEL) | 1 | ******************** |
| BALBRVC | 1 | ******************** |
| CREF | 1 | ******************** |
| K-1735 C-23 | 1 | ******************** |
| tsTM4 | 1 | ******************** |
| ERC33 | 1 | ******************** |
| cells | 1 | ******************** |
| DW34 | 1 | ******************** |
| 38B9 | 1 | ******************** |
| Rat PC-12 cells | 1 | ******************** |
| C6 glioma cells | 1 | ******************** |
| Chinese hamster ovary (CHO) cells | 1 | ******************** |
| P19EC cell | 1 | ******************** |
| WEHI Cell | 1 | ******************** |
| JCRB0410-dRLh-84 | 1 | ******************** |
| LTA | 1 | ******************** |
| Swiss 3T3-L1 | 1 | ******************** |
| Y16 | 1 | ******************** |
| 2H6 GR | 1 | ******************** |
| hybridoma cell 2F4 | 1 | ******************** |
| Chinese hamster ovary cells | 1 | ******************** |
| differentiated C2C12 | 1 | ******************** |
| OKT10 | 1 | ******************** |
| RF8 ES cells | 1 | ******************** |
| Knowles/Solter mouse B6D2F1 2 cell | 1 | ******************** |
| A4ac hybridoma | 1 | ******************** |
| L5178Y-S | 1 | ******************** |
| L5178Y-R | 1 | ******************** |
| 32D | 1 | ******************** |
| d3 embryonic stem cell | 1 | ******************** |
| 14C2-S1-4 | 1 | ******************** |
| M2-1 | 1 | ******************** |
| M2-15 | 1 | ******************** |
| M2-56 | 1 | ******************** |
| M2-80 | 1 | ******************** |
| M2-86 | 1 | ******************** |
| M2-139 | 1 | ******************** |
| mesangial cells | 1 | ******************** |
| MC3T3-E1 cells | 1 | ******************** |
| R1 ES | 1 | ******************** |
| KT12; iNKT hybridoma | 1 | ******************** |
| STO | 1 | ******************** |
| 3(8)21 | 1 | ******************** |
| 3(8)21-EGFP | 1 | ******************** |
| T206 | 1 | ******************** |
| T536.1 | 1 | ******************** |
| T536.2 | 1 | ******************** |
| LW13K2 | 1 | ******************** |
| undifferentiated ES cells | 1 | ******************** |
| B16F10 | 1 | ******************** |
| hybridoma 3B4C-4 | 1 | ******************** |
| C6 glioma; ATCC CCL-107 | 1 | ******************** |
| N1E115 | 1 | ******************** |
| macrophage RAW 264.7 | 1 | ******************** |
| hybridoma SM5-1 | 1 | ******************** |
| 300.19; Abelson-transformed leukemic cells | 1 | ******************** |
| Sol8 myoblast | 1 | ******************** |
| K46 | 1 | ******************** |
| memory T hybridoma 1D1 | 1 | ******************** |
| VSMC A-10 | 1 | ******************** |
| CHO-S | 1 | ******************** |
| hybridoma F24F2 | 1 | ******************** |
| hybridoma F26G3 | 1 | ******************** |
| hybridoma F30D1 | 1 | ******************** |
| hybridoma 21Bl | 1 | ******************** |
| hybridoma F24G7 | 1 | ******************** |
| hybridoma F26G4 | 1 | ******************** |
| CHO DUKX | 1 | ******************** |
| REF cells | 1 | ******************** |
| C8-D30 (Astrocyte type III clone) | 1 | ******************** |
| Chinese hamster ovary (CHO) | 1 | ******************** |
| D1B | 1 | ******************** |
| mas-transfected CHO/dhFr- | 1 | ******************** |
| SV40LT-SMC | 1 | ******************** |
| mIMCD3 | 1 | ******************** |
| MTHC-D2 | 1 | ******************** |
| MEF | 1 | ******************** |
| AML-12 | 1 | ******************** |
| TIB-219 (ATCC) | 1 | ******************** |
| HB-8592 (ATCC) | 1 | ******************** |
| ACC1 hybridoma | 1 | ******************** |
| ACC2 hybridoma | 1 | ******************** |
| ACC3 hybridoma | 1 | ******************** |
| ACC4 hybridoma | 1 | ******************** |
| GB8 hybridoma | 1 | ******************** |
| UL1 hybridoma | 1 | ******************** |
| P19C6 | 1 | ******************** |
| normal rat kidney (NRK) cells | 1 | ******************** |
| NBR4 | 1 | ******************** |
| hybridoma H1-DNP-epsilon-26.82; hybridoma IgE-53-569 | 1 | ******************** |
| M x W231.1b | 1 | ******************** |
| MOPC315 | 1 | ******************** |
| 702/3 | 1 | ******************** |
| 70Z/3/3 | 1 | ******************** |
| DDT-1 MF-2 | 1 | ******************** |
| transgenic 1G10 | 1 | ******************** |
| transgenic 3G3 | 1 | ******************** |
| transgenic 1E9 | 1 | ******************** |
| lymphoid cell line 70Z/3 | 1 | ******************** |
| lymphoid cell line 7OZ/3 | 1 | ******************** |
| fibrosarcoma cell line Meth A | 1 | ******************** |
| JB-6 | 1 | ******************** |
| 3T3 L1 | 1 | ******************** |
| KiSV-MC1 | 1 | ******************** |
| IF2 | 1 | ******************** |
| MOPC41 | 1 | ******************** |
| Cl.Ly1+2-/9 | 1 | ******************** |
| HPC76 | 1 | ******************** |
| TEPC 1017 | 1 | ******************** |
| RBL 2H3 | 1 | ******************** |
| H35 Reuber | 1 | ******************** |
| alpha T3-1 | 1 | ******************** |
| DHD / K12 / TRb | 1 | ******************** |
| GC3 | 1 | ******************** |
| Con8.hd6 | 1 | ******************** |
| T10 | 1 | ******************** |
| hybridoma A23A41 | 1 | ******************** |
| UMR106-01 | 1 | ******************** |
| D3 embryonic stem | 1 | ******************** |
| OX8, OX22 | 1 | ******************** |
| uninduced murine erythroleukemia MEL | 1 | ******************** |
| V79-743x-tr5 | 1 | ******************** |
| WEHI3 | 1 | ******************** |
| RNK-16 natural killer cell leukemia | 1 | ******************** |
| A32H1.1B | 1 | ******************** |
| 2.73 | 1 | ******************** |
| HIT (insulinoma) | 1 | ******************** |
| peritoneal macrophage | 1 | ******************** |
| BRL | 1 | ******************** |
| 2772 | 1 | ******************** |
| 53R-1 | 1 | ******************** |
| 53R-4 | 1 | ******************** |
| 56R-3 | 1 | ******************** |
| 56R-7 | 1 | ******************** |
| 57R-1 | 1 | ******************** |
| pre-B cell 22D6 | 1 | ******************** |
| 208F fibroblast | 1 | ******************** |
| COS-6m | 1 | ******************** |
| BTC-3 | 1 | ******************** |
| Pam cell | 1 | ******************** |
| CRNK-16 | 1 | ******************** |
| 70 z/3 | 1 | ******************** |
| anti-Sm hybridoma 1-18 | 1 | ******************** |
| anti-Sm hybridoma 1-4 | 1 | ******************** |
| anti-Sm hybridoma 1-42 | 1 | ******************** |
| anti-Sm hybridoma 1-5F6 | 1 | ******************** |
| anti-Sm hybridoma 1-8 | 1 | ******************** |
| anti-Sm hybridoma 1-8C2 | 1 | ******************** |
| anti-Sm hybridoma 10C8 | 1 | ******************** |
| anti-Sm hybridoma 2-12 | 1 | ******************** |
| anti-Sm hybridoma 2-4 | 1 | ******************** |
| anti-Sm hybridoma 22G12 | 1 | ******************** |
| anti-Sm hybridoma 2A1 | 1 | ******************** |
| anti-Sm hybridoma 3-19 | 1 | ******************** |
| anti-Sm hybridoma 3-56 | 1 | ******************** |
| anti-Sm hybridoma 3-7 | 1 | ******************** |
| anti-Sm hybridoma 3G2 | 1 | ******************** |
| anti-Sm hybridoma 4A9 | 1 | ******************** |
| anti-Sm hybridoma 1-12 | 1 | ******************** |
| anti-Sm hybridoma 11A10 | 1 | ******************** |
| anti-Sm hybridoma 14C10 | 1 | ******************** |
| anti-Sm hybridoma 18F7 | 1 | ******************** |
| anti-Sm hybridoma 19B8 | 1 | ******************** |
| anti-Sm hybridoma 20A2 | 1 | ******************** |
| anti-Sm hybridoma 22B8 | 1 | ******************** |
| anti-Sm hybridoma 22F6 | 1 | ******************** |
| anti-Sm hybridoma 2E10 | 1 | ******************** |
| anti-Sm hybridoma 3-31 | 1 | ******************** |
| anti-Sm hybridoma 3-69 | 1 | ******************** |
| anti-Sm hybridoma 4D12 | 1 | ******************** |
| anti-Sm hybridoma 5E9 | 1 | ******************** |
| anti-Sm hybridoma 12D11 | 1 | ******************** |
| anti-Sm hybridoma 1-10 | 1 | ******************** |
| anti-Sm hybridoma 1-4K | 1 | ******************** |
| anti-Sm hybridoma 1-5F6K | 1 | ******************** |
| anti-Sm hybridoma 1-8C2K | 1 | ******************** |
| anti-Sm hybridoma 18F7K | 1 | ******************** |
| anti-Sm hybridoma 2-11 | 1 | ******************** |
| anti-Sm hybridoma 2-11K | 1 | ******************** |
| anti-Sm hybridoma 2G7 | 1 | ******************** |
| anti-Sm hybridoma 3-19K | 1 | ******************** |
| anti-Sm hybridoma 3-56K | 1 | ******************** |
| anti-Sm hybridoma 5B5 | 1 | ******************** |
| anti-Sm hybridoma 7B6 | 1 | ******************** |
| anti-Sm hybridoma 7C5 | 1 | ******************** |
| anti-Sm hybridoma 7E10 | 1 | ******************** |
| anti-Sm hybridoma 8G3 | 1 | ******************** |
| anti-Sm hybridoma 1-12K | 1 | ******************** |
| anti-Sm hybridoma 1-18K | 1 | ******************** |
| anti-Sm hybridoma 1-42K | 1 | ******************** |
| anti-Sm hybridoma 1-8K | 1 | ******************** |
| anti-Sm hybridoma 11A10K | 1 | ******************** |
| anti-Sm hybridoma 14C10K | 1 | ******************** |
| anti-Sm hybridoma 19B8K | 1 | ******************** |
| anti-Sm hybridoma 22F6K | 1 | ******************** |
| anti-Sm hybridoma 2E10K | 1 | ******************** |
| anti-Sm hybridoma 3-31K | 1 | ******************** |
| anti-Sm hybridoma 3-7K | 1 | ******************** |
| anti-Sm hybridoma 4D12K | 1 | ******************** |
| anti-Sm hybridoma 5E9K | 1 | ******************** |
| anti-Sm hybridoma 7B6K | 1 | ******************** |
| anti-Sm hybridoma 7C5K | 1 | ******************** |
| anti-Sm hybridoma 1-10K | 1 | ******************** |
| anti-Sm hybridoma 10C8K | 1 | ******************** |
| anti-Sm hybridoma 12D11K | 1 | ******************** |
| anti-Sm hybridoma 2-12K | 1 | ******************** |
| anti-Sm hybridoma 20A2K | 1 | ******************** |
| anti-Sm hybridoma 22B8K | 1 | ******************** |
| anti-Sm hybridoma 2A1K | 1 | ******************** |
| anti-Sm hybridoma 2G7K | 1 | ******************** |
| anti-Sm hybridoma 3-69K | 1 | ******************** |
| anti-Sm hybridoma 3G2K | 1 | ******************** |
| anti-Sm hybridoma 4A9K | 1 | ******************** |
| anti-Sm hybridoma 5B5K | 1 | ******************** |
| anti-Sm hybridoma 7E10K | 1 | ******************** |
| anti-Sm hybridoma 8G3K | 1 | ******************** |
| anti-Sm hybridoma Y2K | 1 | ******************** |
| anti-Sm hybridoma SM7-13 | 1 | ******************** |
| anti-Sm hybridoma SM7-13K | 1 | ******************** |
| anti-Sm hybridoma Y12 | 1 | ******************** |
| anti-Sm hybridoma Y12K | 1 | ******************** |
| anti-Sm hybridoma Y2 | 1 | ******************** |
| A5 | 1 | ******************** |
| 7B9 | 1 | ******************** |
| BC3H-1 | 1 | ******************** |
| acinar | 1 | ******************** |
| CA77 | 1 | ******************** |
| C1300 | 1 | ******************** |
| Hybridoma OKT9 | 1 | ******************** |
| 231F1 | 1 | ******************** |
| KRC-7 | 1 | ******************** |
| ES-D3 stem cell | 1 | ******************** |
| ES-D stem cell | 1 | ******************** |
| Balb/MK | 1 | ******************** |
| MC/9 | 1 | ******************** |
| H35 | 1 | ******************** |
| W3129 | 1 | ******************** |
| R15.3 | 1 | ******************** |
| F3 azamyoblasts | 1 | ******************** |
| ATCC CCL 61 | 1 | ******************** |
| 70/Z | 1 | ******************** |
| NIH-3T3-L1 | 1 | ******************** |
| PC60d10S (mouse x rat T cytotoxic hybridoma) | 1 | ******************** |
| BrE-3 | 1 | ******************** |
| M2.2.2 | 1 | ******************** |
| 22D6 (pre-B) | 1 | ******************** |
| CC46 | 1 | ******************** |
| CC92 | 1 | ******************** |
| 6889 | 1 | ******************** |
| bfd03 | 1 | ******************** |
| bfd05 | 1 | ******************** |
| bfd37 | 1 | ******************** |
| bfd38 | 1 | ******************** |
| bfd39 | 1 | ******************** |
| bfd89 | 1 | ******************** |
| Y1 | 1 | ******************** |
| basophilic leukemia (RBL-2H3) | 1 | ******************** |
| B49 | 1 | ******************** |
| CCHL | 1 | ******************** |
| P3XAg.8 | 1 | ******************** |
| te71 | 1 | ******************** |
| NMS 90 | 1 | ******************** |
| GM-CSf | 1 | ******************** |
| BW5-85, unknown specificity. | 1 | ******************** |
| BW5-2 | 1 | ******************** |
| BW5-8 | 1 | ******************** |
| BW5-130 | 1 | ******************** |
| BW5-17 | 1 | ******************** |
| BW5-25 | 1 | ******************** |
| BW5-31 | 1 | ******************** |
| BW5-50 | 1 | ******************** |
| BW5-55 | 1 | ******************** |
| BW5-56, secondary response anti-influenza virus (A/PR/8/34) hemagglutinin. | 1 | ******************** |
| BW5-56 | 1 | ******************** |
| BW5-57 | 1 | ******************** |
| BW5-59 | 1 | ******************** |
| BW5-63 | 1 | ******************** |
| BW5-6 | 1 | ******************** |
| BW5-77 | 1 | ******************** |
| BW5-93 | 1 | ******************** |
| IL-1 induced stroma-derived AC.6 | 1 | ******************** |
| M27 | 1 | ******************** |
| 3E10 | 1 | ******************** |
| alpha D11 | 1 | ******************** |
| TSLA29 | 1 | ******************** |
| MA-10 | 1 | ******************** |
| LTK- | 1 | ******************** |
| BW5-78 | 1 | ******************** |
| MELC | 1 | ******************** |
| 70Z3 | 1 | ******************** |
| G8-NIH3T3 | 1 | ******************** |
| KS13 | 1 | ******************** |
| mel cells c-88 | 1 | ******************** |
| SO1 | 1 | ******************** |
| KO3-34 | 1 | ******************** |
| KO3-256 | 1 | ******************** |
| R1-38 | 1 | ******************** |
| R18-9 | 1 | ******************** |
| S2B154 | 1 | ******************** |
| DS-19 | 1 | ******************** |
| II 1H-30.1, XI 1H-3.11, XIII 1H-20.4, XIII 1H-21.1, XIV 1H-3.4 | 1 | ******************** |
| I 1H-11.7, II 1H-35.2, XIV 1H-1.6, XIV 1H-2.7 | 1 | ******************** |
| XIV 1H-4.4 | 1 | ******************** |
| C94-10B9 | 1 | ******************** |
| C94-5B11 | 1 | ******************** |
| C95-4F10 | 1 | ******************** |
| C95-5A1 | 1 | ******************** |
| C96-6D7 | 1 | ******************** |
| C97-1A4 | 1 | ******************** |
| C97-2B6 | 1 | ******************** |
| CHE | 1 | ******************** |
| HC4A | 1 | ******************** |
| 132A | 1 | ******************** |
| Cyd-1 | 1 | ******************** |
| Guo-1 | 1 | ******************** |
| GB-1 | 1 | ******************** |
| Guo-2 | 1 | ******************** |
| LBRM-33 | 1 | ******************** |
| SO4 | 1 | ******************** |
| hybridoma cell line clone BA7.1 | 1 | ******************** |
| H67 | 1 | ******************** |
| erythroleukemia cells | 1 | ******************** |
| 3alpha4D10 | 1 | ******************** |
| M12 | 1 | ******************** |
| alpha-T3-1 | 1 | ******************** |
| E-5 | 1 | ******************** |
| CB-Nm.1 | 1 | ******************** |
| PR-23 | 1 | ******************** |
| sarcoma cell line s180 | 1 | ******************** |
| T3C | 1 | ******************** |
| C1300 neuroblasts | 1 | ******************** |
| Chinese hamster ovary-K1 | 1 | ******************** |
| alpha T3 | 1 | ******************** |
| D4 | 1 | ******************** |
| D33W25 | 1 | ******************** |
| CF-150 | 1 | ******************** |
| DR31, RJK | 1 | ******************** |
| 14-7FD (cytotoxic T-cell line) | 1 | ******************** |
| 302 | 1 | ******************** |
| 339 | 1 | ******************** |
| 3C2 | 1 | ******************** |
| 471 | 1 | ******************** |
| E1 | 1 | ******************** |
| 4050 | 1 | ******************** |
| 1255 | 1 | ******************** |
| 21D2 | 1 | ******************** |
| 386 | 1 | ******************** |
| WEHI-279 | 1 | ******************** |
| MTC | 1 | ******************** |
| 3E6 | 1 | ******************** |
| 1H6A | 1 | ******************** |
| Abelson transformed pre-B-cell line 22D6 | 1 | ******************** |
| RAW264.7 (treated with LPS) | 1 | ******************** |
| transgenic line 8 | 1 | ******************** |
| MN7 | 1 | ******************** |
| 32Dc13 | 1 | ******************** |
| AtT-20/D16v corticotrope tumor cell | 1 | ******************** |
| RF33.21.22 | 1 | ******************** |
| 21C5 hybridoma | 1 | ******************** |
| 21C5 | 1 | ******************** |
| CT6 | 1 | ******************** |
| SCH94.03 | 1 | ******************** |
| C6 glioma, CCL107 | 1 | ******************** |
| HIT-T15 M2.2.2 | 1 | ******************** |
| tumor cell line MA-10 | 1 | ******************** |
| UMR106 osteosarcoma | 1 | ******************** |
| 27J and 28J | 1 | ******************** |
| C1-V13D | 1 | ******************** |
| D10 | 1 | ******************** |
| D10.G4.1 | 1 | ******************** |
| mouse-rat, neuroblastoma-glioma hybrid NG108-15 | 1 | ******************** |
| AB1 | 1 | ******************** |
| CHO-K1 (ccl-61) | 1 | ******************** |
| hemangioendothelioma-derived cell line | 1 | ******************** |
| splenocyte/nonsecreting Sp2/O-Ag14 fusion cell line | 1 | ******************** |
| C10 | 1 | ******************** |
| D3 ES cells | 1 | ******************** |
| GS-9L | 1 | ******************** |
| BHK-21(C-13) | 1 | ******************** |
| WKY12-22 | 1 | ******************** |
| B cell/myeloma X63.Ag8.653 | 1 | ******************** |
| HCMV16 | 1 | ******************** |
| PO18 | 1 | ******************** |
| PO18+ | 1 | ******************** |
| PO18- | 1 | ******************** |
| hybridoma A2B5 | 1 | ******************** |
| hybridoma HNK-1 | 1 | ******************** |
| hybridoma O1 | 1 | ******************** |
| hybridoma O4 | 1 | ******************** |
| FF | 1 | ******************** |
| c23.5 | 1 | ******************** |
| hybridoma 104-8 | 1 | ******************** |
| hybridoma 111-1 | 1 | ******************** |
| hybridoma G2a-1 | 1 | ******************** |
| hybridoma G1-1 | 1 | ******************** |
| hybridoma G3-3 | 1 | ******************** |
| hybridoma G2b-3 | 1 | ******************** |
| hybridoma G2b-4 | 1 | ******************** |
| hybridoma 56-1 | 1 | ******************** |
| hybridoma G1-14 | 1 | ******************** |
| hybridoma G1-2 | 1 | ******************** |
| hybridoma 52-1 | 1 | ******************** |
| hybridoma G1-9 | 1 | ******************** |
| hybridoma G2b-2 | 1 | ******************** |
| AHL-1 | 1 | ******************** |
| Sol 8 | 1 | ******************** |
| Chinese hamster V79B | 1 | ******************** |
| C3H/F2-11 | 1 | ******************** |
| C3H/F2-12 | 1 | ******************** |
| C3H/F2-15 | 1 | ******************** |
| C3H/F2-20 | 1 | ******************** |
| C3H/F2-21 | 1 | ******************** |
| C3H/F2-22 | 1 | ******************** |
| C3H/F2-2 | 1 | ******************** |
| C3H/F2-3 | 1 | ******************** |
| C3H/F2-4 | 1 | ******************** |
| C3H/F2-6 | 1 | ******************** |
| TtT97 | 1 | ******************** |
| L-cell | 1 | ******************** |
| erythroleukemic C19 | 1 | ******************** |
| erythroleukemia C19 | 1 | ******************** |
| CHO-K1 G0 phase | 1 | ******************** |
| Wehi 7.1 | 1 | ******************** |
| RIN m5F | 1 | ******************** |
| difluoro-methylornithine-resistant myeloma | 1 | ******************** |
| cf C3H | 1 | ******************** |
| B6.2 | 1 | ******************** |
| hybridoma AIDA 10/3 | 1 | ******************** |
| 70Z/3B | 1 | ******************** |
| B1-8.delta | 1 | ******************** |
| hybridoma AIDA 10/9 | 1 | ******************** |
| hybridoma AIDA 10/14 | 1 | ******************** |
| hybridoma AIDA 10/16 | 1 | ******************** |
| hybridoma AIDA 10/17 | 1 | ******************** |
| hybridoma AIDA 23/3 | 1 | ******************** |
| MOPC 460 | 1 | ******************** |
| LB8 | 1 | ******************** |
| 2AB5 | 1 | ******************** |
| Id29 | 1 | ******************** |
| MOPC 467 | 1 | ******************** |
| V to DJ rearranging pre-B cell | 1 | ******************** |
| normal T-cell line L12 | 1 | ******************** |
| CP5 A21-1 hybridoma | 1 | ******************** |
| CP3 23-24 hybridoma | 1 | ******************** |
| hybridoma DA.33.C2 | 1 | ******************** |
| hybridoma BB1.D5 | 1 | ******************** |
| hybridoma ZZ38 | 1 | ******************** |
| hybridoma AF.3.G7 | 1 | ******************** |
| Ly-5 | 1 | ******************** |
| BC-3-H-I | 1 | ******************** |
| 38C13 | 1 | ******************** |
| 40-40 | 1 | ******************** |
| 40-140 | 1 | ******************** |
| 40-160 | 1 | ******************** |
| 35-20 | 1 | ******************** |
| 2H7 | 1 | ******************** |
| 389PC | 1 | ******************** |
| 506S | 1 | ******************** |
| 1A1PC | 1 | ******************** |
| 12P10S | 1 | ******************** |
| 7E9S | 1 | ******************** |
| 1B1S | 1 | ******************** |
| 13G3S | 1 | ******************** |
| 1B3S | 1 | ******************** |
| 12B11S | 1 | ******************** |
| 5D6S | 1 | ******************** |
| IA1PC | 1 | ******************** |
| 40-150 | 1 | ******************** |
| 3T3-DM | 1 | ******************** |
| HT-2Th | 1 | ******************** |
| HT-2 Th | 1 | ******************** |
| 511 | 1 | ******************** |
| T15 | 1 | ******************** |
| cell library 38 | 1 | ******************** |
| extra-embryonic endoderm-like cell line F9ACc19 | 1 | ******************** |
| DN7.3 | 1 | ******************** |
| CTLLA11 | 1 | ******************** |
| G/C | 1 | ******************** |
| HTC hepatoma | 1 | ******************** |
| vinblastine-resistant J774.2 (J7.V1-1) | 1 | ******************** |
| S107.3.4 | 1 | ******************** |
| 3T3R500 | 1 | ******************** |
| ABPC48 | 1 | ******************** |
| GH | 1 | ******************** |
| 2.19 | 1 | ******************** |
| WE | 1 | ******************** |
| 3A9 | 1 | ******************** |
| C11.A2 | 1 | ******************** |
| A4.A1 | 1 | ******************** |
| A2.2B2 | 1 | ******************** |
| 18N.30 | 1 | ******************** |
| A6.A2 | 1 | ******************** |
| dendritic epidermal T cell (DETC) Y93A | 1 | ******************** |
| dendritic epidermal T cell (DETC) T195/BW hybridoma | 1 | ******************** |
| Abelson virus transformed AT11-2-derived AT16.1 | 1 | ******************** |
| Abelson virus transformed AT11-2-derived AT16.1-1 | 1 | ******************** |
| Abelson virus transformed AT11-2-derived cell line AT16.101-1 | 1 | ******************** |
| hybridoma 3A112 | 1 | ******************** |
| hybridoma 3A183 | 1 | ******************** |
| hybridoma 3C52 | 1 | ******************** |
| hybridoma 3D61 | 1 | ******************** |
| hybridoma 3C13 | 1 | ******************** |
| hybridoma C32 | 1 | ******************** |
| hybridoma 3B44 | 1 | ******************** |
| hybridoma 3B5 | 1 | ******************** |
| hybridoma 3B62 | 1 | ******************** |
| hybridoma B423 | 1 | ******************** |
| E7 | 1 | ******************** |
| D23 | 1 | ******************** |
| myogenic L6/C15 | 1 | ******************** |
| C-243-3 | 1 | ******************** |
| 281.12 | 1 | ******************** |
| 281.10 | 1 | ******************** |
| 280.17 | 1 | ******************** |
| 280.21 | 1 | ******************** |
| 280.8 | 1 | ******************** |
| 280.15 | 1 | ******************** |
| 281.4 | 1 | ******************** |
| AS-overproducing | 1 | ******************** |
| MuLV-transformed cell line AT8-1 | 1 | ******************** |
| AH130 | 1 | ******************** |
| F9 teratocarcinoma stem cells | 1 | ******************** |
| MAb 6A4 | 1 | ******************** |
| pre-B cell line 1H6A | 1 | ******************** |
| BC-3H-1 | 1 | ******************** |
| PSA-1 | 1 | ******************** |
| PU5-1.8 | 1 | ******************** |
| 40 hour ConA blast cell line | 1 | ******************** |
| D10.G.4.1 | 1 | ******************** |
| hybridoma G1-10 | 1 | ******************** |
| P65D6-3 | 1 | ******************** |
| SL12.4 | 1 | ******************** |
| 3T3 A31 | 1 | ******************** |
| 45-49 | 1 | ******************** |
| hybridoma LD1 | 1 | ******************** |
| hybridoma LD3 | 1 | ******************** |
| hybridoma MT1-14 | 1 | ******************** |
| hybridoma MT1-27 | 1 | ******************** |
| hybridoma MT1-6 | 1 | ******************** |
| hybridoma MT1-33 | 1 | ******************** |
| hybridoma MT1-7 | 1 | ******************** |
| hybridoma P1F12C4 | 1 | ******************** |
| hybridoma P1D3A6 | 1 | ******************** |
| hybridoma 1E1O | 1 | ******************** |
| hybridoma 7/6AH1 | 1 | ******************** |
| hybridoma 2B11 | 1 | ******************** |
| HM-1 | 1 | ******************** |
| EL-4/MEL-14hi | 1 | ******************** |
| H120-2 | 1 | ******************** |
| H130-5 | 1 | ******************** |
| H130-6 | 1 | ******************** |
| H146-24B1 | 1 | ******************** |
| H147-25H1 | 1 | ******************** |
| H163-130F2 | 1 | ******************** |
| H163-130H9 | 1 | ******************** |
| H2-4C2 | 1 | ******************** |
| H220-1 | 1 | ******************** |
| H220-10 | 1 | ******************** |
| H220-22 | 1 | ******************** |
| H220-23 | 1 | ******************** |
| H220-5 | 1 | ******************** |
| H220-7 | 1 | ******************** |
| H230-2 | 1 | ******************** |
| H230-5 | 1 | ******************** |
| H250-6 | 1 | ******************** |
| H280-10 | 1 | ******************** |
| H280-15 | 1 | ******************** |
| H35-C10 | 1 | ******************** |
| H35-C7 | 1 | ******************** |
| H61-15 | 1 | ******************** |
| H9-A15 | 1 | ******************** |
| H9-D3 | 1 | ******************** |
| 1C5-3A4 | 1 | ******************** |
| L11-2E2 | 1 | ******************** |
| L2-10C1 | 1 | ******************** |
| L2-5D2 | 1 | ******************** |
| H136-130H9 | 1 | ******************** |
| IC5-3A4 | 1 | ******************** |
| HINS-B3 | 1 | ******************** |
| MB66 MCA ACL6 | 1 | ******************** |
| 2F10 | 1 | ******************** |
| 4E1 | 1 | ******************** |
| 3F3 | 1 | ******************** |
| B8-2, 2F10 | 1 | ******************** |
| IP/IR | 1 | ******************** |
| P19 embryonal carcinoma (EC) | 1 | ******************** |
| 4C11 | 1 | ******************** |
| mitogen (PMA-P)-stimulated lymphocyte | 1 | ******************** |
| 6-19 | 1 | ******************** |
| HIT T-15; M2.2.2 | 1 | ******************** |
| DG 5.1 PCR product | 1 | ******************** |
| DF 15 PCR product | 1 | ******************** |
| ML | 1 | ******************** |
| 2772A | 1 | ******************** |
| HIR 3.5 | 1 | ******************** |
| WEHI-2 cells | 1 | ******************** |
| KiSV-MC | 1 | ******************** |
| MGF-10 | 1 | ******************** |
| 40-100 | 1 | ******************** |
| 40-60 | 1 | ******************** |
| 40-90 | 1 | ******************** |
| 7D4 | 1 | ******************** |
| 2B5 | 1 | ******************** |
| 6A7 | 1 | ******************** |
| 14D2 | 1 | ******************** |
| 2F8 | 1 | ******************** |
| 4A9 | 1 | ******************** |
| 3A3 | 1 | ******************** |
| 5F8 | 1 | ******************** |
| 6H2 | 1 | ******************** |
| 1G1 | 1 | ******************** |
| 1F5 | 1 | ******************** |
| 2E5 | 1 | ******************** |
| NFS-60 | 1 | ******************** |
| hepatoma line H4IIEC3 | 1 | ******************** |
| PC12 pheochromocytoma and FTO-2B hepatoma | 1 | ******************** |
| 40-20 | 1 | ******************** |
| 3T3 fibroblast | 1 | ******************** |
| ATCC TIB 208 | 1 | ******************** |
| hybridoma TE34 | 1 | ******************** |
| serum-free mouse embryo (SFME) | 1 | ******************** |
| NFS 58 | 1 | ******************** |
| hybridoma Z44 | 1 | ******************** |
| hybridoma Z22 | 1 | ******************** |
| BHK 165-23 | 1 | ******************** |
| JEL 42 | 1 | ******************** |
| JEL 44 | 1 | ******************** |
| JEL 324 | 1 | ******************** |
| 24F3 | 1 | ******************** |
| 32F3 | 1 | ******************** |
| 4F8 | 1 | ******************** |
| UMR 106-01 | 1 | ******************** |
| brain | 1 | ******************** |
| AD5D4A | 1 | ******************** |
| D11 | 1 | ******************** |
| 3A4 | 1 | ******************** |
| RAC65 | 1 | ******************** |
| SP20/spleen fusion hybridoma | 1 | ******************** |
| Bsp73 ASML | 1 | ******************** |
| NC1/34HL | 1 | ******************** |
| SL12.4.10 | 1 | ******************** |
| 10001 | 1 | ******************** |
| 9C12.7 | 1 | ******************** |
| LB4, and LL2 | 1 | ******************** |
| LB4 | 1 | ******************** |
| LL2 | 1 | ******************** |
| EB22 | 1 | ******************** |
| H140-1E6 | 1 | ******************** |
| H142-3H5 | 1 | ******************** |
| H144-17C5 | 1 | ******************** |
| H146-24E9 | 1 | ******************** |
| H151-31D10 | 1 | ******************** |
| H152-42A3 | 1 | ******************** |
| H152-43B2 | 1 | ******************** |
| H153-70A12 | 1 | ******************** |
| H165-156A2 | 1 | ******************** |
| H17-L19 | 1 | ******************** |
| H17-L7 | 1 | ******************** |
| H20-A15 | 1 | ******************** |
| H220-11 | 1 | ******************** |
| H220-19 | 1 | ******************** |
| H280-4 | 1 | ******************** |
| H33-48 | 1 | ******************** |
| H37-90 | 1 | ******************** |
| IC5-4F4 | 1 | ******************** |
| H152-42B11 | 1 | ******************** |
| dE16 | 1 | ******************** |
| Bac12F5 | 1 | ******************** |
| Bac1 2F5 | 1 | ******************** |
| NIH 3T3 transformed | 1 | ******************** |
| CLB-T3/4.A- Ig anti-CD3 mAb | 1 | ******************** |
| pre-B cell line 22D6 | 1 | ******************** |
| FGF-responsiveSC-3 | 1 | ******************** |
| M-MSV-transformed NRK cell line 6m2 | 1 | ******************** |
| BMS2 | 1 | ******************** |
| ABFTL-6 | 1 | ******************** |
| ABPL-2 | 1 | ******************** |
| CMT-93 | 1 | ******************** |
| 2B4 | 1 | ******************** |
| 2H10 | 1 | ******************** |
| anti-pigeon cytochrome c specific cell line | 1 | ******************** |
| Kirsten Sarcoma Virus Immortalized MC-1 | 1 | ******************** |
| NH15-CA2 | 1 | ******************** |
| A20/2J | 1 | ******************** |
| F9EC tk- | 1 | ******************** |
| Nb2 rat lymphoma cell line | 1 | ******************** |
| NCB-20 | 1 | ******************** |
| myogenic C2 | 1 | ******************** |
| RDM4 | 1 | ******************** |
| MP1 (BHK-derived) | 1 | ******************** |
| 4N2.1 plasmacytoma | 1 | ******************** |
| DSP2.2 | 1 | ******************** |
| DFL16.1 | 1 | ******************** |
| DSP2.11 | 1 | ******************** |
| M14T | 1 | ******************** |
| hepatoma H4 | 1 | ******************** |
| 03F9 | 1 | ******************** |
| DFL16.2 | 1 | ******************** |
| K-1735 mouse meanoma, subclone M2 | 1 | ******************** |
| osteosarcoma | 1 | ******************** |
| MCT | 1 | ******************** |
| 3T3-R500 | 1 | ******************** |
| H-16.B11 | 1 | ******************** |
| L-9.2 | 1 | ******************** |
| H-16.G10 | 1 | ******************** |
| L-9.7 | 1 | ******************** |
| L-3A | 1 | ******************** |
| L-1A | 1 | ******************** |
| L-8w.45 | 1 | ******************** |
| H-10.B5 | 1 | ******************** |
| L-9.37 | 1 | ******************** |
| H-12.C4 | 1 | ******************** |
| L-9.10 | 1 | ******************** |
| H-16.B6 | 1 | ******************** |
| H-15.G9 | 1 | ******************** |
| H-15.E3 | 1 | ******************** |
| L-9w.7 | 1 | ******************** |
| H-12.E4 | 1 | ******************** |
| WEHI7TG | 1 | ******************** |
| dexamethasone+cyclohexamide treated thymocyte | 1 | ******************** |
| P19(P19S1801A1) | 1 | ******************** |
| RFP-EC | 1 | ******************** |
| RFP-EC (Rat fat pad endothelial cell) | 1 | ******************** |
| Rat 1 | 1 | ******************** |
| Bam3 | 1 | ******************** |
| 4G11 | 1 | ******************** |
| D2 | 1 | ******************** |
| erythroleukemia 745A, subclone DS19-Sc9 | 1 | ******************** |
| Balb/c 3T3 fibroblasts | 1 | ******************** |
| GK1.5 | 1 | ******************** |
| tumor 10 | 1 | ******************** |
| L6-ALPHA-1 | 1 | ******************** |
| BC1 | 1 | ******************** |
| v-fos-transformed Rat-1 | 1 | ******************** |
| 23A2 | 1 | ******************** |
| NS1.1 | 1 | ******************** |
| C127 | 1 | ******************** |
| hybridoma EpD3 | 1 | ******************** |
| lmtk | 1 | ******************** |
| P19 EC | 1 | ******************** |
| ATCC CRL 1458 | 1 | ******************** |
| CHO-K1 ATCC CCL-61 | 1 | ******************** |
| YTH 906.9.21 | 1 | ******************** |
| YTH 655(5)6 | 1 | ******************** |
| YFC 51.1.1 | 1 | ******************** |
| B03H.25 | 1 | ******************** |
| BO3H.25 | 1 | ******************** |
| bm2T3.1 | 1 | ******************** |
| bm4T6.2 | 1 | ******************** |
| bm4T17.2 | 1 | ******************** |
| sEnd.1 | 1 | ******************** |
| C3HA | 1 | ******************** |
| CH12 | 1 | ******************** |
| undifferentiated F9 embryonal carcinoma cell | 1 | ******************** |
| BB128 | 1 | ******************** |
| BB223 | 1 | ******************** |
| BB344 | 1 | ******************** |
| BI1279 | 1 | ******************** |
| MOR39.3.9 | 1 | ******************** |
| MOR131.5.13 | 1 | ******************** |
| MOR115.1.13 | 1 | ******************** |
| MOR158.1.3 | 1 | ******************** |
| MOR180.2.4 | 1 | ******************** |
| MOR8.2.1 | 1 | ******************** |
| MOR33.2.9 | 1 | ******************** |
| MOR35.4.12 | 1 | ******************** |
| MOR44.4.1 | 1 | ******************** |
| MOR83.3.10 | 1 | ******************** |
| MOR76.7F.16 | 1 | ******************** |
| 3B11-1C | 1 | ******************** |
| 1246 | 1 | ******************** |
| HEV | 1 | ******************** |
| C3H 10T1/2 | 1 | ******************** |
| #22 | 1 | ******************** |
| D6 | 1 | ******************** |
| buffalo rat liver | 1 | ******************** |
| 705 | 1 | ******************** |
| K30a | 1 | ******************** |
| CYP4F1 | 1 | ******************** |
| T15 M.2.2.2 | 1 | ******************** |
| 4N2.1 | 1 | ******************** |
| TK1.c114 | 1 | ******************** |
| MAb 109 | 1 | ******************** |
| MAb 115 | 1 | ******************** |
| MAb 33 | 1 | ******************** |
| MAb 5 | 1 | ******************** |
| F2 | 1 | ******************** |
| S49 lymphoma cell (UNC variant) | 1 | ******************** |
| KML1-7 | 1 | ******************** |
| met-18b-2 | 1 | ******************** |
| H8 | 1 | ******************** |
| 1C6 | 1 | ******************** |
| 1A3 | 1 | ******************** |
| 2C8 | 1 | ******************** |
| 1B8 | 1 | ******************** |
| 7H5 | 1 | ******************** |
| P24 | 1 | ******************** |
| 4C1 | 1 | ******************** |
| 2779 | 1 | ******************** |
| CB3 | 1 | ******************** |
| Kirstem sarcoma virus transformed kidney (KN) | 1 | ******************** |
| myeloma MOPC 41 | 1 | ******************** |
| CHO k1 cell line | 1 | ******************** |
| B72.3 hybridoma | 1 | ******************** |
| basophilic leukemia cell line RBL | 1 | ******************** |
| WEHI-274 | 1 | ******************** |
| G8-1 | 1 | ******************** |
| (NZB X NZW)F1 hybridoma cells | 1 | ******************** |
| CC14 | 1 | ******************** |
| myeloma cell line MOPC 315.43 | 1 | ******************** |
| AM7B2.1 | 1 | ******************** |
| KNRK | 1 | ******************** |
| 5C2 | 1 | ******************** |
| E401 hybridoma | 1 | ******************** |
| FRTL-Tc | 1 | ******************** |
| spleen cell-SP20 hybridoma | 1 | ******************** |
| ACT19 hybridoma cells | 1 | ******************** |
| P3-X63Ag8.653 anti-thyroglobulin myeloma cells | 1 | ******************** |
| lung cell V79 | 1 | ******************** |
| PQXB1/2 anti-paraquat monoclonal cells | 1 | ******************** |
| Bac 1.2F5 | 1 | ******************** |
| ABPL-4 | 1 | ******************** |
| B6.1 | 1 | ******************** |
| EL4 cell line | 1 | ******************** |
| MEL (Murine Erythroleukemia) | 1 | ******************** |
| 2-96-12 | 1 | ******************** |
| 4-128-6 | 1 | ******************** |
| 4-74-6 | 1 | ******************** |
| N61 | 1 | ******************** |
| N92 | 1 | ******************** |
| NN3 | 1 | ******************** |
| AH7 | 1 | ******************** |
| A09 | 1 | ******************** |
| M2A1 | 1 | ******************** |
| A-20 | 1 | ******************** |
| P388/ADR/3 | 1 | ******************** |
| 60.3 hybridoma | 1 | ******************** |
| Ar-5 murine T cell line | 1 | ******************** |
| MST cells | 1 | ******************** |
| Rat-1 EJ | 1 | ******************** |
| C3H, clone 8, 10T1/2 | 1 | ******************** |
| Y1 adrenal carcinoma; CCL-79 | 1 | ******************** |
| MTLn3, MTC.4 | 1 | ******************** |
| L60WT4F (clones cMXR1-28 and -32) | 1 | ******************** |
| 425 | 1 | ******************** |
| 10T1/2 | 1 | ******************** |
| PC60-d1OS | 1 | ******************** |
| RIE-1 | 1 | ******************** |
| TUC5.37 | 1 | ******************** |
| TA4 stroma | 1 | ******************** |
| RIN-1027-B2 cells | 1 | ******************** |
| neuroblastoma cell line N1A103 | 1 | ******************** |
| C4G1 | 1 | ******************** |
| HCMV37 | 1 | ******************** |
| Y1 adrenocortical tumor cell | 1 | ******************** |
| 3S10/1 | 1 | ******************** |
| AT-3 | 1 | ******************** |
| BST1-1.8 | 1 | ******************** |
| BST1-8.18 | 1 | ******************** |
| OS-51 | 1 | ******************** |
| 13762 rat mammary adenocarcinoma | 1 | ******************** |
| Fao hepatoma | 1 | ******************** |
| 112KNS-31.8 | 1 | ******************** |
| B44 | 1 | ******************** |
| 3T3-L1 differentiated to adipocytes | 1 | ******************** |
| A3B10 | 1 | ******************** |
| L-9.W7 | 1 | ******************** |
| BCL1 (CW13.20-3B3, ATCC CRL 1669) | 1 | ******************** |
| MM14DZ | 1 | ******************** |
| HC7 | 1 | ******************** |
| PC8b (subclone PC12) | 1 | ******************** |
| PC8b (subclone of PC12) | 1 | ******************** |
| WEHI 265.1 RNA | 1 | ******************** |
| MSL-G2-Tu-6 | 1 | ******************** |
| BAC1.2F5 | 1 | ******************** |
| 22D6 pre-B lymphocyte cDNA library | 1 | ******************** |
| Chinese hamster ovary Var-261 cells | 1 | ******************** |
| Hepa 4B | 1 | ******************** |
| 10T1/2 cells | 1 | ******************** |
| TK-1 | 1 | ******************** |
| SRD-1 | 1 | ******************** |
| SRD-1 Cells | 1 | ******************** |
| MPC-11 | 1 | ******************** |
| S49.1 ATCC TIB 128 | 1 | ******************** |
| 14CoS/14CoS | 1 | ******************** |
| S49 mouse lymphoma | 1 | ******************** |
| As4.1 | 1 | ******************** |
| ES-D3 | 1 | ******************** |
| BIII.136 | 1 | ******************** |
| E36 | 1 | ******************** |
| MuLV transformed pre-B cell 22D6 | 1 | ******************** |
| UMR 106-01 rat osteosarcoma | 1 | ******************** |
| 23A2 myoblast, derived from 10T1/2 fibroblasts by 5-azacytidine treatment and cloning | 1 | ******************** |
| ATCC CRL-1442 | 1 | ******************** |
| Chinese Hamster Ovary, CHO | 1 | ******************** |
| CTLL2 | 1 | ******************** |
| RAW | 1 | ******************** |
| LNKB-2 | 1 | ******************** |
| 13762 MAT B1 | 1 | ******************** |
| ROS 17, osteosarcoma | 1 | ******************** |
| WB (rat liver epithelial) cell line | 1 | ******************** |
| DMSO treated P19 cells | 1 | ******************** |
| DMSO treated P19 cells | 1 | ******************** |
| SCB.29 | 1 | ******************** |
| WEHI-7TG | 1 | ******************** |
| T101-4 | 1 | ******************** |
| 6132A PRO | 1 | ******************** |
| 6132 HLF | 1 | ******************** |
| WEIHI3 | 1 | ******************** |
| C29 | 1 | ******************** |
| EGV-6; MNNG immortalized line | 1 | ******************** |
| W9.5 | 1 | ******************** |
| ATCC CRL 1934 | 1 | ******************** |
| 208F fibroblasts | 1 | ******************** |
| MDAY-Dw33 | 1 | ******************** |
| mIMCD-K2 | 1 | ******************** |
| CDC25 | 1 | ******************** |
| HP1/2 | 1 | ******************** |
| NG108-15 mouse neuroblastoma X rat glioma hybrid cells | 1 | ******************** |
| RPE.40, derived from CHO-K1:ATCC CCL61 | 1 | ******************** |
| CHO-K1 ATCC CCL61 | 1 | ******************** |
| 70Z | 1 | ******************** |
| HIT T15 M2.2.2 | 1 | ******************** |
| SRD-2 | 1 | ******************** |
| SRD-3 | 1 | ******************** |
| MIN6 insulinoma cells | 1 | ******************** |
| RINm5F insulinoma cells | 1 | ******************** |
| 2C10 | 1 | ******************** |
| H241 | 1 | ******************** |
| mouse neuroblastoma cells NB2a | 1 | ******************** |
| PC12-Gr5 | 1 | ******************** |
| ST514 embryonic stem cell line carrying an insertion of the pGT1.8TM gene trap vector | 1 | ******************** |
| MR3 | 1 | ******************** |
| ST519 mouse embryonic stem cell line carrying an insertion of the pGT1.8TM gene trap vector | 1 | ******************** |
| HIT (hamster insulin tumor) | 1 | ******************** |
| hybridoma cell line O25G3D6 | 1 | ******************** |
| hybridoma cell line 025G3D6 | 1 | ******************** |
| hybridoma cell line 7-4 | 1 | ******************** |
| hybridoma cell line 177 | 1 | ******************** |
| hybridoma cell line N1F10 | 1 | ******************** |
| hybridoma cell line 5c-101 | 1 | ******************** |
| hybridoma cell line MF15-4 | 1 | ******************** |
| N10 hybridoma | 1 | ******************** |
| B cell line 70/Z | 1 | ******************** |
| FTH5 | 1 | ******************** |
| BRL-3A (CRL1442) | 1 | ******************** |
| AT13/5 hybridoma | 1 | ******************** |
| AT-2 cardiomyocyte cell line | 1 | ******************** |
| H4IIEC3 | 1 | ******************** |
| CPII | 1 | ******************** |
| 32D myeloid | 1 | ******************** |
| Mc3 hybridoma | 1 | ******************** |
| lymphohematopoietic multipotent progenitor clone PR-23 | 1 | ******************** |
| mouse monoclonal hybridoma cell line, H-MabB23 | 1 | ******************** |
| mouse monoclonal hybridoma cell line, H-MabB9 | 1 | ******************** |
| mouse monoclonal hybridoma cell line, H-MabA34 | 1 | ******************** |
| RAW 264.7 mouse monocyte-macrophage (ATCC TIB 71) | 1 | ******************** |
| hybridoma 27-7C3 | 1 | ******************** |
| hybridoma 31-23-1 | 1 | ******************** |
| hybridoma 31-34-2 | 1 | ******************** |
| hybridoma 1B8E5 | 1 | ******************** |
| hybridoma 31-4-2 | 1 | ******************** |
| hybridoma 32-11-1 | 1 | ******************** |
| hybridoma 24-1b10 | 1 | ******************** |
| hybridoma 24-1b11 | 1 | ******************** |
| hybridoma 24-2b24 | 1 | ******************** |
| DA-2 | 1 | ******************** |
| promyelocytic MPRO | 1 | ******************** |
| UMR201, Ng et al., J. Bone Miner. Res. 3:53-61 (1988) | 1 | ******************** |
| CHO CUR3 | 1 | ******************** |
| Rin14B | 1 | ******************** |
| CCL16-B1 | 1 | ******************** |
| Yac-1 lymphoma | 1 | ******************** |
| hybridoma 13.1 | 1 | ******************** |
| FDCP MIX A4 | 1 | ******************** |
| insulinoma RINm5F | 1 | ******************** |
| carcinoma F9 | 1 | ******************** |
| M25 | 1 | ******************** |
| M77 | 1 | ******************** |
| J774 1.6 | 1 | ******************** |
| L1210/SKI | 1 | ******************** |
| Chinese Hamster Ovary cell line | 1 | ******************** |
| L1210/C2 leukemia | 1 | ******************** |
| STC6-14 | 1 | ******************** |
| FRTL5 | 1 | ******************** |
| mammary tumor AC-816 | 1 | ******************** |
| SL12.4 T lymphoma cell line | 1 | ******************** |
| C26 mouse colon adenocarcinoma cell line | 1 | ******************** |
| AE5 | 1 | ******************** |
| F9 embryonal carcinoma cell line | 1 | ******************** |
| 3T3-L1 cell line | 1 | ******************** |
| RAW 264.7m | 1 | ******************** |
| MEL cell | 1 | ******************** |
| 10T1/2 fibroblast | 1 | ******************** |
| ES cell line D3 | 1 | ******************** |
| Ar-5 T cells | 1 | ******************** |
| PC12 cells | 1 | ******************** |
| B cell line WEHI-231 | 1 | ******************** |
| BAC1.2F5 - spleen-derived macrophage cell line | 1 | ******************** |
| H35 hepatoma cells | 1 | ******************** |
| EL-4, T cell lymphoma | 1 | ******************** |
| hemopoietic cells B6SUtA | 1 | ******************** |
| C2C12 continuous myoblast | 1 | ******************** |
| mucosal mast cell line RBL-2H3 | 1 | ******************** |
| RBL-2H3 mast cell line | 1 | ******************** |
| 14-4-4 | 1 | ******************** |
| 81.A | 1 | ******************** |
| 10.A | 1 | ******************** |
| FDCPmixA4 | 1 | ******************** |
| CHO cells | 1 | ******************** |
| mouse neuroblastoma x rat glioma NG108 cells | 1 | ******************** |
| PCC4, P19, NT2D1, Tera 1 | 1 | ******************** |
| WEHI 7.2 cells (derived from a murine lymphoma) | 1 | ******************** |
| erythroleukemia cell line 745/DS19 | 1 | ******************** |
| Ba/F3 cells | 1 | ******************** |
| R33 retinal cell line | 1 | ******************** |
| 3T3 cell | 1 | ******************** |
| hematopoietic cell line FDCPmixA4 | 1 | ******************** |
| macrophage RAW cells | 1 | ******************** |
| ST-1 cell line, derived from the medullary thick ascending limb of Henle of mice transgenic for the SV40 T antigen | 1 | ******************** |
| embryonal carcinoma ATDC5 | 1 | ******************** |
| WEHI-274.1 | 1 | ******************** |
| non-secreting myeloma cell line S194 (ATTC TIB19) | 1 | ******************** |
| cytolytic T-cell clone P1:5, specific of antigen P815A | 1 | ******************** |
| cytolytic T-cell clone P35:10, specific of antigen P815B | 1 | ******************** |
| cytolytic T-cell clone TiL 3I(4), specific of antigen P815AB | 1 | ******************** |
| cytolytic T-cell clone TiL 3I(5), specific of antigen P815AB | 1 | ******************** |
| cytolytic T-cell clone TiL 3III(16), specific of antigen P815AB;probable sister clone to TiL 3III(18) | 1 | ******************** |
| cytolytic T-cell clone TiL 3III(18), specific of antigen P815AB;probable sister clone to TiL 3III(16) | 1 | ******************** |
| cytolytic T-cell clone P1:515, specific of antigen P815C | 1 | ******************** |
| cytolytic T-cell clone P1.204:8, specific of antigen P815D | 1 | ******************** |
| GG2EE | 1 | ******************** |
| NG108-15 and AtT-20 | 1 | ******************** |
| 3T3 fibroblasts | 1 | ******************** |
| WEHI 274.1 murine macrophage line | 1 | ******************** |
| CHO-cells | 1 | ******************** |
| hematopoietic progenitor cell | 1 | ******************** |
| 3Y1 fibroblasts | 1 | ******************** |
| Mouse promyelocyte MPRO (S.Tsai and S.Collins, Proc.Natl.Acad.Sci.USA, 90, 7153-7157, 1993) | 1 | ******************** |
| Chinese hamster ovary cells: CHO-K1 | 1 | ******************** |
| WEHI265.1 | 1 | ******************** |
| I193 gene trapped embryonic stem cell line | 1 | ******************** |
| T cell hybridoma line 312.13 | 1 | ******************** |
| UMR 106-01 BSP | 1 | ******************** |
| RAW 264.7 cells | 1 | ******************** |
| Mouse P19 embryonic carcinoma | 1 | ******************** |
| RBL.2H3 | 1 | ******************** |
| 70Z/3 B-cell lymphoma line | 1 | ******************** |
| 363p.119 | 1 | ******************** |
| 363p.138 | 1 | ******************** |
| 363p.165 | 1 | ******************** |
| 363p.168 | 1 | ******************** |
| 363p.16 | 1 | ******************** |
| 363p.193 | 1 | ******************** |
| 363p.197 | 1 | ******************** |
| 363p.202 | 1 | ******************** |
| 363s.57 | 1 | ******************** |
| 363p.24 | 1 | ******************** |
| 363p.8 | 1 | ******************** |
| 363s.8 | 1 | ******************** |
| 363s.53 | 1 | ******************** |
| 363s.36 | 1 | ******************** |
| 363s.71 | 1 | ******************** |
| 363s.62 | 1 | ******************** |
| 363s.68 | 1 | ******************** |
| 363s.80 | 1 | ******************** |
| 363s.73 | 1 | ******************** |
| 373p.95 | 1 | ******************** |
| 373p.72 | 1 | ******************** |
| 373p.25 | 1 | ******************** |
| 373p.114 | 1 | ******************** |
| 373p.99 | 1 | ******************** |
| 373p.77 | 1 | ******************** |
| 373p.66 | 1 | ******************** |
| 373s.16 | 1 | ******************** |
| 373s.83 | 1 | ******************** |
| 373s.70 | 1 | ******************** |
| 373s.29 | 1 | ******************** |
| 373s.77 | 1 | ******************** |
| 373s.114 | 1 | ******************** |
| 373s.5 | 1 | ******************** |
| 373s.51 | 1 | ******************** |
| 373s.139 | 1 | ******************** |
| 373s.21 | 1 | ******************** |
| 373s.55 | 1 | ******************** |
| 373s.17 | 1 | ******************** |
| 373s.20 | 1 | ******************** |
| 373s.32 | 1 | ******************** |
| 373s.144 | 1 | ******************** |
| 373s.46 | 1 | ******************** |
| 373s.22 | 1 | ******************** |
| 373s.52 | 1 | ******************** |
| 373s.91 | 1 | ******************** |
| 373s.119 | 1 | ******************** |
| 373s.116 | 1 | ******************** |
| 384p.19 | 1 | ******************** |
| 384p.41 | 1 | ******************** |
| 384p.86 | 1 | ******************** |
| 384p.113 | 1 | ******************** |
| 384p.20 | 1 | ******************** |
| 384p.26 | 1 | ******************** |
| 384p.62 | 1 | ******************** |
| 384p.66 | 1 | ******************** |
| 384s.73 | 1 | ******************** |
| 384s.80 | 1 | ******************** |
| 384s.95 | 1 | ******************** |
| 384s.53 | 1 | ******************** |
| 384s.17 | 1 | ******************** |
| 384s.62 | 1 | ******************** |
| 384s.63 | 1 | ******************** |
| 384s.85 | 1 | ******************** |
| 384s.14 | 1 | ******************** |
| 384s.15 | 1 | ******************** |
| 384s.20 | 1 | ******************** |
| 384s.40 | 1 | ******************** |
| 384s.89 | 1 | ******************** |
| 423p.16 | 1 | ******************** |
| 423p.78 | 1 | ******************** |
| 423p.176 | 1 | ******************** |
| 423p.83 | 1 | ******************** |
| 423p.107 | 1 | ******************** |
| 423p.135 | 1 | ******************** |
| 423p.153 | 1 | ******************** |
| 423p.195 | 1 | ******************** |
| 423p.197 | 1 | ******************** |
| 423p.226 | 1 | ******************** |
| 423s.35 | 1 | ******************** |
| 423s.96 | 1 | ******************** |
| 423s.17 | 1 | ******************** |
| 423s.38 | 1 | ******************** |
| 423s.92 | 1 | ******************** |
| 423s.187 | 1 | ******************** |
| 452p.148m | 1 | ******************** |
| 452p.109 | 1 | ******************** |
| 452p.132m | 1 | ******************** |
| 452p.177m | 1 | ******************** |
| 452p.17 | 1 | ******************** |
| 452p.18 | 1 | ******************** |
| 452p.207 | 1 | ******************** |
| 452p.53 | 1 | ******************** |
| 452p.71m | 1 | ******************** |
| 452p.93 | 1 | ******************** |
| 452p.70 | 1 | ******************** |
| 452p.58 | 1 | ******************** |
| 452p.81 | 1 | ******************** |
| 452p.88 | 1 | ******************** |
| 452p.133 | 1 | ******************** |
| 452p.146 | 1 | ******************** |
| 452p.84 | 1 | ******************** |
| 452p.119 | 1 | ******************** |
| 452p.108 | 1 | ******************** |
| 452p.33 | 1 | ******************** |
| 452p.151 | 1 | ******************** |
| 452p.97 | 1 | ******************** |
| 452p.125 | 1 | ******************** |
| 452p.106 | 1 | ******************** |
| 452p.153 | 1 | ******************** |
| 452s.7 | 1 | ******************** |
| 452s.49 | 1 | ******************** |
| 452s.11 | 1 | ******************** |
| 452s.36 | 1 | ******************** |
| 452s.41 | 1 | ******************** |
| 452s.64 | 1 | ******************** |
| 452s.88 | 1 | ******************** |
| 452s.204 | 1 | ******************** |
| 452s.26 | 1 | ******************** |
| 452s.69 | 1 | ******************** |
| 452s.101 | 1 | ******************** |
| 452s.2 | 1 | ******************** |
| 452s.123 | 1 | ******************** |
| 452s.160 | 1 | ******************** |
| 452s.96 | 1 | ******************** |
| 452s.174 | 1 | ******************** |
| 452s.104 | 1 | ******************** |
| 452s.5 | 1 | ******************** |
| 452s.43 | 1 | ******************** |
| 452s.61 | 1 | ******************** |
| 373p.108 | 1 | ******************** |
| 423s.88 | 1 | ******************** |
| 452p.62 | 1 | ******************** |
| cytotoxic T-lymphocyte CTLL-2 | 1 | ******************** |
| Hybridoma cell line SSI 57-2 | 1 | ******************** |
| Hybridoma cell line WIS 8D9 | 1 | ******************** |
| Hybridoma cell line WIS 11B6 | 1 | ******************** |
| R- | 1 | ******************** |
| B6SUtA1 myeloid progenitor | 1 | ******************** |
| E17.5 | 1 | ******************** |
| C3H/F7-7 | 1 | ******************** |
| P19 (ATCC CRL 1825) | 1 | ******************** |
| hybridoma cell line MN12H2 | 1 | ******************** |
| Yac-1 | 1 | ******************** |
| ldTgBri | 1 | ******************** |
| ldTgHd | 1 | ******************** |
| ldIn2 | 1 | ******************** |
| 804G bladder cell line | 1 | ******************** |
| J774A.1 macrophage cell line | 1 | ******************** |
| hybridoma cell line, fusion of SP2/0-Ag14 myeloma cells with BALB/c spleen cells | 1 | ******************** |
| CHO-K1 cell line mutant Lec4A | 1 | ******************** |
| CHO-K1 cell line mutant Lec4 | 1 | ******************** |
| hybridoma cell line MF23-1 | 1 | ******************** |
| EL-4, P-388 | 1 | ******************** |
| HIT-T15 (ATCC CRL1777) | 1 | ******************** |
| BL6 | 1 | ******************** |
| FDC-P1 and WEHI-3B | 1 | ******************** |
| Lec1 | 1 | ******************** |
| hybridoma 2A81G5 | 1 | ******************** |
| L1210/R83 | 1 | ******************** |
| K-1735 | 1 | ******************** |
| REF-112 | 1 | ******************** |
| mouse hybridoma 30AA5 | 1 | ******************** |
| liver WB and GN4 epithelial cells | 1 | ******************** |
| C13 | 1 | ******************** |
| mAb 1-5 | 1 | ******************** |
| mAb 8-4-1 | 1 | ******************** |
| T cell lymphoma cell line V13 | 1 | ******************** |
| CTLL | 1 | ******************** |
| myeloma | 1 | ******************** |
| tumour cell line AtT-20 | 1 | ******************** |
| RNK-16 NK-like cells | 1 | ******************** |
| GC GH4 | 1 | ******************** |
| 129J ES | 1 | ******************** |
| 15P-1 | 1 | ******************** |
| mouse insulinoma cell line MIN6 | 1 | ******************** |
| 835T2, tumor derived | 1 | ******************** |
| CHO/HIRc | 1 | ******************** |
| hybridoma 2G3-6E3-2EZ | 1 | ******************** |
| XS52 dendritic cell line | 1 | ******************** |
| myeloma Y3 | 1 | ******************** |
| vascular smooth muscle | 1 | ******************** |
| hybridoma C14/A1 | 1 | ******************** |
| CFTL-12 | 1 | ******************** |
| A20.2J B cell lymphoma | 1 | ******************** |
| AR4IP | 1 | ******************** |
| AL1-2 hybridoma | 1 | ******************** |
| AL1-3 hybridoma | 1 | ******************** |
| AL3-2 hybridoma | 1 | ******************** |
| AL3-3 hybridoma | 1 | ******************** |
| AL3-4 hybridoma | 1 | ******************** |
| AL3-5 hybridoma | 1 | ******************** |
| AL3-6 hybridoma | 1 | ******************** |
| AL3-7 hybridoma | 1 | ******************** |
| AL3-8 hybridoma | 1 | ******************** |
| 2A2 | 1 | ******************** |
| 3F4 | 1 | ******************** |
| AtT-20/D16v-F2 | 1 | ******************** |
| LY-TH lymphoma | 1 | ******************** |
| B cell line WEHI231 | 1 | ******************** |
| WEHI-3 macrophage | 1 | ******************** |
| myeloid cell line FDC-P1 | 1 | ******************** |
| ras-transformed 3T3 cells | 1 | ******************** |
| 9C127 | 1 | ******************** |
| PCC4-teratocarcinoma | 1 | ******************** |
| MRPD | 1 | ******************** |
| P388D1 macrophage-like | 1 | ******************** |
| B12A7H | 1 | ******************** |
| B12A7L | 1 | ******************** |
| B12A8H | 1 | ******************** |
| B12A8L | 1 | ******************** |
| B1A7H | 1 | ******************** |
| B1A7L | 1 | ******************** |
| H11A2H | 1 | ******************** |
| H11A3L | 1 | ******************** |
| H11A2 | 1 | ******************** |
| H11A3 | 1 | ******************** |
| C12A6H | 1 | ******************** |
| C12A6L | 1 | ******************** |
| F10E4 | 1 | ******************** |
| F10E4L | 1 | ******************** |
| C12B5H | 1 | ******************** |
| C12B5L | 1 | ******************** |
| G4A9H | 1 | ******************** |
| G4A9L | 1 | ******************** |
| B1B6H | 1 | ******************** |
| B1B6L | 1 | ******************** |
| C11g5H | 1 | ******************** |
| C11G5L | 1 | ******************** |
| C11G1H | 1 | ******************** |
| CllG1L | 1 | ******************** |
| SV-3Y1-C66 (SV40-transformed subline of 3Y1 fibroblasts) | 1 | ******************** |
| Pa-4 | 1 | ******************** |
| ES I193 | 1 | ******************** |
| 3T3-L1 after 8 days of differentiation into adipocytes | 1 | ******************** |
| SV40-virus transformed TCMK-1 cells | 1 | ******************** |
| CFSC; a fat-storing cell line derived from a CCl4-treated cirrhotic rat | 1 | ******************** |
| Rat 1A | 1 | ******************** |
| Hepa 1c1c 7 | 1 | ******************** |
| B-16 | 1 | ******************** |
| HB8759 | 1 | ******************** |
| OKT8 | 1 | ******************** |
| 1H12 | 1 | ******************** |
| TM86 | 1 | ******************** |
| J558 plasmocytoma | 1 | ******************** |
| PU 5.1.8 | 1 | ******************** |
| KLH-specific hybridoma FN1-18 | 1 | ******************** |
| KLH specific hybridoma FN1-18 | 1 | ******************** |
| lymphoma RL-12 | 1 | ******************** |
| NR6 fibroblasts | 1 | ******************** |
| mouse P3K plamacytoma cells | 1 | ******************** |
| B151 | 1 | ******************** |
| CH(R)C5-(MDR CHO) | 1 | ******************** |
| B77 | 1 | ******************** |
| myeloma P3-X63-Ag8.653 | 1 | ******************** |
| 112-2 | 1 | ******************** |
| Balb.B10 CTL | 1 | ******************** |
| 11E7-1 hybridoma | 1 | ******************** |
| AH60C (ascites hepatoma) | 1 | ******************** |
| AH60C(ascites hepatoma) | 1 | ******************** |
| primary Ars-Bruc hybridoma | 1 | ******************** |
| primary Ars-Bru hybridoma | 1 | ******************** |
| primary Ars-Bru hyridoma | 1 | ******************** |
| secondary Ars-Bru hybridoma | 1 | ******************** |
| hybridoma 8F1 | 1 | ******************** |
| B10.D2 | 1 | ******************** |
| PSA5-E | 1 | ******************** |
| L cell. | 1 | ******************** |
| CTL P14 | 1 | ******************** |
| Hybridoma (fusion Rat LOU spleen + Y3 myeloma) | 1 | ******************** |
| TA1 | 1 | ******************** |
| T2D4 | 1 | ******************** |
| IXN/A6 | 1 | ******************** |
| MOPC 167 | 1 | ******************** |
| L10A | 1 | ******************** |
| BALB/c | 1 | ******************** |
| 6B12 | 1 | ******************** |
| 6B8 | 1 | ******************** |
| hybridoma 10B10S | 1 | ******************** |
| hybridoma 10H12S | 1 | ******************** |
| hybridoma 12B11S | 1 | ******************** |
| hybridoma 12F10S | 1 | ******************** |
| hybridoma 13G13S | 1 | ******************** |
| hybridoma 1A1PC | 1 | ******************** |
| hybridoma 1B1S | 1 | ******************** |
| hybridoma 3B9PC | 1 | ******************** |
| hybridoma 3D11PC | 1 | ******************** |
| hybridoma 6C7S | 1 | ******************** |
| hybridoma 7E9S | 1 | ******************** |
| hybridoma 8B3S | 1 | ******************** |
| hybridoma 12H12S | 1 | ******************** |
| lymphoma B16.2K3 | 1 | ******************** |
| lymphoma B16.2H1 | 1 | ******************** |
| BRL-3A | 1 | ******************** |
| MB66 | 1 | ******************** |
| CTL clone 2c | 1 | ******************** |
| embryonal | 1 | ******************** |
| Krebs' ascites cell (LPS-stimulated) | 1 | ******************** |
| MTL 2.8.2 | 1 | ******************** |
| L-cells | 1 | ******************** |
| CHD Alb-R 52 | 1 | ******************** |
| Py T21 | 1 | ******************** |
| AH60C | 1 | ******************** |
| E6 hybridoma | 1 | ******************** |
| DMBA-8 | 1 | ******************** |
| DN7.1 | 1 | ******************** |
| DN 2.3 | 1 | ******************** |
| Shionogi carcinoma 115 | 1 | ******************** |
| Nulli SCC 1 | 1 | ******************** |
| confluent PYS-2 cells | 1 | ******************** |
| WEHI3B | 1 | ******************** |
| TUC 7.51 | 1 | ******************** |
| Bal nu/nu anti B10.BR | 1 | ******************** |
| 38c13, variant 4 | 1 | ******************** |
| 38c13-variant 3 | 1 | ******************** |
| 38c13-variant 1 | 1 | ******************** |
| 38c13-variant 4 | 1 | ******************** |
| T3 HEP-1. | 1 | ******************** |
| Ehrlich ascites cell HD34 | 1 | ******************** |
| M1536B3 | 1 | ******************** |
| MBP 68-88-specific T-cell hybridoma 510 | 1 | ******************** |
| MRL-histone | 1 | ******************** |
| MRL-RF24 | 1 | ******************** |
| MRL-RF28 | 1 | ******************** |
| MRL-histone 7 | 1 | ******************** |
| MRL-RF33BL | 1 | ******************** |
| PXTL11 | 1 | ******************** |
| Friend murine | 1 | ******************** |
| AH60C. | 1 | ******************** |
| MOPC 315 (Balb/c plasmacytoma) | 1 | ******************** |
| L cells. clone=P36. | 1 | ******************** |
| 32D C13 | 1 | ******************** |
| ethoxyquin induced liver | 1 | ******************** |
| NIE 115 | 1 | ******************** |
| 416B | 1 | ******************** |
| 3T3 cells | 1 | ******************** |
| myeloma Y3-Ag 1.2.3. | 1 | ******************** |
| CSML-O | 1 | ******************** |
| Yoshida ascites sarcoma (YS) | 1 | ******************** |
| MOPC 315 | 1 | ******************** |
| PCC3-A/1 | 1 | ******************** |
| DG44 | 1 | ******************** |
| FRTL5. | 1 | ******************** |
| 38 B9 | 1 | ******************** |
| TFP-10 | 1 | ******************** |
| DMBA8 | 1 | ******************** |
| CCL 39 | 1 | ******************** |
| C5 | 1 | ******************** |
| ECA2 (a subline of PCC4Azal) | 1 | ******************** |
| NIH 3T3. | 1 | ******************** |
| TG15 derived from V79S | 1 | ******************** |
| PDV-C57, malignant | 1 | ******************** |
| MRK16-producing | 1 | ******************** |
| B13H4C8 hybridoma | 1 | ******************** |
| 103-7E | 1 | ******************** |
| 105-2H | 1 | ******************** |
| 106-10E | 1 | ******************** |
| 1E10 | 1 | ******************** |
| 31-9D | 1 | ******************** |
| 34-2B | 1 | ******************** |
| 34-3C | 1 | ******************** |
| 4C8 | 1 | ******************** |
| P3U1 | 1 | ******************** |
| T-cell hybridoma EpSM 30 | 1 | ******************** |
| BHK-21 and ts11 | 1 | ******************** |
| F9 EC cells | 1 | ******************** |
| indirectly derived from Mo/D(b) | 1 | ******************** |
| F9 EC | 1 | ******************** |
| CT.4R | 1 | ******************** |
| 7OZ/3 | 1 | ******************** |
| 1-6C10 hybridoma (with SP2/0) | 1 | ******************** |
| TK1 | 1 | ******************** |
| C2, FaO, Rev7 and somatic cell hybrid line | 1 | ******************** |
| PC19-S1801A1 | 1 | ******************** |
| NC1-A7 | 1 | ******************** |
| NC5-A11 | 1 | ******************** |
| NC6-A12 | 1 | ******************** |
| NC12-H8 | 1 | ******************** |
| NC19-B8G2 | 1 | ******************** |
| NC19-E10 | 1 | ******************** |
| NC19-E11 | 1 | ******************** |
| NC19-F2 | 1 | ******************** |
| NC19-F5 | 1 | ******************** |
| NC17-D8 | 1 | ******************** |
| NC6-C12 | 1 | ******************** |
| 62H3 | 1 | ******************** |
| (C58NT)D | 1 | ******************** |
| Lym-1 | 1 | ******************** |
| E225 hybridoma | 1 | ******************** |
| MAH-B2. | 1 | ******************** |
| ATCC CCL39 | 1 | ******************** |
| 33.1.1+ | 1 | ******************** |
| L6-myoblast | 1 | ******************** |
| mouse mammary carcinoma cells | 1 | ******************** |
| SP2/0-derived hybridoma C8 | 1 | ******************** |
| F9 embryonal carcinoma cells | 1 | ******************** |
| JLSV9 | 1 | ******************** |
| primary rat myotubes | 1 | ******************** |
| Ehrlich ascites tumor cell | 1 | ******************** |
| MCA-RH 7777 | 1 | ******************** |
| HCPC-1 | 1 | ******************** |
| NS/0 | 1 | ******************** |
| hybridoma 15C5 | 1 | ******************** |
| H5 | 1 | ******************** |
| F9, P19 | 1 | ******************** |
| No.8 | 1 | ******************** |
| B5-10 | 1 | ******************** |
| B11-5 | 1 | ******************** |
| B5-46 | 1 | ******************** |
| B10-4 | 1 | ******************** |
| B12-1 | 1 | ******************** |
| B13-2 | 1 | ******************** |
| B413-2.3 | 1 | ******************** |
| B615-1 | 1 | ******************** |
| B7-15.19 | 1 | ******************** |
| B2-13 | 1 | ******************** |
| lipopolysaccharide-blast | 1 | ******************** |
| RNK | 1 | ******************** |
| CB-7, DP18-19 | 1 | ******************** |
| E.coli C600Hf1 | 1 | ******************** |
| MHV-infected DBT cells | 1 | ******************** |
| SJL-HE-1.1 | 1 | ******************** |
| Schwann cells | 1 | ******************** |
| myeloid & lymphoid | 1 | ******************** |
| teratocarcinoma F9 | 1 | ******************** |
| osteoblast MC3T3-E1 | 1 | ******************** |
| line 1 lung carcinoma | 1 | ******************** |
| Hybridoma 12S18-G | 1 | ******************** |
| Hybridoma 12S18-K | 1 | ******************** |
| Hybridoma 12S28-G | 1 | ******************** |
| Hybridoma 12S28-K | 1 | ******************** |
| Hybridoma 12SB4-G | 1 | ******************** |
| Hybridoma 2D3-G | 1 | ******************** |
| Hybridoma 2D3-K | 1 | ******************** |
| Hybridoma 6B1-G | 1 | ******************** |
| Hybridoma 6C4-G | 1 | ******************** |
| Hybridoma B3675-G | 1 | ******************** |
| Hybridoma B3682-G | 1 | ******************** |
| Hybridoma B3938-G | 1 | ******************** |
| Hybridoma DB-3-G | 1 | ******************** |
| Hybridoma E3-G | 1 | ******************** |
| Hybridoma E3-K | 1 | ******************** |
| Hybridoma E4-G | 1 | ******************** |
| Hybridoma E4-K | 1 | ******************** |
| Hybridoma GB4-10-G | 1 | ******************** |
| Hybridoma H8-G | 1 | ******************** |
| Hybridoma H8-K | 1 | ******************** |
| RSV19 | 1 | ******************** |
| 3T3 DM | 1 | ******************** |
| DD-3 | 1 | ******************** |
| Li-5A8 | 1 | ******************** |
| Li-6A12 | 1 | ******************** |
| Li-5D2 | 1 | ******************** |
| Li-5A1 | 1 | ******************** |
| Li-3B3 | 1 | ******************** |
| Li-5C9 | 1 | ******************** |
| Li-5F8 | 1 | ******************** |
| Li-5C12 | 1 | ******************** |
| L14-5D8 | 1 | ******************** |
| L14-3C11 | 1 | ******************** |
| L14-3D10 | 1 | ******************** |
| L14-2G9 | 1 | ******************** |
| L14-7H4 | 1 | ******************** |
| L14-6C4 | 1 | ******************** |
| L20-2H5 | 1 | ******************** |
| L20-5G3 | 1 | ******************** |
| L20-7F7 | 1 | ******************** |
| L1-3B3 | 1 | ******************** |
| L1-5A8 | 1 | ******************** |
| L14-3H8 | 1 | ******************** |
| T1-107 | 1 | ******************** |
| T10-1 | 1 | ******************** |
| T10-5 | 1 | ******************** |
| T2-150 | 1 | ******************** |
| T4-57 | 1 | ******************** |
| T5-131 | 1 | ******************** |
| T5-224 | 1 | ******************** |
| T5-314 | 1 | ******************** |
| T5-334 | 1 | ******************** |
| T5-58 | 1 | ******************** |
| T5-626 | 1 | ******************** |
| T6-112 | 1 | ******************** |
| T6-416 | 1 | ******************** |
| T6-510 | 1 | ******************** |
| T6-19 | 1 | ******************** |
| T6-626 | 1 | ******************** |
| T7-4 | 1 | ******************** |
| T8-2 | 1 | ******************** |
| T8-3 | 1 | ******************** |
| T9-1 | 1 | ******************** |
| C-2 | 1 | ******************** |
| ND-7 (hybrid, DRG neurons X N18Tq2 mouse neuroblastoma C1300) | 1 | ******************** |
| glioma C6 | 1 | ******************** |
| P 815 | 1 | ******************** |
| PCC4.aza 1 | 1 | ******************** |
| C6 glioma cell ATCC CCL 107 | 1 | ******************** |
| 107C3 | 1 | ******************** |
| B.6.1 | 1 | ******************** |
| FAO rat hepatoma | 1 | ******************** |
| YTH 34.5HL | 1 | ******************** |
| PL2-1 hybridoma | 1 | ******************** |
| PL2-2 hybridoma | 1 | ******************** |
| PL2-3 hybridoma | 1 | ******************** |
| PL2-6 hybridoma | 1 | ******************** |
| PL2-7 hybridoma | 1 | ******************** |
| PL2-8 hybridoma | 1 | ******************** |
| PL2-4 hybridoma | 1 | ******************** |
| ocular lens tissue | 1 | ******************** |
| adult heart | 1 | ******************** |
| G8 hybridoma | 1 | ******************** |
| balb/c 3T3 fibroblast | 1 | ******************** |
| CA4-1 | 1 | ******************** |
| NRK (normal rat fibroblast) | 1 | ******************** |
| 3Y1, NRK | 1 | ******************** |
| 70Z, A20 | 1 | ******************** |
| fos-SR-3Y1-202 | 1 | ******************** |
| 16a1 | 1 | ******************** |
| CCL39 | 1 | ******************** |
| Hepa-1a | 1 | ******************** |
| Leydig cell tumour H-500 | 1 | ******************** |
| kidney T cell genomic | 1 | ******************** |
| Rat1 (Fisher rat fibroblast 3T3-like cell line) | 1 | ******************** |
| embryonic fibroblast (3T3) | 1 | ******************** |
| EC | 1 | ******************** |
| SV3T3 C138 | 1 | ******************** |
| hamster lung cell line - V79 | 1 | ******************** |
| JS28/32 | 1 | ******************** |
| JS34/32 | 1 | ******************** |
| mRNA prepared from mouse injected with 0.6mg isoprenaline for 10 days | 1 | ******************** |
| Hybridoma 3F11 | 1 | ******************** |
| Hybridoma 4A5 | 1 | ******************** |
| rat GH3 | 1 | ******************** |
| F9 embryonic carcinoma | 1 | ******************** |
| rat Schwann cells (primary culture) | 1 | ******************** |
| whole mouse mammary gland | 1 | ******************** |
| B16 melanoma | 1 | ******************** |
| Pheochromocytoma PC12 | 1 | ******************** |
| SHOK | 1 | ******************** |
| DMBA-8 metastic ascites | 1 | ******************** |
| P19 EC/3T3 | 1 | ******************** |
| IgG+, Lambda+, Np-specific B cells | 1 | ******************** |
| TKR1902 | 1 | ******************** |
| MRB2 hybridoma | 1 | ******************** |
| MRB6 hybridoma | 1 | ******************** |
| MRB7 hybridoma | 1 | ******************** |
| MRB9 hybridoma | 1 | ******************** |
| MRB11 hybridoma | 1 | ******************** |
| PL9-8 hybridoma | 1 | ******************** |
| NZA3 hybridoma | 1 | ******************** |
| NZA4 hybridoma | 1 | ******************** |
| NZA6 hybridoma | 1 | ******************** |
| BWA2 hybridoma | 1 | ******************** |
| BWA6 hybridoma | 1 | ******************** |
| Ki-MSV-transformed normal rat kidney | 1 | ******************** |
| Ki-MSV-transformed natural rat kidney | 1 | ******************** |
| A20-2J | 1 | ******************** |
| 3T3-BALB/c | 1 | ******************** |
| 3.7 | 1 | ******************** |
| transplanted tumor T7 | 1 | ******************** |
| PL9-2 | 1 | ******************** |
| PL9-3 | 1 | ******************** |
| PL9-6 | 1 | ******************** |
| PL9-7 | 1 | ******************** |
| PL9-9 | 1 | ******************** |
| PL9-10 | 1 | ******************** |
| PL9-11 | 1 | ******************** |
| LG4-3 | 1 | ******************** |
| RJKO GM+120 | 1 | ******************** |
| Hybridoma M-T310 | 1 | ******************** |
| Hybridoma M-T404 | 1 | ******************** |
| Hybridoma M-T413 | 1 | ******************** |
| Hybridoma M-T151 | 1 | ******************** |
| Hybridoma M-T321 | 1 | ******************** |
| Hybridoma M-T408 | 1 | ******************** |
| Hybridoma M-T406 | 1 | ******************** |
| BCl-1 | 1 | ******************** |
| LG4-1 hybridoma | 1 | ******************** |
| Cloudman S91 melanoma | 1 | ******************** |
| Mott hybridomas | 1 | ******************** |
| FBR-VR910 | 1 | ******************** |
| 300-19P/22D6P /38B9 | 1 | ******************** |
| 300-19P/22D6P/38B9 | 1 | ******************** |
| KLN205 | 1 | ******************** |
| CP3 | 1 | ******************** |
| 3Y1 (fibroblast) | 1 | ******************** |
| Gt4-1 | 1 | ******************** |
| Gt4-2 | 1 | ******************** |
| Gt10 | 1 | ******************** |
| ovary | 1 | ******************** |
| ConA-stimulated lymphocytes | 1 | ******************** |
| LG2-1 | 1 | ******************** |
| LG2-2 | 1 | ******************** |
| BWA3 | 1 | ******************** |
| hybridomas fused from NS1 and Splenocytes | 1 | ******************** |
| rat brain | 1 | ******************** |
| 2B4.11 | 1 | ******************** |
| T cell hybridoma 57.7 | 1 | ******************** |
| conconavalin A activated | 1 | ******************** |
| FRTL- | 1 | ******************** |
| B16 melanoma cell line | 1 | ******************** |
| Tdt | 1 | ******************** |
| MEC-7 | 1 | ******************** |
| mastocytoma (MTC) | 1 | ******************** |
| alphaTN6 derived from lenses of transgenic mice | 1 | ******************** |
| 3T3-L1 and 3T3-F442A | 1 | ******************** |
| GR | 1 | ******************** |
| Schwannowa cells | 1 | ******************** |
| F11 hybridoma (BALB/c spleen cells fused with myeloma cell line X63 AG8 653) | 1 | ******************** |
| beta-TC3 | 1 | ******************** |
| PCR on total psoas mdm mouse cDNA | 1 | ******************** |
| 4H10 | 1 | ******************** |
| CB5 | 1 | ******************** |
| 9A6 | 1 | ******************** |
| CB1 | 1 | ******************** |
| CB6 | 1 | ******************** |
| M alpha 2-3 | 1 | ******************** |
| Friend erythroleukaemia F4-12B2 | 1 | ******************** |
| rat kidney | 1 | ******************** |
| primary tissue (rat brain) | 1 | ******************** |
| NIE-115 | 1 | ******************** |
| PC12 induced with NGF | 1 | ******************** |
| Eo | 1 | ******************** |
| hybridoma D9D10 | 1 | ******************** |
| F4NWO | 1 | ******************** |
| M5T | 1 | ******************** |
| J774 macrophage | 1 | ******************** |
| L8E63 | 1 | ******************** |
| beta-TC1 | 1 | ******************** |
| embryonic stem cell line E14 | 1 | ******************** |
| 6-myoblast | 1 | ******************** |
| (X63-Ag8.653 X BALB /c spleen) | 1 | ******************** |
| (X63-Ag8.653 X BALB/c spleen | 1 | ******************** |
| MEL cells | 1 | ******************** |
| A2b | 1 | ******************** |
| ASWAI hybridoma | 1 | ******************** |
| ASWA2 hybridoma | 1 | ******************** |
| ASWB1 hybridoma | 1 | ******************** |
| ASWP1 hybridoma | 1 | ******************** |
| ASWS1 hybridoma | 1 | ******************** |
| ASWU1 hybridoma | 1 | ******************** |
| ASWA1 hybridoma | 1 | ******************** |
| patented rat parathyroid cell line | 1 | ******************** |
| EL4 murine T cell line | 1 | ******************** |
| PA1 hybrodoma | 1 | ******************** |
| PA3 heavy chain variable region | 1 | ******************** |
| PA4 hybridoma | 1 | ******************** |
| PD1 hybridoma | 1 | ******************** |
| QB1 hybridoma | 1 | ******************** |
| QC1 hybridoma | 1 | ******************** |
| P41 hybridoma | 1 | ******************** |
| PA3 hybridoma | 1 | ******************** |
| from lymph nodes of mice | 1 | ******************** |
| 21/61 | 1 | ******************** |
| A16, mAb raised against glycoprotein D of HSV-1 | 1 | ******************** |
| A16, mAb raised against glycoprotein D of HSV 1 | 1 | ******************** |
| P2.3 | 1 | ******************** |
| CMT93, mouse rectal carcinoma | 1 | ******************** |
| Ehrlich ascites tumour cell | 1 | ******************** |
| P17 embryonal carcinoma | 1 | ******************** |
| F28C4 | 1 | ******************** |
| XIII 1H-21.1, XIV 1H-3.4 | 1 | ******************** |
| Lyt 1+2- /9 (murine T helper clone) | 1 | ******************** |
| Mouse T cell line EL 4 | 1 | ******************** |
| hybridoma kini 4B12 | 1 | ******************** |
| hybridoma kini4B12 | 1 | ******************** |
| 14a (F344), 48RI (DA) | 1 | ******************** |
| distal colon treated with dexamethasone | 1 | ******************** |
| IIV44 hybridoma (Balb/c spleen cells fused with melanoma cell line SP2/0) | 1 | ******************** |
| IIV44 hybridoma (Balb /c spleen cells fused with myeloma cell line SP2/0) | 1 | ******************** |
| C3H10t1/2 fibroblasts | 1 | ******************** |
| C3H10T1/2CL8 | 1 | ******************** |
| 3F7-8 | 1 | ******************** |
| MTC (mast cell tumor) | 1 | ******************** |
| MTC(mast cell tumor) | 1 | ******************** |
| B300-P8 | 1 | ******************** |
| MEC6 | 1 | ******************** |
| MEC4 | 1 | ******************** |
| MEC8 | 1 | ******************** |
| MEC5 | 1 | ******************** |
| MEC3 | 1 | ******************** |
| neonatal skin | 1 | ******************** |
| testis germ cell | 1 | ******************** |
| murine erythroleukemis (MEL) | 1 | ******************** |
| HD34, Ehrlich ascites tumor | 1 | ******************** |
| rat liver RNA | 1 | ******************** |
| hybridoma 9E10 | 1 | ******************** |
| hybridoma NQN/A14.4.3 | 1 | ******************** |
| hybridoma MAC188 | 1 | ******************** |
| hybridoma 33.1.C2 | 1 | ******************** |
| D16 hybridoma | 1 | ******************** |
| T cell hybridoma G8.25 | 1 | ******************** |
| T cell hybridoma D12.8 | 1 | ******************** |
| T cell hybridoma B11.1 | 1 | ******************** |
| T cell hybridoma M3.13 | 1 | ******************** |
| T cell hybridoma B9.1 | 1 | ******************** |
| T cell hybridoma C6.2 | 1 | ******************** |
| T cell hybridoma C11.3 | 1 | ******************** |
| T cell hybridoma D3.5 | 1 | ******************** |
| T cell hybridoma B5.1 | 1 | ******************** |
| T cell hybridoma B4.2 | 1 | ******************** |
| T cell hybridoma B10.2 | 1 | ******************** |
| T cell hybridoma C9.1 | 1 | ******************** |
| T cell hybridoma C8.10 | 1 | ******************** |
| T cell hybridoma C5.4 | 1 | ******************** |
| DF3 ES cells | 1 | ******************** |
| cDNA from total kidney RNA | 1 | ******************** |
| Hybridoma G10 | 1 | ******************** |
| Hybridoma D6 | 1 | ******************** |
| Hybridoma B3 | 1 | ******************** |
| Hybridoma A65 | 1 | ******************** |
| Hybridoma A64 | 1 | ******************** |
| Hybridoma A63 | 1 | ******************** |
| Hybridoma A62 | 1 | ******************** |
| Hybridoma A60 | 1 | ******************** |
| Hybridoma A58 | 1 | ******************** |
| Hybridoma A9 | 1 | ******************** |
| Hybridoma A8 | 1 | ******************** |
| Hybridoma A7 | 1 | ******************** |
| Hybridoma A49 | 1 | ******************** |
| Hybridoma A43 | 1 | ******************** |
| Hybridoma A42 | 1 | ******************** |
| Hybridoma A26 | 1 | ******************** |
| Hybridoma A24 | 1 | ******************** |
| Hybridoma A1 | 1 | ******************** |
| Hybridoma A18 | 1 | ******************** |
| HIT-T15.M2.2.2 | 1 | ******************** |
| HIT-T15 M.2.2.2 | 1 | ******************** |
| HIT.T15 M2.2.2 | 1 | ******************** |
| gammaHFc1gE II-481 | 1 | ******************** |
| Swiss 3T3 fibroblasts | 1 | ******************** |
| 8a | 1 | ******************** |
| PYS-2 /11 | 1 | ******************** |
| PYS-2/11 | 1 | ******************** |
| rat ventral prostate | 1 | ******************** |
| Ehrlich-Lettre mouse ascites tumour cell | 1 | ******************** |
| mouse testis cDNA library | 1 | ******************** |
| Nb2 Tcell | 1 | ******************** |
| mouse hybridoma | 1 | ******************** |
| T hybridoma 1.2 | 1 | ******************** |
| T hybridoma 6.13 | 1 | ******************** |
| T hybridoma 61-21 | 1 | ******************** |
| T hybridoma 7.2 | 1 | ******************** |
| CH31 | 1 | ******************** |
| rat testis cDNA | 1 | ******************** |
| UV-2237 M-C 13 | 1 | ******************** |
| hybridoma splenic lymphocyte + sp2/0 /Ag14 | 1 | ******************** |
| NIH 3T3 (HT2 M206) | 1 | ******************** |
| Ehrlich ascites tumour | 1 | ******************** |
| MAb C3 hybridoma | 1 | ******************** |
| J774 A.1 (ATCC TIB67) subline J774 1.6 | 1 | ******************** |
| KKF cell | 1 | ******************** |
| DC-3F /9.OHE | 1 | ******************** |
| ATCC CCL 39 | 1 | ******************** |
| 10B8 hybridoma | 1 | ******************** |
| 1B10 hybridoma | 1 | ******************** |
| 2D4 hybridoma | 1 | ******************** |
| 3E6 hybridoma | 1 | ******************** |
| 4F6 hybridoma | 1 | ******************** |
| 4G2 hybridoma | 1 | ******************** |
| 60C3 hybridoma | 1 | ******************** |
| 7H2 hybridoma | 1 | ******************** |
| 8B6 hybridoma | 1 | ******************** |
| hybridoma-Id3 | 1 | ******************** |
| BS181p10 | 1 | ******************** |
| D72 | 1 | ******************** |
| D73 | 1 | ******************** |
| GH31B6 | 1 | ******************** |
| BKD10 | 1 | ******************** |
| BKD12 | 1 | ******************** |
| BKD17 | 1 | ******************** |
| BKD19 | 1 | ******************** |
| BKD23 | 1 | ******************** |
| BKD34 | 1 | ******************** |
| BKV1 | 1 | ******************** |
| BKV22 | 1 | ******************** |
| BKV29 | 1 | ******************** |
| BKV39 | 1 | ******************** |
| C6-BU-1 | 1 | ******************** |
| cris-1 hybridoma | 1 | ******************** |
| ATCC CCL 107-C6 | 1 | ******************** |
| BN lymphoma | 1 | ******************** |
| 15H8 | 1 | ******************** |
| 5A6 | 1 | ******************** |
| 11/160 | 1 | ******************** |
| ALN/9/94 | 1 | ******************** |
| day 7, vascular smooth muscle | 1 | ******************** |
| TS-A-3T3 | 1 | ******************** |
| SMF murine breast tumor | 1 | ******************** |
| Hybridoma HRC.1 | 1 | ******************** |
| Hybridoma HDB.1 | 1 | ******************** |
| Hybridoma HCQ.4 | 1 | ******************** |
| Hybridoma HRC.2 | 1 | ******************** |
| Hybridoma HCQ.6 | 1 | ******************** |
| Hybridoma HCQ.3 | 1 | ******************** |
| Hybridoma HM2.2 | 1 | ******************** |
| Hybridoma HCQ.1 | 1 | ******************** |
| Hybridoma HCQ.11 | 1 | ******************** |
| Hybridoma HM2.1 | 1 | ******************** |
| Hybridoma HD13.7 | 1 | ******************** |
| Hybridoma HDBR.1 | 1 | ******************** |
| Ehrlich ascite | 1 | ******************** |
| NFS107 | 1 | ******************** |
| J774.2 | 1 | ******************** |
| IgA hybridoma 3C6 | 1 | ******************** |
| IgA hybridoma 3G8 | 1 | ******************** |
| IgA hybridoma 2D11 | 1 | ******************** |
| IgA hybridoma 2F7 | 1 | ******************** |
| IgA hybridoma 3C10 | 1 | ******************** |
| IgA hybridoma 1B5 | 1 | ******************** |
| IgA hybridoma 2B4 | 1 | ******************** |
| IgA hybridoma 1F6 | 1 | ******************** |
| retinoic acid differentiated embryonic stem cells | 1 | ******************** |
| primary cultures of cerebral cortical astrocytes | 1 | ******************** |
| Hepa-1 | 1 | ******************** |
| Ehrlich ascites tumor cells | 1 | ******************** |
| Ehrlich HD34 | 1 | ******************** |
| LPS stimulated monocytes | 1 | ******************** |
| FDPC-mix A4 | 1 | ******************** |
| hybridoma F11 | 1 | ******************** |
| Non-producing Balb/c hybridoma (P3X63Ag8) fused to DBA/1 lymphocytes | 1 | ******************** |
| Nb2 T cell | 1 | ******************** |
| Hybridoma HDC.1 | 1 | ******************** |
| Hybridoma HM1R.2 | 1 | ******************** |
| hybridoma 6C6 | 1 | ******************** |
| EpD3 T cell hybridoma | 1 | ******************** |
| hybridoma HD37 | 1 | ******************** |
| P19 teratocarcinoma induced with retinoic acid | 1 | ******************** |
| insulinoma | 1 | ******************** |
| hybridoma 13AD | 1 | ******************** |
| hybridoma 42PF | 1 | ******************** |
| MOv19 | 1 | ******************** |
| F9 and C3H10T1/2 | 1 | ******************** |
| T2D4 cells | 1 | ******************** |
| ST5 | 1 | ******************** |
| S49.1 | 1 | ******************** |
| hybridoma CP8B3-D3 | 1 | ******************** |
| N1-S1 rat hepatoma (ATCC No.CRL 1604) | 1 | ******************** |
| mouse lymphoid 70Z /3 | 1 | ******************** |
| AA8 | 1 | ******************** |
| y1090r- | 1 | ******************** |
| 4A6 | 1 | ******************** |
| Neuroblastoma cell line Neuro2A | 1 | ******************** |
| CC63 | 1 | ******************** |
| BRL 3.1 | 1 | ******************** |
| Bip 1 | 1 | ******************** |
| primary hepatocytes | 1 | ******************** |
| sEND1 (skin haemangioma derived endothelial cell line) | 1 | ******************** |
| F-1 | 1 | ******************** |
| CC15 hybridoma | 1 | ******************** |
| CC8 hybridoma | 1 | ******************** |
| CC63 hybridoma | 1 | ******************** |
| CHO, AA8 | 1 | ******************** |
| LA7 derived from RAMA 25 (mammary) | 1 | ******************** |
| hybr-2 | 1 | ******************** |
| OLI-NEU | 1 | ******************** |
| CHO-AA8 | 1 | ******************** |
| IW32 | 1 | ******************** |
| L929r2 | 1 | ******************** |
| clone 6 | 1 | ******************** |
| 771, an MCF 1233 MuLV transformed B-cell line derived from a tumor of a C57BL /10 mouse neonatally inoculated with this virus strain | 1 | ******************** |
| TUC5 37 | 1 | ******************** |
| FMC63 mouse hybridoma | 1 | ******************** |
| ES1 | 1 | ******************** |
| AK-5 | 1 | ******************** |
| NA1-34.HLK | 1 | ******************** |
| RT-PCR | 1 | ******************** |
| hybridoma A102 | 1 | ******************** |
| B cell hybridoma | 1 | ******************** |
| DC-3F/S16 | 1 | ******************** |
| MAT-LyLu and AT-2 prostate cancer cells | 1 | ******************** |
| rat PC12 | 1 | ******************** |
| X63Ag8 | 1 | ******************** |
| CB.IFN2.4 | 1 | ******************** |
| 1F5.H5V HYBRIDOMA | 1 | ******************** |
| DB19/1 | 1 | ******************** |
| DB19/25 | 1 | ******************** |
| AJ9 | 1 | ******************** |
| CP-2 | 1 | ******************** |
| DD-1 | 1 | ******************** |
| DC3F/C-10 | 1 | ******************** |
| DC3F/WT/To | 1 | ******************** |
| TH2 D.10 | 1 | ******************** |
| 185.6 | 1 | ******************** |
| 10.43 | 1 | ******************** |
| 111.109 | 1 | ******************** |
| 111.185vh | 1 | ******************** |
| 111.185 | 1 | ******************** |
| 111.33 | 1 | ******************** |
| 111.34 | 1 | ******************** |
| 111.55 | 1 | ******************** |
| 111.67 | 1 | ******************** |
| 111.68 | 1 | ******************** |
| 163.100 | 1 | ******************** |
| 163.1 | 1 | ******************** |
| 163.42 | 1 | ******************** |
| 163.43 | 1 | ******************** |
| 163.47 | 1 | ******************** |
| 163.67 | 1 | ******************** |
| 163.87 | 1 | ******************** |
| 163.69 | 1 | ******************** |
| 163.72 | 1 | ******************** |
| 165.14 | 1 | ******************** |
| 165.27 | 1 | ******************** |
| 165.33 | 1 | ******************** |
| 165.3m | 1 | ******************** |
| 165.3 | 1 | ******************** |
| 165.41 | 1 | ******************** |
| 165.49 | 1 | ******************** |
| 165.45 | 1 | ******************** |
| 165.52 | 1 | ******************** |
| 165.54 | 1 | ******************** |
| 165.5 | 1 | ******************** |
| 165.60 | 1 | ******************** |
| 165.6 | 1 | ******************** |
| 17p.101 | 1 | ******************** |
| 17p.3 | 1 | ******************** |
| 17p.73 | 1 | ******************** |
| 17p.79 | 1 | ******************** |
| 17p.80 | 1 | ******************** |
| 17s.128 | 1 | ******************** |
| 17s.130 | 1 | ******************** |
| 17s.139 | 1 | ******************** |
| 17s.13 | 1 | ******************** |
| 17s.145 | 1 | ******************** |
| 17s.161 | 1 | ******************** |
| 17s.166 | 1 | ******************** |
| 17s.16 | 1 | ******************** |
| 17s.21 | 1 | ******************** |
| 17s.23 | 1 | ******************** |
| 17s.2 | 1 | ******************** |
| 17s.5 | 1 | ******************** |
| 17s.74 | 1 | ******************** |
| 17s.83 | 1 | ******************** |
| 17s.93g | 1 | ******************** |
| 17s.93m | 1 | ******************** |
| 202.105 | 1 | ******************** |
| 202.135 | 1 | ******************** |
| 202.17 | 1 | ******************** |
| 202.33 | 1 | ******************** |
| 202.54 | 1 | ******************** |
| 202.61 | 1 | ******************** |
| 202.80 | 1 | ******************** |
| 202.9 | 1 | ******************** |
| 202.38m | 1 | ******************** |
| 202p.38 | 1 | ******************** |
| 202.s38 | 1 | ******************** |
| 202s.38 | 1 | ******************** |
| 25.12 | 1 | ******************** |
| 74.119 | 1 | ******************** |
| 74.122 | 1 | ******************** |
| 83.22 | 1 | ******************** |
| 78 | 1 | ******************** |
| TKR19.02 | 1 | ******************** |
| AT8.i | 1 | ******************** |
| TGVH9 | 1 | ******************** |
| 11.4 | 1 | ******************** |
| DG8 | 1 | ******************** |
| ME12 | 1 | ******************** |
| MC2 | 1 | ******************** |
| D9.1 | 1 | ******************** |
| AtT-20 pituitary cells | 1 | ******************** |
| melan-c (described in Development 105,379-385, 1989) | 1 | ******************** |
| CIICB105 hybridoma | 1 | ******************** |
| CIICB20 hybridoma | 1 | ******************** |
| CIICB239 hybridoma | 1 | ******************** |
| CIICB268 hybridoma | 1 | ******************** |
| CIICB313 hybridoma | 1 | ******************** |
| CIICB334 hybridoma | 1 | ******************** |
| CIICB340 hybridoma | 1 | ******************** |
| CIICB379 hybridoma | 1 | ******************** |
| CIICB391 hybridoma | 1 | ******************** |
| CIIH113 hybridoma | 1 | ******************** |
| CIIC2 hybridoma | 1 | ******************** |
| CIID3 hybridoma | 1 | ******************** |
| CIIF4 hybridoma | 1 | ******************** |
| IPC-81 | 1 | ******************** |
| NBT-II | 1 | ******************** |
| TGVH 9 | 1 | ******************** |
| 3J10 H2 | 1 | ******************** |
| 2J13 C1 | 1 | ******************** |
| 3J10 E12 | 1 | ******************** |
| 4J10 G12 | 1 | ******************** |
| 1J10 F12 | 1 | ******************** |
| 2J13 H5 | 1 | ******************** |
| 2J13 A11 | 1 | ******************** |
| Ros | 1 | ******************** |
| HETR 83/20 | 1 | ******************** |
| ccl61 | 1 | ******************** |
| IEC-6 ATCC no. CRL-1592 | 1 | ******************** |
| MANEX1A | 1 | ******************** |
| MANEX1B | 1 | ******************** |
| alpha TC1-6 | 1 | ******************** |
| 31D | 1 | ******************** |
| JPC9 | 1 | ******************** |
| MS4.1 | 1 | ******************** |
| M22 | 1 | ******************** |
| AtT20 anterior pituitary corticotroph tumor | 1 | ******************** |
| 1.1ASML | 1 | ******************** |
| CIIC1 | 1 | ******************** |
| CIIC2 | 1 | ******************** |
| CIIE10 | 1 | ******************** |
| CIIE5 | 1 | ******************** |
| CIIF4 | 1 | ******************** |
| L121 | 1 | ******************** |
| L15 | 1 | ******************** |
| L173 | 1 | ******************** |
| L189 | 1 | ******************** |
| L346 | 1 | ******************** |
| L423 | 1 | ******************** |
| L7 | 1 | ******************** |
| L97 | 1 | ******************** |
| M136 | 1 | ******************** |
| M139 | 1 | ******************** |
| M191 | 1 | ******************** |
| M332 | 1 | ******************** |
| M76 | 1 | ******************** |
| M84 | 1 | ******************** |
| M87 | 1 | ******************** |
| M88 | 1 | ******************** |
| VI10 | 1 | ******************** |
| VI11 | 1 | ******************** |
| VI23 | 1 | ******************** |
| VI28 | 1 | ******************** |
| VI32 | 1 | ******************** |
| VI38 | 1 | ******************** |
| VI49 | 1 | ******************** |
| 41.1 | 1 | ******************** |
| 41.2 | 1 | ******************** |
| 41.3 | 1 | ******************** |
| 41.4 | 1 | ******************** |
| 41.6 | 1 | ******************** |
| 41.7 | 1 | ******************** |
| 41.8 | 1 | ******************** |
| 41.9 | 1 | ******************** |
| 41.10 | 1 | ******************** |
| 41.11 | 1 | ******************** |
| 41.13 | 1 | ******************** |
| 41.14 | 1 | ******************** |
| 41.15 | 1 | ******************** |
| 41.17 | 1 | ******************** |
| 42.1 | 1 | ******************** |
| 51.1 | 1 | ******************** |
| 51.3 | 1 | ******************** |
| 51.7 | 1 | ******************** |
| 51.9 | 1 | ******************** |
| 51.12 | 1 | ******************** |
| 51.14 | 1 | ******************** |
| 51.18 | 1 | ******************** |
| 51.20 | 1 | ******************** |
| 66cl4 | 1 | ******************** |
| T1CRP | 1 | ******************** |
| T3CRP | 1 | ******************** |
| T2CRP | 1 | ******************** |
| BP-A31 | 1 | ******************** |
| Y13-238 | 1 | ******************** |
| HuDREG-200 | 1 | ******************** |
| HuDREG-55 | 1 | ******************** |
| hybridoma expressing a monoclonal antibody that recognizes Western equine encephalomyelitis virus | 1 | ******************** |
| hybridoma Ki-3 | 1 | ******************** |
| 293FT | 1 | ******************** |
| 335D1-4 | 1 | ******************** |
| 79E1 | 1 | ******************** |
| 55D1-alpha 1 | 1 | ******************** |
| ARH3 | 1 | ******************** |
| BF-2 | 1 | ******************** |
| derived from cell line PK15 | 1 | ******************** |
| MSB-1 | 1 | ******************** |
| BCBL-1 | 1 | ******************** |
| PEL | 1 | ******************** |
| SNU-20 | 1 | ******************** |
| SNU-1103 | 1 | ******************** |
| BC-1 | 1 | ******************** |
| Human B cell | 1 | ******************** |
| Epithelioma papulosum cyprini (EPC) | 1 | ******************** |
| SHK-1 | 1 | ******************** |
| MDCC-MSB-1 line (transformed by MDV-1) | 1 | ******************** |
| (viral infected) LLC-PK1 | 1 | ******************** |
| C666-1 | 1 | ******************** |
| HSC-CTCL AJ5740 | 1 | ******************** |
| HTLV-I laf | 1 | ******************** |
| MDCC-CU41 | 1 | ******************** |
| RPL-1 | 1 | ******************** |
| persistently infected human prostate | 1 | ******************** |
| infected Chinese hamster ovary cells | 1 | ******************** |
| HeLa; SKG-[I,II] | 1 | ******************** |
| RPL30 virus transformed non-producer cells | 1 | ******************** |
| CHSE | 1 | ******************** |
| MKT-1 | 1 | ******************** |
| S594 | 1 | ******************** |
| teratocarcinoma LuC-1 | 1 | ******************** |
| H19 | 1 | ******************** |
| viral-infected LLC-PK1 cells | 1 | ******************** |
| Berne virus-infected | 1 | ******************** |
| virus-infected embryonic mule skin cells | 1 | ******************** |
| H-19 | 1 | ******************** |
| Vero E6 infected Hautvirus strain | 1 | ******************** |
| Cf2Th | 1 | ******************** |
| Borna virus infected MDCK cells | 1 | ******************** |
| BF2 | 1 | ******************** |
| Spodoptera frugiperda | 1 | ******************** |
| cDNA of infected Vero cells | 1 | ******************** |
| Baby Hamster Kidney (BHK)21 clone 13 | 1 | ******************** |
| grown in MA104 | 1 | ******************** |
| grown in E6 cells | 1 | ******************** |
| infected Vero cells | 1 | ******************** |
| PDV infected Vero cells | 1 | ******************** |
| VWLy4773 | 1 | ******************** |
| VWLy3910 | 1 | ******************** |
| VXLy1793 | 1 | ******************** |
| VULy1504 | 1 | ******************** |
| VULy1503 | 1 | ******************** |
| NTera2D1 teratocarcinoma | 1 | ******************** |
| CEF indused with poly (I):(C) and DEAE-dextran | 1 | ******************** |
| CEF induced with poly (I):(C) and DEAE-dextran | 1 | ******************** |
| RTT | 1 | ******************** |
| DT40 | 1 | ******************** |
| ASE | 1 | ******************** |
| LMH | 1 | ******************** |
| OCP13 | 1 | ******************** |
| EPC | 1 | ******************** |
| A6 | 1 | ******************** |
| EHS cells | 1 | ******************** |
| RTG-2 | 1 | ******************** |
| DT-40 | 1 | ******************** |
| monocytic leukimia cell line (IN24) | 1 | ******************** |
| Goldfish cultured cell from caudal fin | 1 | ******************** |
| quail myoblasts transformed with a temperature sensitive mutant of Rous sarcoma virus | 1 | ******************** |
| A6 cells | 1 | ******************** |
| CHSE-214 | 1 | ******************** |
| DT40-SW | 1 | ******************** |
| ZE | 1 | ******************** |
| BRF41 | 1 | ******************** |
| IN24 | 1 | ******************** |
| OLHdrR-e3 | 1 | ******************** |
| RBCF-1 | 1 | ******************** |
| HL8 | 1 | ******************** |
| cultured Medaka cell OL32 | 1 | ******************** |
| OL32 | 1 | ******************** |
| Marek's virus-transformed chiken T-lymphoma | 1 | ******************** |
| 42TA | 1 | ******************** |
| 160/2 | 1 | ******************** |
| 123/12 | 1 | ******************** |
| 123/6T | 1 | ******************** |
| CEF4-3 | 1 | ******************** |
| CAB | 1 | ******************** |
| HD11 | 1 | ******************** |
| PLHC-1 hepatoma | 1 | ******************** |
| XTC-2 | 1 | ******************** |
| TOP-10 | 1 | ******************** |
| MDCC-MSB1; Marek's disease virus-transformed chicken lymphoblastoid | 1 | ******************** |
| methylcholanthrene-induced tumor cell line QT35 | 1 | ******************** |
| SAE | 1 | ******************** |
| DUS3 | 1 | ******************** |
| XTC | 1 | ******************** |
| X58 | 1 | ******************** |
| P15DI (serum induced) | 1 | ******************** |
| F1 | 1 | ******************** |
| RT | 1 | ******************** |
| ED18 | 1 | ******************** |
| QT6 | 1 | ******************** |
| v-relER transformed BM | 1 | ******************** |
| XTC-cells | 1 | ******************** |
| liver parenchymal | 1 | ******************** |
| fibroblast transformed by Schmidt-Ruppin strain of Rous Sarcoma virus subtype A | 1 | ******************** |
| CEF | 1 | ******************** |
| MDCC-UG9 | 1 | ******************** |
| MDCC-CU132A | 1 | ******************** |
| MDCC-CU12A | 1 | ******************** |
| MDCC-CU32 | 1 | ******************** |
| MDCC-CU108 | 1 | ******************** |
| CEF, primary fibroblasts | 1 | ******************** |
| LSCC-RP9 | 1 | ******************** |
| CEF (chicken embryo fibroblast) | 1 | ******************** |
| chicken embryo fibroblast | 1 | ******************** |
| melanophore cell line | 1 | ******************** |
| CHSE-214 (ATCC #CRL-1681) | 1 | ******************** |
| catfish macrophage cell line 42TA | 1 | ******************** |
| A6 2F3 kidney cell line | 1 | ******************** |
| A6 2F3 | 1 | ******************** |
| REV transformed chicken T cell clone | 1 | ******************** |
| Rainbow trout gonad (RTG-2) | 1 | ******************** |
| VCD | 1 | ******************** |
| distal nephron cell line, A6 | 1 | ******************** |
| Tumor cell line ff2 | 1 | ******************** |
| 28S.1 | 1 | ******************** |
| S13 B lymphoma cell | 1 | ******************** |
| 3B11 | 1 | ******************** |
| gonad cell line RTG-2 | 1 | ******************** |
| 1B10 | 1 | ******************** |
| 857-7 TCRgamma/delta | 1 | ******************** |
| PLHC-1; Hightower, L.E. and J.L. Renfro. 1988. J. Exp. Zool. 248:290-302 | 1 | ******************** |
| CHSE214 | 1 | ******************** |
| R2B Chicken B-cell lymphoma | 1 | ******************** |
| ts21 E26 virus transformed myeloblast cells | 1 | ******************** |
| ts34HD3 | 1 | ******************** |
| chicken BM2 | 1 | ******************** |
| XTC cells | 1 | ******************** |
| CEF primaries | 1 | ******************** |
| S34HD3 | 1 | ******************** |
| DH5 alpha | 1 | ******************** |
| E.coli JM101 | 1 | ******************** |
| E,coli DH5 alpha | 1 | ******************** |
| fibroplast | 1 | ******************** |
| BM2 | 1 | ******************** |
| XL-K2 | 1 | ******************** |
| chicken promacrophage BM2 | 1 | ******************** |
| Pheasant liver | 1 | ******************** |
| Quail liver | 1 | ******************** |
| Turkey liver | 1 | ******************** |
| A6 kidney cell | 1 | ******************** |
| chicken brain embryonic day 14 | 1 | ******************** |
| Sternal chondrocytes | 1 | ******************** |
| BM2 from A.Sippel | 1 | ******************** |
| E.coli TG-2 cells | 1 | ******************** |
| embryo & embryo fibroblast | 1 | ******************** |
| XL2 | 1 | ******************** |
| RPL 1 | 1 | ******************** |
| whole embryo RNA | 1 | ******************** |
| primary E26 transformed multipotent hematopoietic progenitor cells | 1 | ******************** |
| E9 chick brain cDNA | 1 | ******************** |
| E. coli RR1 M15 | 1 | ******************** |
| XLK-2 | 1 | ******************** |
| embryo fibroblast | 1 | ******************** |
| Xenopus laevis oocyte | 1 | ******************** |
| XTC cell | 1 | ******************** |
| BM2 and HD3 cells | 1 | ******************** |
| HD100 | 1 | ******************** |
| CLC | 1 | ******************** |
| QCE-6 | 1 | ******************** |
| GMCl | 1 | ******************** |
| REV-transformed chicken T-cell line | 1 | ******************** |
| neuroretina cells infected by RAV-1 (Rous associated virus) | 1 | ******************** |
| AEV-transformed erythroblasts | 1 | ******************** |
| A6-C1 | 1 | ******************** |
| HD-11 | 1 | ******************** |
| TBM 18-23 | 1 | ******************** |
| Q8 | 1 | ******************** |
| BM-2 | 1 | ******************** |
| lymphoblastoid cell line MSB-1 | 1 | ******************** |
| Xenopus XTC cell line | 1 | ******************** |
| clonal B line 1B10 | 1 | ******************** |
| REV-transformed T cell | 1 | ******************** |
| G5S | 1 | ******************** |
| NHE-deficient cell line AP-1 | 1 | ******************** |
| HD11-macrophage | 1 | ******************** |
| PSM | 1 | ******************** |
| 0 | 1 | ******************** |
| 15B1 | 1 | ******************** |
| embryo fibroblast, DF-1 | 1 | ******************** |
| G-B1 | 1 | ******************** |
| ZF-L | 1 | ******************** |
| DU249 | 1 | ******************** |
| MSB-1; DU249; DT40 | 1 | ******************** |
| BM2 (AMV-transformed myeloblasts) | 1 | ******************** |
| B3/6 | 1 | ******************** |
| QCl-3 | 1 | ******************** |
| HD-3 | 1 | ******************** |
| VSW | 1 | ******************** |
| CEF 7-2 | 1 | ******************** |
| TS32.4 | 1 | ******************** |
| TS32.32 | 1 | ******************** |
| Macrophage | 1 | ******************** |
| germline | 1 | ******************** |
| C-32 | 1 | ******************** |
| RTG2 | 1 | ******************** |
| Cu-2, RP-9 | 1 | ******************** |
| RTS-11 | 1 | ******************** |
| G14D | 1 | ******************** |
| PLHC-1 | 1 | ******************** |
| OU-2 | 1 | ******************** |
| MQ-NCSU | 1 | ******************** |
| RTS11 | 1 | ******************** |
| 1G8 | 1 | ******************** |
| SJD.1 | 1 | ******************** |
| D11/RTG-2 | 1 | ******************** |
| RTH-149 | 1 | ******************** |
| 6C2 | 1 | ******************** |
| Barramundi Brain (BB) | 1 | ******************** |
| IAH C line | 1 | ******************** |
| CB | 1 | ******************** |
| 42TA; macrophage-like cell line | 1 | ******************** |
| C-Li21 | 1 | ******************** |
| SP-49, KOCL-33, KOCL-45 | 1 | ******************** |
| glioblastoma | 1 | ******************** |
| GBC4 | 1 | ******************** |
| TGK | 1 | ******************** |
| K-1 | 1 | ******************** |
| ESK-4 | 1 | ******************** |
| MPK | 1 | ******************** |
| MPK; SK-RST; ST | 1 | ******************** |
| PT-K75 | 1 | ******************** |
| SK-RST | 1 | ******************** |
| ST | 1 | ******************** |
| ESK-4; ST | 1 | ******************** |
| MPK; ST | 1 | ******************** |
| ESK-4; PT-K75; SK-RST | 1 | ******************** |
| PC-1.0 | 1 | ******************** |
| embryonic | 1 | ******************** |
| TRAMP-C2 (transgenic adenocarcinoma of mouse prostate (TRAMP)-derived transplantable tumor cell line C2) | 1 | ******************** |
| T-cell line RL-5 | 1 | ******************** |
| UT-M1 | 1 | ******************** |
| TB2 | 1 | ******************** |
| BoMAC | 1 | ******************** |
| MAC-T | 1 | ******************** |
| ATCC CRL-1803 | 1 | ******************** |
| Se4 | 1 | ******************** |
| infected bovine cell line TaA288 | 1 | ******************** |
| infected ovine cell line TaAS | 1 | ******************** |
| infected bovine cell line TpM803 | 1 | ******************** |
| FHM | 1 | ******************** |
| MDCK2 | 1 | ******************** |
| BCEC-1 | 1 | ******************** |
| NHI-3T3 2.2 | 1 | ******************** |
| Neuro-2a | 1 | ******************** |
| MP 183L | 1 | ******************** |
| 22Rv1 | 1 | ******************** |
| hybridoma; spleen cells fused with non-secretor myeloma cells X63-Ag8.653 | 1 | ******************** |
| L17 | 1 | ******************** |
| 2G2 | 1 | ******************** |
| HaCaT keratinocyte | 1 | ******************** |
| CX-2 colon carcinoma | 1 | ******************** |
| LX-1 lung carcinoma | 1 | ******************** |
| 030D | 1 | ******************** |
| SW840 | 1 | ******************** |
| BLZ-211 | 1 | ******************** |
| GK-2 | 1 | ******************** |
| Clone 15 HL-60 | 1 | ******************** |
| CAPAN-1 | 1 | ******************** |
| SUP-T11 | 1 | ******************** |
| porcine kidney PK15 | 1 | ******************** |
| human diploid fibroblast (HDF) | 1 | ******************** |
| hybridoma 1F1 | 1 | ******************** |
| hybridoma 1I20 | 1 | ******************** |
| hybridoma 2B12 | 1 | ******************** |
| hybridoma RSVG8 | 1 | ******************** |
| B-lymphoblast | 1 | ******************** |
| IDP2 | 1 | ******************** |
| PBL C1 | 1 | ******************** |
| AT5B1 | 1 | ******************** |
| 4F8/B11 | 1 | ******************** |
| AT3F | 1 | ******************** |
| MCF7/ADR | 1 | ******************** |
| 2102Ep.2A6 | 1 | ******************** |
| UVSC | 1 | ******************** |
| BM-MSC | 1 | ******************** |
| BM-MSC 1819 | 1 | ******************** |
| UVSC-AD_AS | 1 | ******************** |
| 3D9 hybridoma | 1 | ******************** |
| MKN7 | 1 | ******************** |
| MIP101 | 1 | ******************** |
| MIP/5FU | 1 | ******************** |
| RKO/5FU | 1 | ******************** |
| RKO | 1 | ******************** |
| HCT116/5FU | 1 | ******************** |
| ECA2 (a line of embryonal carcinoma cells) | 1 | ******************** |
| Mm9707(R77) | 1 | ******************** |
| Jx13 | 1 | ******************** |
| murine hydridoma | 1 | ******************** |
| dual-restricted T-cell hybridoma 7 | 1 | ******************** |
| hybridoma 1A11E11 | 1 | ******************** |
| RIN-m5F | 1 | ******************** |
| PH28 CD4(+) diphtheria toxoid-specific T cell line | 1 | ******************** |
| hybridoma H6-3C4 (cell fusion of mouse myeloma NS1 cells and human peripheral blood lymphocytes) | 1 | ******************** |
| RNK16 | 1 | ******************** |
| N27 | 1 | ******************** |
| hybridoma 4D20 | 1 | ******************** |
| hybridoma 2D1 | 1 | ******************** |
| hybridoma A3E6 | 1 | ******************** |
| heterohybridoma 4G2 | 1 | ******************** |
| MDA-MB231 | 1 | ******************** |
| RWPE-1 | 1 | ******************** |
| LAZ 166 | 1 | ******************** |
| EBV 383 | 1 | ******************** |
| cervical cancer cell HeLa MR | 1 | ******************** |
| KAT-18 | 1 | ******************** |
| ALMC1 | 1 | ******************** |
| RF-1983; rheumatic factor producing EBV transformed lymphoblastoid cell line | 1 | ******************** |
| immortalised B-lymphocytes | 1 | ******************** |
| 6B6C-1 | 1 | ******************** |
| NS1-B lymphocyte | 1 | ******************** |
| 76NTERT | 1 | ******************** |
| PK15A | 1 | ******************** |
| HRF29 | 1 | ******************** |
| YT cells | 1 | ******************** |
| WEHI 274.1 | 1 | ******************** |
| ALVA-31 | 1 | ******************** |
| BY-2 cell | 1 | ******************** |
| NS1 | 1 | ******************** |
| LASTD teratocarcinoma | 1 | ******************** |
| Conditionally immortalized mouse podocytes (MPC5) | 1 | ******************** |
| RB778 | 1 | ******************** |
| embryonic stem cell 366.4 | 1 | ******************** |
| renal clear cell carcinoma Caki-1 | 1 | ******************** |
| HSCj-009 | 1 | ******************** |
| NP69 | 1 | ******************** |
| LOR17 | 1 | ******************** |
| R83 | 1 | ******************** |
| Mm9416 | 1 | ******************** |
| 90120 | 1 | ******************** |
| Mm9275 | 1 | ******************** |
| Mm9922 | 1 | ******************** |
| 91010 | 1 | ******************** |
| R319 | 1 | ******************** |
| R377 | 1 | ******************** |
| R212 | 1 | ******************** |
| 96063 | 1 | ******************** |
| R234 | 1 | ******************** |
| R248 | 1 | ******************** |
| R282 | 1 | ******************** |
| 95014 | 1 | ******************** |
| R220 | 1 | ******************** |
| 90088 | 1 | ******************** |
| R417 | 1 | ******************** |
| 90030 | 1 | ******************** |
| R312 | 1 | ******************** |
| R237 | 1 | ******************** |
| R159 | 1 | ******************** |
| R189 | 1 | ******************** |
| 89075 | 1 | ******************** |
| R343 | 1 | ******************** |
| R261 | 1 | ******************** |
| R241 | 1 | ******************** |
| 89002 | 1 | ******************** |
| R71 | 1 | ******************** |
| R430 | 1 | ******************** |
| R246 | 1 | ******************** |
| R398 | 1 | ******************** |
| R257 | 1 | ******************** |
| A249 | 1 | ******************** |
| RAW 264.7, BALB/c derived | 1 | ******************** |
| GM10826B hybrid cell line | 1 | ******************** |
| GM13139 hybrid cell line | 1 | ******************** |
| GM10253A hybrid cell line | 1 | ******************** |
| GM11580 hybrid cell line | 1 | ******************** |
| GM10611A hybrid cell line | 1 | ******************** |
| GM11418 hybrid cell line | 1 | ******************** |
| RJ.83.1FT16 hybrid cell line | 1 | ******************** |
| HY.137K hybrid cell line | 1 | ******************** |
| GM10449A hybrid cell line | 1 | ******************** |
| GM13140 hybrid cell line | 1 | ******************** |
| HY.136C and GM06317A hybrid cell lines | 1 | ******************** |
| DS19-sc9 | 1 | ******************** |
| MEL-179 | 1 | ******************** |
| 2BZ | 1 | ******************** |
| P991 | 1 | ******************** |
| NCF | 1 | ******************** |
| ATCC CCL-34 (MDCK) | 1 | ******************** |
| CT1258 | 1 | ******************** |
| MTH 53A | 1 | ******************** |
| MTH 52C | 1 | ******************** |
| ZMTH 3 | 1 | ******************** |
| Li-14 | 1 | ******************** |
| MCF 7 | 1 | ******************** |
| opossum kidney cells (OK-P) | 1 | ******************** |
| #17 | 1 | ******************** |
| Mm9426 | 1 | ******************** |
| R440 | 1 | ******************** |
| R77 | 1 | ******************** |
| R333 | 1 | ******************** |
| FHK78 | 1 | ******************** |
| C9.1 | 1 | ******************** |
| Py4.1 | 1 | ******************** |
| embryogenic line AFO 541 | 1 | ******************** |
| 2.4G2 hybridoma | 1 | ******************** |
| NIAS-Bm-aff3 | 1 | ******************** |
| Y8 | 1 | ******************** |
| hybridoma RAC 18 | 1 | ******************** |
| C4-2B | 1 | ******************** |
| 4065 | 1 | ******************** |
| 96091 | 1 | ******************** |
| 4064 | 1 | ******************** |
| 94045 | 1 | ******************** |
| 9313 | 1 | ******************** |
| 97002 | 1 | ******************** |
| 4049 | 1 | ******************** |
| 98022 | 1 | ******************** |
| 4052 | 1 | ******************** |
| wild type | 1 | ******************** |